var title_f6_56_7040="TTE two ASDs";
var content_f6_56_7040=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/80448/asdcdop2_conv.mp4?title=TTE+two+ASDs\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transthoracic echocardiogram with color Doppler showing two atrial septal defects",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 273px; height: 236px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Two-dimensional echocardiogram (parasternal short axis view at the level of the aortic valve) with color flow Doppler shows significant left to right atrial flow through two atrial septal defects.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7040=[""].join("\n");
var outline_f6_56_7040=null;
var title_f6_56_7041="PDA color Doppler echo III";
var content_f6_56_7041=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76785&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76785&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Color doppler echocardiograph of patent ductus arteriosus from suprasternal notch view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 408px; height: 326px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The two-dimensional echocardiogram, with color Doppler, recorded at the suprasternal notch view, demonstrates a patent ductus arteriosus coursing between the descending aorta and pulmonary artery (arrow).",
"    <div class=\"footnotes\">",
"     LA: left atrium; PA: pulmonary artery; DAo: descending thoracic aorta.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Doyle, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7041=[""].join("\n");
var outline_f6_56_7041=null;
var title_f6_56_7042="Cavernous transformation PV CT";
var content_f6_56_7042=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F51167&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F51167&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cavernous transformation of portal vein thrombosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 387px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Contrast-enhanced CT scan of the upper abdomen in a 45-year-old male alcoholic demonstrates multiple periportal collateral vessels (small arrows) which have developed secondary to chronic portal vein thrombosis. The portal vein thrombosed due to chronic pancreatitis; a small pancreatic pseudocyst is seen in the body of the pancreas (large arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7042=[""].join("\n");
var outline_f6_56_7042=null;
var title_f6_56_7043="Brown widow";
var content_f6_56_7043=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F79607&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F79607&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Brown widow",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 293px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard S Vetter, MS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7043=[""].join("\n");
var outline_f6_56_7043=null;
var title_f6_56_7044="Capreomycin: Patient drug information";
var content_f6_56_7044=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Capreomycin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/59/11189?source=see_link\">",
"     see \"Capreomycin: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F145236\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Capastat&reg; Sulfate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10029030\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700773",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause kidney function to get worse and hearing loss. This drug has not been fully studied in women who are pregnant and children. Talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692117",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat TB (tuberculosis).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029031\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to capreomycin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029036\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697256",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have hearing loss, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029037\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698395",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Kidney function that gets worse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697961",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in hearing may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029039\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698616",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in hearing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698630",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cloudy or pink-red urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029034\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695976",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle or vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10029035\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10029040\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029041\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11309 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-218.28.111.102-E73EFF4BA8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7044=[""].join("\n");
var outline_f6_56_7044=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F145236\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029030\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029032\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029031\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029036\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029037\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029039\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029034\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029035\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029040\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029041\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?10/59/11189?source=related_link\">",
"      Capreomycin: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_56_7045="Atopic dermatitis antecubit";
var content_f6_56_7045=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F57982&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F57982&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Atopic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDWSENKGkmPHP3SMH2FMeKSQYYLvXqBwMfWrc0g3qUAZ9uORk/lUFyR5e3ClXGGAJ4+lcFz1rNFN4Ec9XGBgZJIxUsCiEeVMuHHo3JBq/aNGoYBN5x1cZGfU1BcXB++YVBzhWPelpuO1yWMwoyxxEnKnd3P51IpAX92AUPPzdfYHvVa3hM7ZizvKl13Hbn/AApiW0pZTMWkDfwv1H19armYuUsFBIZHOUORwwzvH9KY8Pk3JOADgbkJ5p6x8AbmiUHDDB6f406SVUmBI83b6jkjFG40rEZSacIgI3udy/NjA9M9qtwQoSuYykkfGR1GPTtUQ+zhSYDjcdpCjJJ/pUiyCBN8eAWP3WHJHvTQWL8EAebEgZ1bncgwM4z+dVruOC1cJE7CMtuf6nqcetWVucQrGRFK/U/MRg1XwhUuyEkdc5+U9/8A9dNuw0hsdtEkIc4VMjJTpjtj0qa3C7flZmz2Iwd3v7c050Ux4JXBy4APA9BUas8sWBI8agjqnBNZt2LUSbyT5odkBVlJI7HB/qadFDtEYUkbTknPAHPykDpQC0axuQCoILAgfd96h8zZM3kIdsnO/GPqSPfpRzFJEiSw78DaPM+bnJx7+9MBWSRcKuAuWzwf/r1FHA0ihZVZUVsHLYA9PqOtSwyi3mLTQiTBLeYw6egx6Gp5myuUTiJCiHIbneeMev8AhiqTrcKVKEIH4VVAOB6Vb8+OVA+QWkAACnIXJ7D0qZAocOwD4JC5G3n1A/Kk9RxVtSGJVJkd3csfuoSSD0HH1q5E6JLIkmPkJ3bySc4/p0pohRI2VTwBwcdAaZEkgMpR8hm+bgjPIOf0xTTsNpMXykKyBQjSMd4KjJGQP1xUSReY0CTKyoFLsW7+gP8AnvTrSQTXJhtn3Mg81iSR9AePXtTxHJs3RAvKSSVfJyT29utLRj1IIE33Xl4DsDvO3gE+hNS3duDIiK6/LxlWzjuT7c1HZwSNIGld924B9pOWHf3xVy7SCOOLyAQG/eBmXBAzyPxprVag1rYzY9LF3ZPCyb1IHmbjhSe+cfWoFtIbe7JjibfFCkPJ3AKoIHPpWzNGkcH3yXb5ipA4z9PwrIkt4ZhI4WNE+6Iwx/Ok4rexcb7HOyzpLcxE25kChgJMfLnPY/1FanhTS3s5LmQvIzzYw5+bb6CrN3a+RKGKoq/LsjAJA9+vStxf3dwQhbavGCduF6Y/OoUVzXe51qfucq6mJdKYm2hlELcYKn8Rio7yILbyRXfy287YdY15YYGADz15+la119jjtpVuRulPzKQeM9BnHPvXO3l5HdSxxx7GMa4yM5B9fSnKxgr30F0+Fo7aUackag5wNwJPtiuisJboxTnETnGSCeA3fPsKXS7SKGHzG8xkwSm1uATnjpVlYVleOKSNtjEgoBnHHHP4VSpuKuiZVL7obblU85pzHncFYRE/NgYPvjv1qxaoyOJAqxIQVQgDaSRnp9D3p1raRzZO6NcPtjMuPmznnHeroOIpQgaY8uo2bVXHHJzxnPpWkU2YSkthghmedi2XlZdw/h5xxnpUMgUMjIwcrgFVPyg54ye/4VOzSHDu7TO6FRkcY9v0/KntapCBKGC7lyAOTx368d6rl7GdysWLeb5h+VXIXjhjnGTUMoiaQxB3b5QxOM4P+fpWnLA6q6JH87yDIGT74IA9Kjmt0WTEwJ3jopH8+3H8qHF2BNFLcUeKEKwldeW7JnPP8/zqKJYVuo28xUkXKhQeT9euKvMhcL8yklsE5xioPsyrIsqk7d2eFwT7VDbHZCx4ChWw7jJ+gP8AOkmtxIABw7HHGD37/jWgY1CoqkAPn5QMkj29qhiiDsm0Lx2PT6Yq15ktJlV7QDd0cg4bPH1pYo9sZ2EYB45x/PFSyROVAGNx42jH9OlLFAFXBb6f7Io6isiCOJQD1wxyBjp6D9KHhDbw3zcY46CrajhumQc9wBUiwrKuWYEsN3HamLlRjC13zFEUgKcjI4PtnvTFs90kiLwgbLMRwfYVtLEglMbBj6baa4ZZV2qcL19cegHr70WEzFt9MCI0UMYXJwT7f1rJ1XwjpGoOftthbSsflLeWM/pXZyWjBF3OFz1Ocgf41E1ovlu+9i3YEgcU1KUdmRKEZKzR5FqPwn8PzgtCtza5OBsbj6gGuZv/AINzpuOn6iHz90Tpj+Ve+KBIpzGD23DpUYhZsYjUDuWrWOMqx+0c88HTl0OU+zEy+ZuYZ5JU8intaSYjljKhHJDbxyR/Q06zlAkZCBh84YcYPvUiXJUeWF2uW2knPFcUWjuaGiKSNfkA3rjjI+aodjXQHmwhgDg7MZx7+/0q2H80Zf5Sq4AUZ3expslpG6OqsyO5wZATx/tD/CnsFhtlOMoiwmTAyccdO4PtSxkRzDcEVpDlXPb3PtRFCgycfK3IGcZUd8+pq0sUao7xKMkAZYZAP/6qfMw5UVfIPnn98pzllUtkn3NV3UurBhksPlLHgAdx61ZuDExaWQE7iBuwAOnP/wCupbMC5mRFiMwAIBJGD7UnK41FGajJCixlRtBHzMBlvXb61dO+OJ3cMI2G1HAyae1sLhnB2lACELdF9qnaHdKhUHauQpKYGcd/frVJvYfKkVL1RZQwuejbVJI+9nsR7+tOM+TgtsU+hyD9DVjU5f3kRZYrsJy6ZIBHuPSqEEVwHMptxIruxQq2FUYHAHtn8qUtHYqMb7l+KZJDvJ8pSMcjBb3HvU8KFFxGhBLFmIGMdOeaIoinlROpD7M8dO/HvUU9yIJNqOo2kLuznOe1Q3bcai3sRXsskQcMpJYYGMbjg8/pVqEmVUbaDheWIB49xUCzSXTbIwGgV8mTd3q7albeKSKHYWI5UDgA+9NbmnLpawyRFedmUsSAFYMc+5A9KZIBMDkMQQFKjoOfai4ms4hHJdAxqr8biF+Y9xz096YGlUOgRjG+fLZfmD+ppNoahoOtrOGzQJBgQqCE7gNnk+oqYRS/Z2eVip6klSMnPb8KkRCbJd6MzkEMAMZC9Oe31qG2lM8jyZYxKMKsi8YJx/PFF0FmK8jALGN+x0IEuR09h9c80WsZayYpLIxlOMMDuA9aZpNobRLmFikheR2xuHyhT+gqzC6hmEJVkJGBvK8n/wCsKa7ia1sibTkt7ezNqiorvIrSN1aXjHPP1qvOiLKQqhFyHdIyQT6UsLsqzOqRnPzI24dAfTjmksZUkDTTTSPvKjGDhP8APtTck9Bcm7Dzn2ojROB93zFX5uTyCfTFRywD5XdPMXplmyApPXFTXMiLI778qCfmYHg475/zzWVHdMgNuVadnJ3Ssdu3npzn1rKUraM1hTb2NO0WWQAlSuc4yoOMdOtVYo3gZ2kZRubPC53fWraLO1oZniMIjB2gnPTvWQLn7ZAJljYbPmJYY4HOab2RUYbss7RI/nFMITkebkj6AZ7Yqnrt5LHamUq3k+WWLFSMc8Dpn2qzFdBJI4AkkruSTEp+YZHOD2x1x3qvq6MVcStIYijIhDYUPwRx6dahS00NIrVJnM6trkMjC1RGa5f5WdScZI6c96tafBLFEUuZJNoYfIZMDOO/86o6jZKL2FYUQ3cnzP5ZIBx1/l1p2oNFpkTi0S3mvW+YK78EgcnJ4rFTavKR0VKcJJRgbMniaxikksvPVxEMvhh+7UAH5u2au+HfEdjqd8IdOuow1su9m3ADngZJHT6etcTe6ZJcW8kt5CkSECS4SJcD7vPPbPFc3okskHia3mSFoSGDeWCfu5yBz1UD1603iZQfvLQ0pYGFVO26Pf4fLgBeO4QsWAEhXcBxngdePU06MCS1f9zIULD95ISuT1zjoB071y99rv2i/Fvb7hMnzsXYAKAMcDHIrVsdSiYC1e4kku3GVTORnHHJ49+O1dsa0NkefUwskr2NMPCdojhUyMAGVDkgEdvzzVkHyZIWj8tI0GdpIVj7dM49q5dpU+3w38V8VWPiRMMyE9CF455Hauj+1q3l2lvJ8zLkAR4J6HjuPenCopXMZ0eWxPafaZPLSTzRu3MdqktwMDccDmrFtal5hPIsZhyAEKE4H1zyScen41CI3zHGWX93IrAEZJOeR16GriBRve3jbOcgDgc9h27Vukc00BhKzM0mwxhiuduG59B2qY2aKIgVOEPzE9eeBjikBWSM75UTcwdV3HsTnp1NSJcRNNIijJ3AhiMgjPPA/lVWRk79CpcWpgkYJJuKtjgc/h+dRuI4tqkPvQljjHGeBz/StO6eLbOQm4hdw3nao9//AK1Z7kPsAJ2kESPtzwOgGO9RJWHGTsVXdoR5RUAlQWyPz49ajUneGIUKvAKgkn8TVzy1IikQ5L8uG+7UPlPKqqu0NJnACk8eorJ8xpdDWZQgZnZiM5APQ9s/4UKTntyN3PBpttayR3Do5Y8ZVgOhHUCpDHKFUbisZH3iOtCv1G7DpCEUEbiOmWOPy9aVhncCBuAznPI+lQru3sHLMc9AuABRMhK42qMD5eQfw+tO9xcq2HMWf5WOD14aopJCY2yoOD0HOPakeI7GEuOx5zwKhdHWX5JCI9pBQLwfQ57flSuLlJ43BBjXfu25+XjAoY7cjDjP8R5qBY5cNtAHGeBgmhXYMg+51JLdSaaaE0YaxxmQCPnYMkg5GR0qF41BdgX34+Y9Qf608ylmfaFDleoAyAelOtGcSfMjbiOHPOR/Osm+holYEhBReCXHAYD+pplwMxFSrKyNjjuMc81djgwMgAEkYz1HqKjlEfmrtOFxhge5z1oKK0EbqjAgsrLuUsTkGpssCyYXa42lsdPce9TlGLssC5YLlCcH8DSSLubZkBwmWUEdf6UrhYiztQxiIOpIB3DJ/D0qtcrIHZYMI33jlTkVpy/ugOEGCTk9Sf8ACqiFjK7qfn9G5yc9OtPyCPccmzyjhApBy6scbvwpYbjEckSOUjlYM43HkDocmq88jb3M4dwBmRlxtUY6Y/wpVYPDkIccDJByPajmtoiuS422SX7WZ5HPklT8u3P45/Crc/zBIFCujfvCckevH0prttClpUVgAoB71Ulk8qMvEVLEbQ2eM/zpXsWo3ZpxqI4dhZXZSSGzj8T39qz7uzhvrfcC8vO4NnA3nv8AoatbTNHGPMC5yVJON2D3FMa4zKUi3ZXjkdDnp6471LaasXFNPQihjO4xYVV2jkA9e5pEkiRk6Kw+Z8R53L2xinzIWgYyESSklnLDAwxznH8sUWsVyRIzIm7C7XHGV79+1Jt9CnrqySewh1CNDc7nYAn51IA9+vSnF4reezjiJRYkDMQM7ecZznB4/nSWyOm+ZwxkchFQ5wc9OO2R6Ux4ZlvpGZxbjavlMPvHrn+VF7a21Cy6sgvtVhXUoLdnbeclVMuBg9OM98cCr1zqUOntFbSzKm8jAfnPp0757e1Rvotpdut2lvDtjYM0ssZLEDnJJ75J6VLc2cdxcxKYEG8M7SEZ5PoPXFJOpqyv3eiZSW9jTz5DKh3A7XY4Vh2/DrWHrevOdAE/l+X8+5E3qVfnpnt2/OtebRo4nW3nuGaF1I/1eMc8jPrwOKo3nhezkvZGIkRmDMFyFUEj07nHrWc1V6G1P2MZXZxOpfEC6jaN3gt/LCqrsWJdenHGMYOT3JwK7fw5qWoxIG1JA6SBXgeJ93GSM4IzkjmsfU/h3Z3tyLma4aPozwGMFJGHGSAQcYHrXRyXNtY2i3MglMYPkpheEXoo57VMYTWs3qdNSVGUeWmtzSd1mZVJlEEiclhgrx0P5Cqtz5tscQxiaVVGwH+MdRz696mYJLC80wBDJuMQA64oiu5LtYGjj3QBBgtGF2gf5/St3uce3oI96GjxKd0xXLQjkMccgVFZsHi3W67Y3H7vcwb6fhWdr1i7vavbqxVHVSyEgK27Pr0966HTbOOJuIwIwSPkXAPPDE/0oi5N2ZU4xjTTT3MK00yWC4d52d1cq49V54OfapJpLycyi9iYxQ5CqOCyjHOOnfjvWvIo3Suy7o3XGzj8fwrOyo+0lyjA8Fs5G30NKNNR0Qe0ctWYlvZyvHcrMQXn+UEjHlp3BJ/D9au3Gixz6GY7iQssLHySpIZVxyDjrT7C2Wa7drgAwp1CnjOeCvXsBXSX0UaafJCVdg/ztsJ49SMUQpRluKVWSkrHBXCPPGLOydsuvzHPJX05zgil0jwXFFfrNC7wSb97KcucgZ27iec+tbWlxTwX6SqIiQxIUnGAeOPSumstNUyC7EhOPlGD8owCPz9frT9jGpuOWIlSb5XY5pLFP7RvZ5BtklRhnH3F7jHqTg59qbp9nHLZvp1rcyOQpcy9CW7gf7IGPatKcpNfzK6EBcruCn5h9ff+tXNJ8iBjblEEznnLZIXJxjH4VHs05W6FutLlK2mWBZIleCJU27SB1G3tnoBx171FeCbDG1uYv9HlLSRQgnep6LuPPWti4jE0DRtvMYByeePTI71nSWyRR5jD+WTgbmA3kj0Hv61bhbQwjUu7s5fUPEbaNb/ark/8TBvu2zsCgwccEfXp1rttN1hr20aIBl2Ha6xqcBh745NZGi+GnlvL1NcjjmhaUSWwVBhB+OOc811DRCaGMGRwpJI8sbXZuvIqqMKlr307FYmdH4Ute5GZVCAXKhiucBm9/wD61WLi/it/LQzx28cqqEZTlmJ5x65qjMZYol2QlJSDGvOWwCMfzrnNftLy4vdHFnI0AMpiygLhD1JJxkfnVTrSgtFdnPToRqvV2R6Hbw+dsD8AjDbFx15zUEroofIJKyA4z0PPJqxap5MHygySKQu3HBNE0bFZSEBbO75uQxHfHsc11taHn394rso3PLCflXbtAyQKiMAhlDFy5yWLDryentUg2wI6BSyyMcADOecn3AzQXjTLyHfld6luucdAKytc0REIFVBw4CSZ+Y47VM5G6QP0B3BR/KpJmVgzKoz8r4B+/wCuKhQM8mGITIKjcc4/xo20He5BEDsDEMHZNxXcCA3cZ9qMmLZsTJwSWWpQoWIHb/H8pPrRHGibhgMignb9e+KnUbtuUokfc8Up85g5Jw3ReoB/CllCRq5yCWPb26Vaki2sWdiVOQFHP+fxqMoA55XbgAIAOD71LTQFeOBHk3szYPJ4zmop1jRWUFyQMk56+/0q26w5IBJbdyetRyKoG1R0XBx15oewHPxMrtlHzjjIHAPv6VMAS6+Y6FlGDjrilt9/lbGxljnPHFQGU+YykYKnhuOSam5W5Jh3dtqBCeCynof6VEIWjkd3cPxgKp6/jUskTH51yFP3m6fMaqpAxuvNFxKIgNhiKgqx9c9ahsuKJ7cbDkomYxz8x/DPNIxZliMasd/U46kH8e9SzxxxzecgVTjbtA5bHtTV/dKjPgMBu+bg9aa8x2JPMynlptcn746jC+9NeWOQnYr4Iyc45PtUQn84sZWLIN2FJx9eajYfuEk2qD2yS2R6ccUx8qJxBDGjH+8S3tn3FK++O4QjBKLy6t1zz2ot4m8+3lGAgO5RjAOPfvSRxbZPnZ2ZyWd+AoI7ClYaGXe4zIHc4OGII6+lOS3yRJIsZxkgDOCOwxVuaTzI0BZSpPQj7vpyKI5BCYw6McdDkMFz345puKuK7QF2EDxlIi/KhmXBGfT3rNeKKORhvVZXHyy8ljxjitEyOMuzZU/MGP0rIt5DeahM8qSiON9iNjBYDk1MuiNIJ7lqGERRsryZlIBTLe3X9K0LacfZpmlKxyI20Hrz7evTFUIBIl88rMJkAwiYI56gY/EfrViSVIrO5mdimSjZ6kDPIxVR0FJDoRNOUIK7JBhVdcZUdz3HPSmWdlLGHcFGkZWxvfJUgkAe3H862LYRG2iuITAzyx4Zcc5/nxSbWEo2qrZ52d1wOu70z7VahsyefdIoXW6KAIdglRkYDdhXb1Pfg1ZhijlAuEkUPwSzLyVGAf8APtTboJKqq0SHaS/mA4O7rj6ZqexD/YmFxGwI5Kk8HvwaaXvE30KxiUsFdY5SSXUL/Fz1FQizjuBLJcRyJJJ84TOMMMYFXLVolC7ULqVUcNjGOv0qR4zb7znIY5Bbkjt1ocb7jcrOxnXFski7ZZWRmwCB09wccGkvLS3Ng0U6RmPjoNw45xilF0bjcoAiCttLoBj8feq7zK8uZElkIT94EPbGM9fpUWRom7liKNTbkPjygMKNvHpgdePaknhw2392AF+URMeB9KVJ3tpBFb5CsT8j9FwKc8jtFOWCkYwTu6g+mKGlYHJ3KM8ZlmMAlBCYwp4z+Jq3GGhCxuh+bIVR908Z5qrZxOD9olTJYdCowOfr7VoOUbG5WZjyMZ4/DNFhzlayHTxx28aEEMuCzv3PsPc1ihQxMhjY5yxXaRuH5c8Vtyri13O4LMcMoOMViSGOJJDePtjcZVmYkD04HP0xTaHGV0S6IiKirbs2xm5Oc47n8M/pUmv3KW0Lbnlwy4/djjd2/rUWjRSQxFFjUYwowmCB2/GptUcFsyKyhTnlc549D05pRV0NfHczNIMcUyIQSJXBDOu0seTwcmunknAgeKLYYgQAqfwg9T+nTvWTp0Q2xvuEkiZfeRjnp+dXYmaSSM7vmYljtGA3PvRFNJk1Gm7kaRtBuZFd9zEo56A4/wD1Vk2VnPb64rqZAGQlzjg8fd/PP5VvqwKqFxIzOd5dx8vHAx2HFMeLaPMVsg5OE5zjjr2qHTUrFU6zjfzJrFcoobHzZ3Ajrx3NNkw90UhMhi67yM/h07Gp4ZSImCIuR8+ScKPXI/rTJhLHa7EAjmClxkdc+5rVrSyMlLUSPybiIIm8bXG5nUckAZ+vNP1a8SwjaSSEunJwqEqMDjcR93p1qJ7Ez2pS3LQkNlSnqCO9XmtGkaMNJuH3eT8xwOw/+tTjzPYTcU9SxZIjhLhWCowDDHOQf8iq8suGVIN3yuTz1Py4zgdOlWEVLeVIShVAVTJycn6DtzUM9ugQLI8wPmFzglQc8DmradrIxTXNccl2YIwqoryTYZXbBwT2XPU+9MkvUgdJJJVJZtp3Eks3TH1+lKlhGbqOcbxgAEKA3bHfnnPpUV/pAmhgEglBjkDlQRxyPWpbqKOg4+z5tepdDLO0e5SyqNuSOvvSiYJ0QuN+N+Nxxjp7Uz7QjpLHMvlqMBeASeeCad5ck4g38Bnw3HA/L61aZm1bRis7m7WQKUjcmNgO2KY5MSjewDFlOM4yOn+RVmO3BaRmlVEVsby3PX3pWEaPISHf5/vex7jNFr6k8yuUmkUuziM8YRctkZJxTy/z7sMiucYx36fj2p7GMR7VXkNvXAwcYxk1NIQzElGICgqWPf1xxml1G9ehC8BdEdpY3dhjLc4/KoWiCouI97YDljxj8KtRjy0TjG8nLHpjmoJ5RAqCQgknYCD70PuEXrYhYEFw5xjjg8c+lOmUbwI0GR0A4zT2+XOTuYHZ1557/lTJSI1O9BuU7TjOfr+FTaxRyrv5bjPzHH3QOv4062aJEZjgjOenAPTAqSRpFVY/K4dcl1I59sU75/KfcqDskecdPrWT0NbaDJ9hlPz/ACxjdnOB649KZlY2WYJ8v3VJOOT9etSJ5TSgxgDfgEg4yRSKrCQFtzKM9D+ZFK2pSfQdDB5zKpBzjAwmef8AClI3Y8w73YkjHC1GsjbJJSwBP3MYHBP/AOupDEkjwpvbYBgsePw561Qh8m5kRUKjIBYAfeOaj8vzGTcwGWwDtxUEIbzX3suNxAwMn64PQVblSIpH8qhlBUHdyT9Pp6ULUewKm5hIVMeTgKGPIHcVLO37ouCvOMNtyCfaqv2cp5IdDFGQG3dSD1qzuYCFJo1cMdxCHaeemB26Ug66CiNyY1CqAFzuznBpxZTtQKiyEklgcEe1LEDKTgIpY9MgnGTTUiV2TcN0jj7uOQM8H0oGVL2IyYWQ7Fzgsh5HfHt70QHyo1aKR22kBTjoeeB7/WpdRQT6eTjAxhgeN/PX1pbdNgHyKeQDs6k44ND0Zpe8SRVWdBLsw4jI2nO4EDj8fWnQNK8c8R2NGuVG9c54Gcn0qeUeZIGxIfLwNobGPxqjAssM0xnyEwQuQMlR1HHXrT2IWqH2s0MkqMGV2jwMq2CWIyQAPQdqtJiOG4mjVmCgcNnCk8AD2zUNnaLCzyNEyxyjdyAWTnJx6f8A16eGIItwMq0xbJbg4+7/AFNVHRajlZvQfbq9zCsgi3eZJlwr8qAOP8Ks3byRpOkTH90Mhj2JPTHeoom8hfs8KsVaTc7n0xkgH8P1q5M7/YZmWNSdgeRMbflyOT/WrWxk3Z+RQitZY1hAQBwMMCSAT1NLcSefGIDy0g2A/wB7IznjrVqPy3jclQEPOQMg5B6frVa4kaJI2YjAGAGXpxgYH1xRy22C7bIrYs4jeREEjgbTjAI7kD29/Wq7xRQ3Up+di/yptAUdCfp3/lV21mVI2d8g52hc5yM9fWmyScMiEEucv5gGd2e1ILu7IvsKxCHeTlmBwy5GG4HSpzEUhIAUlTkcc4z1qztdSq4XKEAEAnPrzTHkJh2opWM4OGGDT5USm2ZTQTJ8igOrHAOMAn168nNMYNDMzqx3BhyT+BxV+NJZHzLskKZOAwGB65FIUPLqqlycMueAfrWUl1NObXUqahdvJEI4FjSTO4k/xYPXioNUEdwIIY8QAKpwVBI+YZwfz/OraQJ5PmTNwG43YADeg9ehqO0uolsrxZnjBZSAp5bDemR0z3p6vTuaKSSulsXbPdHlvMHzH5iFH8v61SunDRzCV2XcNhbnueMj8Ks6UYZYkjkcoHwFxwcVVv3ja5k2NG+M5IXO48j+lF/dM4/EQWyyQW+2dxk4KgHqeMfnVqGcmVVEflmIEcHPPp7d6jV43tQpjIkYZByABj/9VQWCAwBVcNxyxP8AIVOySRo9TXSGJwSojVwFG1RuJweR2ps1wjloQzpLtOTjk9unT9aW0KLMwjI3SD0GePbtVmOJjLNJtULOp44BGSOntWsV2Mm7MgtyztIVUSIqBvlXapOcYH61fCzFYsxOjCLaAQCVHOOvvVCDdLqPlYl+zjAZgTuwOpHvmpRPm5MSMQqZ7HcQcdfzppkNNskldW8kROqygc7DuPX2+lEPnF533MVK7hubb39e2akh8u3kUsVb5vlXqD2z6im2TAJJkgAkZ54xnoKfmMmjkMbbtoK5EpGM5zSRx5S4WXdllPMh6gdMUz7VsCwxOHZxtDY5xn+nNPllja5bavyt8z5AOOP05o5lYnlfYrQX72sBN+GYqo3MrEkrzzt9qmtNVt7xiIJPMQICVzkDvySOtRy+Wwt9w4wDkKAeD/kVFaaTaQahJd8KZlYsC5I5PoelTeaaS2NOWm03Lc0J0DKnlkKCCDs5AyT3/KpSstxAIWAwmXPOM/iO9SxTkqixRDyyPlJbJFO86WSdNqosRHzZ4JI65rWyRzNvawxrd0eQIFKkLJtHOfyomCYk3oNhZVwGwM5qe6cNbhSN0hUBVXt9ajuYWYFXTKjpjkEj+WKGt7Exd9yC4jVco25mwd3YnngH2pwVTIjKNgxtY5zjjtVp5V2SfutuFBIPUH1zVWechZQScHlccHP1pO3ccW2JIzmLaQo52jPJ9/pVR9pkDcvtblWPoOelTuu7e+3cWUcZP6n86Y0qxCR5NkaKpLFyABxjP0qGzRaCwKsUrM2dwG4DHTJpk21XchRjIGd3GPSljTyso23n+6eBnnNV3lyiFSxUZB+v40ubQLXMO7VCXHvnIGc5/QVVtxmSQ78jGQnU1ZMw+zBSZVRhnK5GSegNMjwrkKUUqMNkZIz2OOayep0JWH5eGVVZhkHCnocUO4SEtGCihTgg9TVaTezosi55JGOc/Q9adIhRhGx4lAByOn4/1ov2Dl7ioz3EFtujiKEb2Y53Lj/9dWLeKT91JEm/ALkcsD+NRxW+xkjhkLRbQow2cD065qxEzpM0q4I+7tJz2P5VS8xS8iOK2LKkk685yzZztA9vyqVkYKMJs3PlQRuP1HtTo7jEAQoSzHl8ZA/GmzMYpVYhvnXhcDr7etF7bEJk8j5g+ZdzHAPGR+nSiDAkTC7So29hnjsaba4KyfKgGQFc9+PTt3q4uEgYNhiuApPzE5PT600r6sL9CJAhmdWULgYIjbkf/X9qYI4gwMbtvCklWAHHQ5/Sp0t1AZxtAPOE5596piJoMzM+CTztXPfih3tsNW7jJldlO1WyMYXopx0P5D9abGrPhhkkEsDjOf1pZDMWw2HkjPZe35/zq/aARnJUYC7gCM7T61KV2aN2WhTu/KuIljPmIwwwI6gjnOT/ACqxAsclpF5Yd1U4yRyze9AljIjVXCYyxUnAPX2+tNE0ayQiJV25J4HU9qq+t2StrIsMHSFIyAz5LMe+fT8qgAHDFA5++R155pWv/LRcL84c8kjGMU0SGNHISQE/KBnPJPSi6Y7NFhdxMTTDbEn/AI8DjgipEKlBCRlpRsbIyAvJ/H6VWEgj2LtkznbkDOc84HtxRHcwp5YjlIHISNDxjux/HirTRLVy9JH5UAcBdi42YHTPUmql15e6UEyfMAuGHQnkn8Ks2dzmMBYl2qwBLHCnr2rP+0+bPAs5WMgjzCe/P8qcpKxMU9RzGZS4d0YA5wRx+XrUjxYkHlxGMbgI2IznHXn1z2qS6ljheTDNuH8Qx8x9ajt5TJ9wEYHOevt/WpemlwtpchW6I+YqzAZIboR6jFTxSfabZ4xk4GA2T83f/wDVUVwrM7MvyF2yG7E45GKFj22+7cV4xkHGD9KSTvYrSxHGHR4hE5aVCcKQBn5TUkcki2yMoQorqpAbpz6ewqO1eKKVUkUl0POOMn1HpVqUwQKrYWUqRkZ7Ht0ot1E3rYpX2wLEsqllVy+AcbiTx9MVSvbgRo6xxuEGQCcdecjp+VSSh7m7CrNs3HcrEc4+neoBaGVmCSSSlGyD0HI7+uT0/Gk4tlqy3JdPk8mQK43MBjH4cnn0q9dRrPaLNFiND8u7aPTkfWoItjyKzPzEQGGCQDjOKnvblPsbrtO/eGUBMAHGDihJWsydZNWMWeIRkRqPnb+IuOe/8q0LVfLtjFGAQOFAyR06VmwIJLgK+Wck/KegJHGc1qxQgPK+3A2YAz39wPes7am09NC5bzRWwJmbaVO1g2BxjFIjyzp5aOkcUXC46DPUk1myMrTL5wGJBuLDBHsDWkqeTb4dCRJkjHbHr+dbRdyHGxCkqNFu8190eDjByxHTn04q5cTzlZGwEjPLHqz8etZwmR4IlVwE2ttLgbhzV9ZBLb7ZCxYYx6H65o30FKKWo2O3YuhiO0soYSHAH3u3496mvpVKTIrt+8PdeD7ZqtbLPJc2jLt2RRcIBkYyeuKuXMQdVUtlxL93HbH3fbNJarQV9dStDzHA7KPLLHnANWUQOg28fMMgL29z9e9Oht9qIVZSC+QGxlBnkU5G4kikTesrYXe2OMHk01G24nK+wzyC6QPvE0RySg9M+/WrbpIihZcZ3AN5mfmznp9KZp7S2UcMUaKoVeC/PGTSXMmx2kUREq2UDNnI6nFVpYybk2FjBHbWpgQtsR95Ifnr6CrMQEYJJyA4MYkGMZPP6VCkzsHAMZUkksBt+v0qSJijOZNzD+Y+tNWRMrvVklw2xpvmIXhtwBOaWG4LSwuu4jGNinIH0qPekrKrB0AZshyWB49KZDd+VsVWUnLMOfuihtXDlurW1J4IzNH5bKckcBzzx6k0yTY0gAVWZUAGRle/50gIljjk37pHU5I7enNV5h5e0uNxbCrznP8AhUyYJK4q5ET7jiQEDb169c+lQzLFeWk9vcqskLgBkYAhh3B9akbY0xyodc7to4XHvSuyxSq6oFG35ioAzUbmliOKC1toWtLddsSLsSOMk4GM81Gq4L7TiNwOcZH0okkD3AcfeXOSOD1oP7yKNFyQhxuHrSHZoxJogIVMqA/3QhxkfhTfszqiy84ZiFVj19adjy2dwzyKo2qCMnHp0/WrETxzSIpJATP3gSMnnp68VNk9C22VRGzXByEyMbdr8r+FOaBnYYkYZ+ZgSOlTnPlZJXzMlhvUggelQMPNiKgSRHdtQb8496drDv1IoI3CSSNtBUgKYuSfrxUqO8UgeRPJEhzhGIAH0qQpJaxxMz7gFJI/vH3BqdoFvolkKLGV5zyPy/xp8vTqJtXuVpS8d1EUkDBwcKCAB9R61NcZYo6u5UDc2xDkHscYxUdxEfL8pGCOBnI+YDn245qSO5eGIMxIO3gBcgEcYxjpzSWmjFa6uhFljkEMbq5kZufm9TwSO38qduOcybRg4wGx+WOKYXjmQ+aN+1eCEwzEnjHT/Ip0kUaQLMSrjdzkc9yB1603d6lJJEkU/kKVO4sW3MevB7foKel00MgT91vU+YFxnBIqodyROxVkeRt2A3Y8Z+ntTL22WCVIVfzIwFDFhgHd060K7Q+RN2Fspf30rzAeZk8+o9cfjVgSRj7ZLvbbj5AW65qsYmIXGFaJVYBecjkA5704J5TeTleX+cnuev8ASpu0PlT2Ip77yJQVVXby8nMny7SO+elTQSSNFE2xo1PUkDBPfBpZoEkudu2Nbdl2nHc8cZP1rV1YLHb29v5e0hN0g/ug/wD1quMHK7E5JWS6mbcfOI0iyFDKQwxjt1rQJmeFUumG4ksoX5iw789KzQTHG8aqgyCUVgCzD+97dqdo90ZotpPECmNWfK/MDzwemelEWlK3ccleN10NLyw6fum2jGOnQdvxqsHVpTIsZcbiCQBjaO2Pr3q3cNJAkvUiE4IIG7AGf1qjY3Mlzb7gGTByygYC+gq5WvYzjqrhqDS4hhthIS7Bd+cd/wDPNRyq28AYZwfmOMgj2q3tla62NbBo4/40OCCcYx75NPtFLXDRSlTKON5YDJ7duelJxGpJIqPCs85LKVIHG8YwMe/0q5BuHLsHJXK4+UYquSJLqcTFmydvXp9KkFvJ9mdoy7KD91jzj1H40kKS01IpbpAQmw8LngcqT2o89PssyM3zSPgc9eO9L9lDzODtTOPk6ZI988VHdllDqAuVUHC8VV2tRO3QjjtyIxOrI/z7PLPBHuOelSXahrxhuSNFw6twVOTgkc9vemzRtaqWSVnjO4kE9SBz9PrTmSXEnkSjb5Z5YDHbPFKKtoTq3cyLi9dZpQIY3jiYkTlMZzkYOO2PT1qDTzc+Tbm6VgzEKWwOCAQPoKLryJI3NwdgPISMYK7T3BHcntU9hIlw7EokzAjr0YjPQeuKTWupq9EaVrAiq0MincS2WL5wfUjtzxUd0j3DOhUk7Rjgjn0/HGat2gDR3B/1ayFgvy5L9DmqV7c7Vb5+QRjBxsXke+Tn2quVIzi3fQpXKvA6FNpYqDvYdfx71P8Aa5JIkYIquBjOe+euKy5EWaWDdPIQVBbcMleOM/rW9a2a2zboyuBjKDHP/wCus1G7Nm7LURbYrdIxX5tin5uvSrtxcq0Ch4GdwCQARgH602co8oac4GcuP7vYVYBXEccKBQowSBnPuK0XWxm5dWVERmigmVFiY5AXAJJzyCDSx7o55UTOzaoHzZJ9e1KjKk4b59wUsMfwgZ4xViHD741UlsLIC3Xpzz+NNWByAqoeCJiQQMFeQAAcnkfWoyS9xm3wVRCDuPyk+o9Pxq2BGdPjVFVmdmVv4iV4xk+veqZ2yOIoMK6EEk42n0A96GTF3LlvKwjgDKfMJIUqRzgc/X2p0CySKWCpnIHspHv9KhAdU3FgpU8uMjAJ/TNTW0Ba2KNKAMM5VQeeRgfzpoT2G3TmLEav5mOpBIyT1qOGO4bEz7ScD5/QDqPYiiSHzriOVjHhym4g+nf2qxGFHl+UQ22XJ5wB7fT+dTa71FstCzHLHvkjXeVfhgvVeOpPuabEzAgFvutg8kYyOuarb3bOIVCbyWAIGeevvVq2tY3iIVykci52878j8fer30I0W4wETqjbSqqN5YcAjocVBNuCnChVRGyQOSO1TXCCJ2D/ADReSGwD93J9aa91DJGoVGLtCFJJ4z0yKzklsy4t9CKFyBHIFZFVePzpkk3mECQ7drHA6/lSSSHcqlSxiIxnoB/WoJXISQsGD7s8YrJ6GyiSrEx8wKxwg4OTmlkV2lUPyg+Xpnk4qATqzMFVicj5mHB9qsSOqyPgYYttbA5ppJg00W2WPzjHJiJWBVvl7jvgVEZv3SLGcOQyLkZP1x2qlc3SLcBoQ2dx3u53fL0JxUTSXCY2AgYJVycZzjjir5lsiFSfUz5jBG7FncJgDBPFL50W5SsZ2EHac9fyq3sDhRt5wTxx/M1DLEZIgYlC7OcBcMc+lZarUtdhqSB13HGxc9zk1JbhDcySHO9iAAVA49aZJAzeSqhgp5LHGSfpmmW6ks7EjAJOH4H+OKabuh2T2J3dZEZ4osqBjcGzjOOMetNjLzqiJFhcZTI2kev1zUMIeNZVhWMhmGMcLuJq1aRtJKjSEB0ypLLxjPQE80+ZsJJIYqMZAdpSbAJBPUdMY9Kt7UKOAoBXpz1yOf8A9VVnW4wznax27VJPGOmB6/WnKsqW4+QgHGe+M/8A6qa00JYsbIkUarEu4ksX7g44I+vtROX2k7Y8Lno3X8KgLpBE5bewIwY4+TkdcZ71ODGAFQyMCMgyDv1GfSldvcrlSJFkURMJIeVHyk88D1Iqg0iyM2xyQTuAGDj/AOtVi4Ty1O5U2rk5ztyw64P0qvHatJIXU7GwBs7D6eoobdrFRStclitmjljd2IQxlDxxk1dSBvM8zAkJHQYyOeoqIxLHdoSCE270ZslPTGPXjNSSyB0UgokhGQByAOePf8aI2WpMpNsilkFxIA6hSzHJcHaMdPaob27lC7HiZgMIwZs8j6/WnSWzzxGOEhGA3AFs8dhURunLBnVtx++eMA+lDk0XGC3RJHbfvsbmkxhwE7gdvpUkjiGMRhXfe+87htK569BUQIiZ1UFHTDN5QyGXPT65q3K7M+1FKRjjc3rgZHB69qqLVroTZMJvJZWyrBV2ySMT82PX2FVYC0qRnaiBzjh/pz9KfOkk1su+byiF+6pJwc4/yTSWMbvDK8ojBHX5eD9CKrmZmkkrkuq7I/LiQJKXI5VuhXAH5nBqXTkjUKJFAkJO5WfgVBdXDw+XExkzwxGBj2H0p0YR7eR9ig4O8YI2n39qG1cLWirlhkD3K+aAEUN82Oc8Yz7dakeJVj3JtMYbnbkYHeobfc1oxxK3c549sDPXHFRxzzrKijdJHgZXHTA44x1NUmk7vqTZ9CG+VkHCgxgglx1JzjgntSw2jS3czKyo4bLDZwRnqPQdammaZ43EkMSylGXbkYbnPA7kU63YRsFly6sCS6HG45yP07c9KLK5L+EbPZkwkjJkVgGZOehPGPoKy9eRotPxFl9kqo6sdhJ684x0PcVuKxMYiWSc/aDncBjbgcknA9KzL6M3dr8uQ53OU39uw59v5VWmxMW7nOQRedeNtcIxYKoxkDuevUk46Vo2KvFODEoMbjDKW+YL2x+dSzeWIh5u4FmAfABx0GR6Dgj8KeEt/tw8tmSMqAkZXsOS2fr2+tZtNGkqly1b4iRFl2NskKtz1U/yrBu4lhvPlcfZ0XfvK8bix2jjrnNbl0i3AaJ32srBSe7DHb9R+NZd0rAyR+Yy7T5SRbuMgggY+lU1ZChLUhtbe4WPfLIMyfKwONwGePw+ta1o5eSdWYr86g/LkAnjBNZ+nwTXrzKwO8feTcAAex/L+daOmxS29zISoJdhwB/Ooj0KlK+5ejhV/NzwcbScgjr60pjyjLE4CxrvQ7fw/wAaWFvKdh5UcZYfePA65/Oh2C2+wqq7Bzz1+taGVyKdEk2SlQWjG9GwQFOR6HnrVJGnZS7NMCrAsoA+bnv7VLIVKx7iQIycBTnHPXipriSIuqwE+Yu0byT8wzk9e9Zt3Noqxa3zrEqxIqhmO3zDn3qK3ebEiB+M/cXkjHvTbhDvO9WfY+flbhsn37A08TxLCzGNFkAwPm4UA9OPaqb1uRZW2LVxIQCzGEKNoLNxjPqO9QM+xpcS79rY3BTwPpUdtFFPcLtCpGzBlVgWPHv27U8SiEMpaUz552gDB9elDd9QslohLnP2iPYIgn3XZsjPpwOOfWrcO1ElnlzsBzHhO/IAxVORYzcFolIDEH96eAOKbdMvnl4y6pnYxLHAHJBBqbtajaukkaCSQrcRGKYCN/3mQeg28n86gil8s27LuG1m2uGznOe1U4kV5o42WRtgGNxGe/P61otaiNYvKCIC4w7AcH0/GjmbJcVHcS6iEVhGr5kTftf5hnHUfQ1A8sCSqXw4kh2rt/hHTH8qjlkkaGRFR3dm3KmOBzzioQCiRFUEgV8Y/rzUuV9i4RsiUSrIkbsGWI4Rstjn2z+FZ/mW32mQyiQptKfKc4bpzVPTmFxPM80bvCAFVGOPKfPGOxzir2o2kv2GSOBRFcOV3DoeOfz/AKVlrJXRukk7NhD5ciRiMSvIQRjHBHXr9K0IpDC05wu2UKAG7iooJQtqVkUrPGQyqerZGDz6VYkVWcYXJ2fd64Iqvh1REuxnXrqJVLSR7sE+WcDj1xUNjeTMm+3EXkGRirQyE70wOSfXOelZ15bXul63qF6dNmvYbmOPbNblS8YHVMEjg9ePxqTw/ZSW8F1JLALSK5ujMlvkHylKgYJHAPBJA9aTugUubQ1P3jLjHTOATgkntz1pQGKkllLbuVx09ahwEkQOM7SMSEhmHbr24rQhHm8sc7j97NNa6EkD4QZUqkiADk85qrOzulxkKOCBvU4xn0/rV2V1ctub5w3JIznHtUfkZLvFiPHzbievPamxXsVXRPLRNzhCobaOOfYGlvmcoiI4Plj5sYLH8KldVaXkggKST2yfU03kfcAJXG3GBlaNSl3FBb7PFGSyP2AHUHnFWEXzbny/NkEWzOODyOp/z61FM0e6LdAxYHcWUcknpUcUyxFlZXkLg5IXt1FUnrqSIu+NbicltoHUNjaOBxVnckU0L7TIrDKgH8+O5qvEI54sK2HIO7JwDg8YFW/syoMIzrj5zknHQ/rmhJ9Bt9yvdXG5GEZHQqAw4PHJ/GodKmMcseMFwCCx7ev0onthcM5a5Vo0UHZkcGmRzMu4ZUAA4YqQD6nNS73LVuWxpNPLDE0zKvmAHdFnnJzjH5VTkd0bKx42jKkgHt3qSKbzElVyCg28knLD1B9OetQJLm5/eNtJzuRW4I55Hp9KbRMYssae+6KSSFx+9THXlTTYQBKWbcEkIZUAz1x+tNhzERMSGJPRueMelPhtkVlCDcWJYDf36/hSvokaNLVmlGCi7BOvljIZimc9fyqvaRyCFiohMTfM5Py846Y/AVB9pKR+WYXDEfKGO4EN1z70+3lJld/Kh3BOgcYZvy61omtDFppFueGN7cAxJ8w2s4475/mBTmARVERTIB2g9OarzzzI0cckEihlChiw4xyf0qJnUusRDRFvmXbkZA9fTODVSZKTsJdWiSKzu2RuACqSc5ycD3qxHFCoLTuo4yVwRt9Mnpk1QjlVpI2C7HQkkglhweuMdc0/5pi+yco8mSCoK5/+v2qLpPYtptblsRlEHlyjaGLYIz09KbbeayqwdAo5+b5ep7+vNPSX7QzYHlqE4BZeO2P/AK1Okzj96iO4BOGADc9O9WyNU7Ma6nyxHIN5YL93nHTp7f8A16bJJGEkNxH5axHCAN90gcgfhxSnzTAGtVjzkt856DH161XeaaSJFlEZDAgsJeRnoxH1pt6CaIpLqW4tJ10/czs6xRQrISW4JIIqfVXjtb57J2lzEIlmKpyRgE89vvVnaBYy6fqMV8Q8vkyBwF6t2JwegxWjqMkt5e6hcA7ppRxsPCqBjAHc0oXavLcmek7R2/Ux7csZ7p55JWi3F42wMBgSeueRg/pV8q7x7n3eZKq5RowVzjB57VnWsHmP5csW2M/KVR8DjgZ4/WtT5lzt2+VGR1OQMDrk8nNCdxz3Il3u5aAhpIiCqlckEEAH25rLuhO981uWBcHepCEkt3JP58Vf1WR4jIrNFvGWdk+Vj0646DmsDz4ZcA3O24UkBUyNvfdv9OtN7WKjHqa1vJFA4ySrdwyjnnvjr0zVyNrjYot2SVvQDqAc1nkWzxZnYTu4BWNNxyemc9M1qW/7u3+bKEjIUduMY4FSk2S7E+7ykDMpLNg5Azz+NLcLI1mwRZBu6Hjr+VQIGjgjLRlZCwb96SeN316YzT5bgusqMcDAwFbnAPB/WqEkR28TLE+d67BhzuC56YOO9NuYUaFiVllIwQYz938xTLlliYl5pgSvCIOB79OabFOm6LHmMw6K54HvjNZOyNUnYs6cJ3BIz5m3B3yDkZzjHerMpjhv4me1BT7u3OcHqc+vFVoZfKgEssUYKtkE9hnoCOnepZAGt5JZSu0SE42gYXPGaqMrCadyY3MizlljjRFfKIgHr1qOK6t7i5kjBAlbac7AwOM8+5zmq2JmSF1KNGsuMMR82eBz2HTms+xtvK1OSYPv5IYE5VTnI/CplJ3Vi4wi07m1fyILiZGI8sLxtAAKnFUxIrtInnM+Cv8ADjHXrirEsefMllnjEbhfmX0zUZt5d5aGMncN3c8djmiSd7iVkie0VBJA0qnhfvbvT69at2kjbI/NVCgbIyOh7H/61Zjl1aFzn5PlyR1wcZ5qe7lFll2AMqnoRyM98Hr9KIu2rE0paDryTNzH5jyDczZIbBAGP61VWQSqsxJwjj5BgEj61Xd/OlnndA0kRLgEdyBirRR47OQ28zLHtXaFUZ5+9Ut3ZekUQSosaXjwo8hLBztHIweF/WtO+lkkWOTdhiQGUDGOOQaoTxKzyx27S+YUBclvvHjp7YpskDfZ2ZGUxpNy4ye3vUXaukOyepZtiQ48yQkbWXaVyfw+tIxYQphwrock57HsKZ++e9CeWzM4bIJHOB2p8VsstlNBLPJHMYThhjIPtxSV2Da3Oa1WezuNeu016G/uYESNbcwxSOiDbyPl755zWn4ej06TTJjpu+3jMhYpJG6sxGOfm5xjFRvoN0IWeLXdVKKV3fvFwOP92r1pYSaZbPG93c3UpJIkmYE8gYAwBgVo3damUVZ6aCyl1dGUFjkcrgj3qWCbaxyeQ2AGGP8A61KZDlFWTcQdxHoKekhyDL0ByMjvUpa3L3Q2WYSzMzZ3ZyABgYqWZAscgAJBII9fxNQNDI6Bjg87jgYp8kzCZ44GKqxG0lMgcZI4ql5ksaNx8yUltpXaTxx61GkgeX7sakKBucAZxS2z7t3KvglSpO0/iKkcPCkWShjbkhjzmnbS4J20HPmSUxRKHZiNzLjv6VXigghixJGy7Rl+TjI9AO/tVvzVeWJmtlcMPmZWA2nFV4g8MbowXy+zA8DPQDNFg1GyQ74kePcoOVbIzjngfjTRNKAwchVLfdLYx/nFSLlbeNlCpsc4Qgt9CeelNns5IvMD+TKckgZOMHqRjnvRZ9Ck+jK6vvuP3sLFQh5bgZp74SaJl8rA+URscHB7+9MWIpIplLqFIBw24MSPT0qZJVNy80oR1ULuZ4yP/wBdTqW2PmDm5WVk3nngkHg9x6AVWmtZkWRg8gcdyowT/wDqPFVdNSaHVbrzSDE2QvUAgj5c/rWisqy3cwR/lUKqkdPQnHrVK0ldjd4uyISvlSGH7QQzgYVlxkYqxBgKPPUShuCG4wT0H4YpJ442m80zLJICAo2bmBJ7EfSnqzbyHhSSMnODndn1IoUWmK90MjMn2UwxxyKq8eYH3Jxz+NRRC7l+cQBNgChdnVQeD0pL0JcQMYvNidGBwjYxjkjH0qeznbepM87YyRmM5I+vSq3FtG6J7XErMksccKoAyup4OcjB7+hqRyiedIiGSWP5sEBgR65rNkup7gqIWk2BsFyuPmzyMEc1oGYQIN4nitmP3ioOcjjJ9OtUnfQmUbMrfaY2EyRx+VvQlMKR26e/Wm+Y620kYMhibKMVH+sxWeWWS9Co24N8q7OCD6+lWbFnt5FtpAMKcFAp4b69OalO7KaSRZtg0ajaJHxjc2AdhOck49u4q7dmNnV45hGUxw6deOMnn/JpLd5DJHiRYihyNrk8H+HBH86p6ndyJKJYmfcCOozjrx9RVW5dzPWUieMxllUfKeWIVgPoPp1qNxI6N5TFAOnlpnGD0z6VJbsdhYSEEjLKAp69D9al3tMhLlgQDhGQ9cdDg07cyIk7MqwyRBG+1Txhyp/dtJgk9s+9V57mOeFLaP5UABy56kHt3HWlubFrnaJXiZ8/N5kRO3A471n+c3mTW6oFKRiIFgCSWPGD2wAearVWGopu5Zt2UWxMgdkYkFSDzz1qW83pGishaPZ1JGceoyelZ08UqTpIjK0LnAQDk9s+3rxUTXTGRrZ2jIMmDhCMenJ69+lQtWHJd6A18sD3iRBRJ5LKGlYYGeMjnn+tRQ3NqtqsDxxq5jXbKyjzG9gR+HWqdwqZkla5WRCcI0QbHHPcAcYxUdteql5LFHlzFZGXe65Acn5WX+WfWiTaZ0Rp3WhvW7qsEU0c4jMhwCB932+vWr0EUio7tIjnaCX2n5R2IrC0tVQo100rSkGQK+FBJ6Ecc1pWszFHDRFwVGxySAvsfrQrbmM12LjOdqjZJKASNzHoAc9Pzp0ZEm6SQEO4+8W6fXmqcjXCqWjjMkbNjhsBR6D8asx7opFkFtCg5OCQ2OBnqc9s0Kz3Js0Rh3Ecm9EljUgKcYIHse9ZWo3/ANkeA28jKHUMflIAP5fhWk7yylCkjDknaAO59h0ongichS4Kc5JbHAzkDA4+tZzV9jWEuXcmWWDdGhlMsTgBsjbwOf601EWa6liSQvE6ktmM9uq9eR70yJI4GYLb25QhVB5fGAOmfrU8aHz32Ip2AEFUxgd/0qkriuQwRW3mSZHJ+4qgH5ehPHpS38vl2rpGnlKDvYqnJAwRzmmzytNtk+QbCQHJ2s3pwOtLdOLny1w3nB9it5ZEfPr60Oy2Dd6kWnaxM8O1QkURUOFdfUd8VcLNOo3XRVAOygZHOfyqJ7S4aWSdYrVZCAMOB1HoM8g9qdbzks8WPLURly6jjd6kjv1qVe1pDbjfQSGZFiRWkJjVd20jJxn9aYVRoZ/MYne4ZSwGPcD1pJLeOIOZg2SM5B+9wP8AGh1ZdvT5cEKWGMHjvUtPqUrbhGcM0mTkqg4GAPX8OO1akc6Bnjjbyz5YI38cjrx61mMGRsNMUMidDjgY9Kk3mQo7jzAkXWTI3cUJ2FJcxaDl1zNlYzGc7BgsB1z70yJw9t5TRuLSVgSoOcDoPek3sxt3OASjZjZsAnHbviqMlzM7weY0TpkpyOhzwOPShySBRbLvMZUCYoIpCFOeFUjtUtyheaXAGdowvY9OapWo81Jsxjyy2SxB4GcflWhGiur4cKxUFSe47ios5A3Yiurx7dZQzogVRISw27OnP0qtY3Et9cvOl3ay2UpBjCjO0Ywfmz1znPFc74i06S41K5RTbi3vWgDSzSgMqIcmMKeTkgdPxq3oUEsc9xJIsdvHcXRYRRkFETAGBjucEmm7onc6K6DRRRt8pUt9cVAJnIk+To2CA39KizI8hOGKR85H8dP88KGGxiCDkHBOfWtNNwRZhkKxyhT8hPAVPT3qGS8ZZtgWPLLxtBYH689fak88ttAZfLHJRmx2xVS3lezgvGQBmaTCoTu8vI5NFwSuaCXrIkWwb3Q5Gwcn1GO9JOVuoFfIxn0ycDoPWm2TJPNnMmdoIJwP1pbgJJHJGVASM9CduWz1561Sd0S0k7EsxDJhEDD2659DTVjXdEsmRGxyVDfh07VXm327TGNFOSHyxyv0AoEziZVb94ufl+THOM/j1pPe5SRYiRggYlQCT8gfGB6HFTSsIpBhDGqqCpPzYFV4AZMRyxEZJDFY8EcZFOYlpI2RnKAHPTr0pvQl7lS8kUSxNb7cbT8+MnPfPpT1mk2EpGwBADtnGT69OKZLGIgSR8wAPlnoT6rj6iiGSMExzcMpyzBWz06GpL0sTyXKxoskzZAXaF80sMH+RANV5JZFzGxVoj80Z4OM9s9xVie1jeOCRxJ+8JCoAULe1NWFIUcS2suTkAjPrgmqs7gnHclRkjgVpITtznKbeD2PJ9T6UjRyGNoszLK/VwNvPr0p8+RGkaW7KEQEMQvOfcnNRJ5dwI5Yti3O37uThkHHT1p9LCTvqRQyROxbz5JflYcpu3kcGpJTJ5pAjJk2ghEyOMenrVyK23JtVFjCI2FMZJJbPIOemarruNu4UeVJkb89xjoOevvTatZA5Jsm8yJCVmgO8kAHzAARz6dDg0+RYVbbNC5U8gCTPbp1461Qi+zzJM3mSyR7iNoQbmxUCx/6QJJZbl4pSN6FcDOOvT29qblYSiT/ANm24VSqzR87t8RDce3vinQ2LzSRNCcopAjWRiN35D3qNow4Xarknrt3AL7jnAOKms41LxKWkEQ4Uq+0Y/HP61CsEr2uR2/yTPvV1kztKgnGB0AzS3dzJ5flqn7qQEdcDI9T6fyqw0UXlyPIArIoEe0Agj8ByfesrUL0BYFVyYmy3+qwBk4GccEVWydwi+Zl6xigkERLKzBSSTnbkDI46Gp3It4ZHBUxnhuuQfz9utUwxMJSG6eLYDuKKVzx6/lU9uYwx8/y54z1OTnHfIpxehnLcazBWtywiaWdCjuzBgx5w2fTisC8vI45mhZIdyna20AE884OeRkdfer2rLZ741TdG4k34TDbeOo9B+FZcVnI7iQzM+VGxEyNoJ4B59BRNtKxcLLUvwz4jQyNmOQELjDEeg+tVZYrgsZbeEYVSSSmNmT6evFXo1eNEBUK55wOvPuT+NMuoke5ENrI7OAecb269MZ9AeKmCe7BSSZkX5u0igQyo28FdxBwOOPbP0qLVhZoALXEirAiyP5rR7mA6HAyQOw9c1LDCt5cxz3FxtIBVCVyNrcFwPYf/Wqx9msoZLjyWWeJV+VwRt68Hp15ptGqlyk2hTOBEYI43MXCrycDnqSK3YDbLOiXU22NUJ4yxzg4zx68VWtEdIEaFkXd8uSeFA7nsc5qeeWNUZ5rnaSAf3RyAfp/9aqSsjGb5mMPlXUMa7nCgA5dDjPr2FRpHEjhYROQ5PBjIA56++ev0qeB7cW2C7FlwSpB+Y470jkeZEbaP5gpIwCTkjB9hxQJdickmIqBLHGzBFC/KHx1+nSq0c8cFwVjZomYHaw+Y479fqPzodPMRIwTLIhDqqrux9cn0zQ86RW/m7ZY33hWRoxhs9x/hUtgrIbdorIDCjzliu8uoO33x0HTP41aYCN3i2o1uFJfLYyeox+NJezQGJlInRigAPXn+HGOme9VFhlW1RI4TKN25mlfHfOKWid0UndDizB0jZkQSnOTjrjrVkAGCVLkAxJ8sZRec9eTjnHNUZIllRZ2ikEiMq7VfaFycZx6YrRiJUH/AFKPy2zOVfnIA59P88UrXYSK7QpDcpHJ5jIyfIS+3k9Dz6URzCN2RFfzOobqSc9Bjv8AWrE213jV2C7xwxUDB64JJ9KqyyQqkmVXy1cDI4z7E/nSlG2w07jpIpC+/wA7g7lIJB2gdM00xliilY8vHvJbljjoB6dKSVWBG1UaLaGUbCP1/r7VMLV5ESUJ+8U7d2egpWvoO/ciMQZiqoqy7c5RicYHfNRoLppcvnYI87k4APPH9aZIEImlZlaOXgLu+YD+lRxzyLJEAHztKop9ASOlRLzKXkTxQ5ltF3HcpL7gO/uarlJFPm7GWESdSM/jipLe1fy7eTc2VO8gAgsT/D05ApPJF2bkh54oYiHAc8k7sEZqeW9ilJIg0+SWR5dobZHvXAbj8q0xOXlKMXIRkHBPQ9atQw2Fo6zYZ5ckvHnAOe+frVaEwhJmd1jmZxuU88Z4xTUHGybIc1LVI5vxHCF1O7nmtJHUzW7xzJCXMYRvmTgZX196uaVbypHckWT2kVxI0sELAhlGByR2yQTj3rK1rUUOtahFdarcWcOIykaTmNZBj5mHbrxj8az9Nu7m21OwYahd3Ecs7Rr5kpYSwgZ8z8DxnvVyacbERTTudq0jxSCPy+WyCB6fWhZd9y6vInAG4Y5VTVeOV9qtsbaehAp6THBDh2U/eBAOD1FO7KJg293wxdRwNx4GfX3qFmE+/eiHOOCTknHfinJcymVxvAz3B59u1TmeYvtlCNL/AAsEyCBQgu0IkhjzjzPMLFeW/hx0H0NL5glTdIzFTjGZc4PfP4VCXlWUR53BzhmMeCB7Ypi3CBJNnkjB5QLg9enNFyt9TTjmT995yeYqJnCvkemeKqeWPNiZY2jtg3JHJx6Hmo1Z/OUR7XaXjywgwo9Pek2yzI6yq4jiOzAjxxgjn8qL6WFa2ppKIIhOw3xtIwADMSAFGKidUjtpCoDsApBTnGeKhgFuokV5JliAy64O4CnRNHuQiNY+AQzAjj1Pf2/Gqcrk2HNDE4bEeYowDvz933z/AJ4p0lmXTzwrGAn5Qr4OCPU9qq3DiOzdXkbkjaQ5UDPr6jtVmyuC8O4P5aY2L0z06c0K3UbTtdB56ecNoH7tQiqVXqSfmGT7gU6Nl+0DyQp2Ebi5yD3Pt+VK6qsrqjPkR5YADGSOv61FDCqqyCNih2HcVxgjORj8aG9RKxbbyY5EiMUUu4cbTgY6jP6023kjNwZERyVAw27A69AO1T3SkKVPyhjx8oPPb8qowyyNMPMZ1blSR91gM981TdmhLVGrO6Slg/mAqNwwST19vpVOO3nYzRJIiSF2KkqSOeR/PpUMGIBl7kOq52nzOg98e9NuLpNkLW0U7Mzop25+Ugc+v69qLpu7Eou9kM8me2Z4pLzZJ5gDsilhjPzfh/Kp9SaK7eJkmkeF8IQAQfb8vWrDIG+WdN5WMcSsOc9Tx+dV7m5aO4wyxiJDkRxbSpwOx7k0mkk+w73fmMlhWzby9/zwtl+Mj2PHt/Op5HU2z+VDGXIypZvlKnnjjkdqdeeTNKTBCyxlQ27zAeoGRxUfleXIiC3DOUyCWxkHPHWqdk2idWlfckiEgDSMZUSVSoCAY3ehwOPrXPHS3QMjIyM2P9Y+7H5cda6CWRoVhDR+fuDP5e/+6M4Hv0rPN0kl7G80YhzgbQwGD278Z4pPla1HG62I7KDy0kkcGbYSSDHjd0wRjvxzWnbpIkQ3ZT+IRHAJOeg4Hr61DaS/alVirFDuwQ3VvTr05qBIXlmVEWP5sKoB4P07CnGySZMtdyG7jS08y4MkmwjIX5Tng9eeOayYAonAhDDJB3PjOOxHX1rXv4Y2kjQpCk3lsBiMsxIJwSfXtWaqnazTKEC/KV5B2/game40tC4izxSO3zqEGHOMd+nIxVVbl2uoJ7hiVyGOMZj3dSOasTXVtLOYiVKFB5pYsSQO+M4rMH2W6MxzFCFf92ixZHHcnv0rVJJEaiwpYWFksElm4eUkuSCwPzHIxngj8qtWSrJBG1pbAMrfvMoMPgDgenrnrWJZxRyq0MnlhS5ZmZtvp6fWtiAiO2QQhCqjG87h3I61N76mjdjWmm/eMhiiXnhASR+VOiaONfnaOMEMrBI9xXPfHXFUAxjCNi3VHGG2g5JycYqxfSStLLIrbH4QhCQD09sdaVybFi3MSB3adxgABAoBHPr71WmkEc6mBZEyDxnAOfYfhzUzTltrBwRk7gFxk9i3v1qpKF80M1y0h8skhUHHPB256HmjbQuKVy6jTh3YuxeMbg5wSD/h6VD9m+R5C65YnBb5sj6dulVWW4SCfz5mkhLA7Vxux04I56Gr1tbwXKbnefbyqEMQRj29aQNcupKohjtommuFlZgF3R5U4buB6iq9zCRDNu+RHxgq2c9KuoYfLYpLKAC0aI0e4Djv+VVJrlVjaWaR3BPKshAJ/Lsf5U2rIlSC4McNn5UVvK0j4IKMQBjr3/Okt4kyOOW5ALHCjHAA7VHNhZvLkcsqAuQvJPufT0qawktmdS8ULqMqshzzx2qHZuxdrIFhdWQu7KSBjBBy3JoulzPeEs3myqPlIByR35IqG+ASCGSNTu3bePmGO/4/yp8Evlu7eZHjgE9+e2aVujG9rkpkT+zoZZN0hjYQlWbknr+Ap93Isl3E2Zdir+8Td/EfT9KiFw32eS2lyCrb2wwI9MfpmrSB3tbVUMkak4IL8MOxPvVbk7FK3thdWxVMDa21sKcg57H2H8qRGRL4rtB2INnU5I7/AIk1YjiaOOJgxLCQ5OQMZ9xUayBJ5E2BViYInX5ql6LUabInuH+yoxGHil+fI4BIzirSPgSxCHEkh80P6fLnH0qrI7GNIysed5wOnQd6jknRX8wFWfyuAVIPGeB7Zqb2Y+W+hK1yZElbMQ3kBSefc4ppZjcKrZCyFX4+n/66zfOM1shyFO49U6cfyq/DDIxVnLAeWCQRjn61nfmNFGyOb1xLma41Hy5IYrOyaJCjxCVj5hwX59M1f0HzV3x3UqzS2spj37AAAACAPbB6etQ3C3Nzrl1DDBYORCIpJLksS6sM4wONoP61NYWUtjZmJo7Vc5cfZyQpU9zuzk05WUSIp8xbSOAR4+aTZ8y9SR9akyCqgswHsSAKdtQXJJAO8YVcHFIqxK0xkLbywAUFumOO1bcpHMMtFkZnMrkjOBxwB+A5q3KQXBJKgc55GR6H6+lUi8iGRpGVVQ4CAkflU8bzq2/JEYU5Tp+OKSXQrcuht7ja6+Zjdy3SqzybHkzJtUjexxyT1Gc9RT3cbiY1cOh4ZhwOPY1LHPDMsSOqoM87iw/HmqSQk7FO5kaR4pm2EFtoG3H6DmiV2lmZBIEDEbginp05z1qW8nSC+iUpHLHLkM4YDHv7VbjaMRo6yvuY8opGP5UuW43Ir2zqbeYpHcpHG2Dz1I6n1xTry68q6VXWYLMADGZBkLnqB609Tci6uHa2nmQkMCZN24YxgA4wM1DcWsT6wlzKyzSRjAXYWGcH09jTadgTV9RL6QXOmuFiZSfuMshH4Z5qGFS8LpPE6beGDAHp6t3+tWrS2U2rRnPlqvLAevQEk1O1tKsMsrCSUq4TDP8Ad/8A10uVvUbmo6BbHYiozyFGHZRywGBn6AUuYlKSyIqyMcbWQZzyOnvSTR+SqNKoLtkZD+nQe1JCI9kb+SyAsQWzkbvXrRysnfUklkSK3flcEFSxTAHrx6/WrdnC6RjOCh+YKqHjJ547VSEm3ML7Cd+SpUc59PXpU9skitH5gERJ3EF8A9h39O1UiXsVnZlup1iZfNJP3FHy9hz6gdqdbz28ZaEPcXDlvmZlAxz0+vvQJVLSGMKGGMZAbcc+lOnncbo43fJHAKAtnuaEuoeQ5oDy8Dsu3A2kE8fp1piuJrk+ViEJ8oZl4B79+PrThcReW6TTqqkHdu6nPf2qG2EUpXYYpB1Ug8Ee9DS6DS01LpCyECaZJUHTDLjGB29zUUW95P8AVqvlgZIfJX8al0+xjR2WRbYF+QAOR26+veoRbwCZI1Tbyykpkj2Geh+tOSZOlxJIIbhN1ykJQPvjdpSDnPQ+2QKxbd3W7ljkgV2DEbAwx+f1reu1XyX2EAqBv7BhnOPrxVVJIjfHMTSbxjJPzH3OBjOewqZR01HF3TENrKElkAcShG/dxtxwM8gdOKNPcumVmYvxg8kj36VoCGBmDeWqszAbwxAGc8fzzUcEnkx2/wBnjCZyThMZHoWpqOwr3VitfzMZVaO5M0iDAGzHbv8AmaoQ77lHjkOxnBYvJ0GMk8D6HGOTV6e4kQOvmwlSvCh8dfqO+Kxomtb3Ubj7RboLiNsKDLgMmD/d9eCKHa9wUXbQtxQwyCUl42eTh9hBCp0ye4qmbBYC0zylEZum3CkYxwe30qlbP9njt7maGKOWVlgKgFXY+tbDwxxbRM0ySSjKxSLuXHI5HT6fSqumhuDTMy1sFjkCLJOwjwfk4weM5/wq9HbyS27kNN8r5U7c5HfPPSpEvnmFvIYJnnbbHJtODn2qZWePcQRGBhNjRHOexyOv/wBYUkkthSTKwiIG/ZIzpkKvQMAPTPrzTZXIl3lHkXYZHDuRt9B/9f2p9+8dxNDKVSSJScqzFdpwQcY74q6oR4ovs0jLclcEcsCM9yKTVws0iG3RlYCW3MLEZcAsxP1OOhyKgMVj58qrbkyAku3dc/w+/t7Vp2jFrXzBcbZ1IDKVJyckY447Zqm77nuJw6SK7fMUIGDjHpmh6IcdWye1jhitnEdvgKv3cANnIwAfxzVhLkRpKs0ZEanG4Bjg46fyqu0MNzA0ck4808xq5zz2z34q1DvMJSORQZCPmIyR6559qL9BNaalVZ2e4dbWRVyu5leLO4AfMAaZqNvLcW6/8sgzDbGR19f51YuVkiCiGQSQu+1mCEE5z79KJrjyrZcltzkHB54FF+jEu6M9XIutxi5Q4cuD84x9aitYJEnmczO8BKmKHACx8YOPXrUzSyLJuBbJBZSoHU0m4yW0bAHKseCR/j0rJu7N+Z2ECuijDPGxOCN/CjHUflSTQmSVCZgC45I5PbFWFBfziiHyyCfmHPT+XvTYQAVG1lCqcHP549c0bkuQskUm47n85iQCy0rmZw32gArEfkGSOM9KnClHtdrEF/4d2CT75qKLcbacD55CRuJJIA3Z4p9RepJInyqZU+X5WCgE59OaqXKO95cmR0JULJGnoRz0q5dRTwyRpOg+4MDAJHIIx19qVVaa+diGbcCoYkHYKlq407EUccb2p2oDJEnnMgB4J/8Ar1CnlqokKnAT5QT0yalQyC0klLgyZ8vBYZIz64qT7PD5kiMoRlQYJJO7Hrmi10LmsVZIUVSpBK78ZAH6U5DInmyIgfKEO2OevBI9elX2tSI5rhvmjDAqew+g9apyKwjuYopnUyxgK4+8GP8AEO1S1bcpTvschqcUX9tTHULG+uojErRSRoxWL1XgjOTWlo6QDS5o7axuLdcg7Zs5J9QCTxWlDoU+xQ2vX5bABXbGP6Vais47S2KS3k10zDdvmxke3y8YqpU3y7kRl72xmvcLBMVjQsCfvBuEH+eKniaIMT5pYtgsfMLZz6iqrzKJFCEbiABjH4dKZbytuMYJYg8nORj/APXW99SOly39ohEoEhwi8/eGOO3NWfLW4k3wRlzIcAE/KB25qtdRiWEReXHuU/Nu/iptnAqRKZ5UAQcqE+Xr65o6iVi3vkBZXRgMFSWA2n6Y71H5tvGsPmT7yzBRgfdP/wCqonCOssm0NE55jxt47fhTVjWN+Y5NoAQIh42Z44plJ2LU8lvY3jDzd+fm3njHoOR36ZpfON0kUigNIWO7a4+UY5HSobiH7aVUwyIMD5mX06AZ7fWp5I9jN9o2RKMKYlb26gDNCTvpsO6tqKrieWP9/wCQQ24RiMdM/wCNEUsSyzTmZBLJkIhjJyO/AqGYwxHFtEsU0in5imduemf/ANdQNPcS2W8TyPIhw+wcsuMHgc9qT3Gld6GmWMZx5blWC71WMAHA45PamK0ktzHjytxUoQ7/ACkf40gtpZbZG2Ofm3FyMAjsvJqZNpKLIu2TPUkYLen0oVwbSAjEW1Y08vPzOcDnHv0qudpDvEhChtxUsDjPYA/SrDq33Z5WQoQ3yoCMk1WuwY5THDGXaQg7jnjnuKTXYSaCG88yMpIwSQH5TkDrzn61OWClTviDnk8/w/QUsLTOuUjbC9GCj6ZzUylivnCNyQeSVAHsM/WhIdzKhmZLgsvlx72wCykAEHJHua0JLxJDEWlBQfIGAAIxTwXmiIQIdgyN2MkfjwTT7aO3cT/aYHfyzlSdoGMenXimosHJPUSKCNmlDFJAUZ1cxAl+x46YqnZ3Hmh5jbwJMXKRhhgjHGeOtaR2zoBFGUcgKDwfb+dULC0uH3HfG8zO3JAU8emOoGDTcbaBGSs7mi0E4j3l4VEWEY7uSW+tUZtSY3rWp8jzCS2xR1GOpPsKnkjjWRY/PGXkVTsUAhgPXByKzbpI49WcSSOkzEFioAJBHGSO1KTtsOCT3NyF5drG5SRd642KvBAHXPtWZd3AhctaXI807ZArrk8gc+5zmtJ5xGiM146sF+6VG1eO9ZUUtu2oxeXNJLcj7krNlv5YpyegoJu7sajyzW+medBhiw+YC3JGDwTgemaRLuHiTyyWX94xxnGDxx7kUjSJKmxTIqyFgd0hTOevXpTIdsUMgkZsmL5Szgkn+6DR0J6amRrUcgiju3Plo0by4BC7Dk/uz7/hzzWRbQ28skUrNEUUfwqQX464J5+nStS6TzLSNZH3R+Y3mREFgM/Mfl9B/dz603yIIUeOARzlzlkjUjd2Ax7HjFS0bx0hYrts+wylovMDHJ3R4AxgArjqR1HPHNKFt7oblEoNvh1Qsw39erEnioG0prnUo5Wt4ROEd1jY4BGDk59iKv6ZbAxuWhjjjc7NrAk7scj8geaqzJnZLQjjijubgzl9sKYcjflhzjj3xnn2qaW7gEhgEjqibmUIwbGPc/hUF5GrXGFURxiLMSKSfMPAx+WTUtqrYaMOADnAyBsb8elK3REva5Xa5KELb+azsAoYgY3Zz/StmK5fTtlwmC5Vtqlfv8ENz2x19DUDrazRzRyTTs6KQuMnDDr0/Gsy4V2WKKKR2lYFhlcEY5/+vSS5SrRnoy3dXzRJCxZi2zmTOAcc5IFT6Xc287AsytFPEJULHO1W6cHkdOaz7iJvLjaQFlO0ENj5uoPGeKsraBVh8qGVHVdgCYO1eg5znpUpvmKtFRsackOZWEkYOWONrADGev8A9am+bHD8jxxGNl+QF/nB/wDr1aihkUMYxtEi5CNg5IHr271XdN7OnnKgLLuwenp29avl6ox5r6Miu7oyWkoVk3BMGJsZyO349s1G1zFPYRTrsXKEE5Hr0/pUib0UqZ2dc5YhcjOcYziqbo1vIsE22RBnbtHCZ7e/FRK4JEiJO0ylhnA28MTjjpUUkbJEomj2cnoQCB+J61KZNrOUIIQDK7jk1FcT7nCKiDI7ZO4+vNTpbU0TLpnjt3kaOZYwV2qpbcCvHXHSq5CvseZSuQQuxeBz/hUhkWQyuYwny8KW4z7Y71RkvfKEKFcqSXb9536ChtPUSXYtCRPtyLtLsq7FGw5UDJBGfxp9tKsLuJZiBK/p09MH3pIZN0xYoVRY88N/j35qvcKRHCymYKnOAAxI6c0r2KSvobV5Osq7yr7mXjBySvB4wOKis7lIShXnB4Plk9fQ4qnpqySeX5RKKqZdsDgmrQjWGCNH3AqwZm68dyOeKvmb1IaUdBDchVG1/l3n5NuCGzweaPNDTGZkV3Aw5z90mqtyjSNJNCfL5CuQN2KftijMZuC7JsDSdR3+nPalq2J26FmTMtuw8sDyyMqDx9fei4tpzFOIDGskkR2ypyFJHoaz98UfzOHZZARxwW54PNDMVkaL5gGXntluKltJjUTmdWv7jTJUhu9cCXIUnCWYbr0yB0zirmiarLeWIb7Y90BLsWRotnQDjHei9spZtRuUgktkknSOZNzYZXQjt3U469qbpkJls5ryQ2ubm4Mu2F9yxjAHBxg5wSaUo3WgQvzWY5VEP74sqMuV3NglxjgnB4zU22MMWYKjdM5GT61TaUNE4DRmUAZVTn9cVNvdHLfZ4uVzywwT6muhLsYKRfiQlTAriRRkox9KSQnA+dWCnYYyPlU/WqEdyz3mw+SqEFSN/OfWmRXDfa2hlcMpkxgZ5A9fektii9GCYpWQPGT/AAqwHHT0qaNV2klnBC43YJwfQVFpkxmimUCTylYg7VP5EdqEZJJjJkKsXDD19M5NVbqK5fUxzIFkfDBcYVMc9s5NAZQ+VMbE4LFovu8dfesm+8hSXW3JL8gk4yeh71Opk3DY7nJywCj5BnA/DFF2O6sXGUxs8k84cMfu9M/iOKga1OySJriVyOV3OOp7jFRajczfbliNxC0BXqmMgD2Her4bMiP9pYAkjGSAfb60tylpqOhkKo0iSNwOVYtlj0AJ7fQUiSBkjSWBN+MkAtnPtmo4n2iRA8MkqnLgnO3PT8T61Isjpaq8mxXU/MjNzz3OOtGonuTRvsgRTEqfKOEUDH4k5qxMvnW8Bkydx54B5HPPPSs+a7f7RFI5C5B3cjIGRnP6elOM7fapVeNmwQVDp8pBH0/zxRsImeDdCvyLGASNqx81JbQpCXguHPl4I3FgcHsPrmoo5GRE+R8k7dhzhfcniq0lw8L7FYEEE46nGep569aLILstWsm15UQRLJwMfLk9hmnGaRCzM6fKO2SGP5fpUCGNrptpkZeMttztwMjJ9aUSXsmrIZmDWrRlY1dOcj2H9aGi7pllNR3hYlIL4xjGAvNRSzK8MbyHys5GE4x16+5qS58yVrSLdEivGfKUHG8Z657nio9kgaRFDAq2SN2QB2/HPem0xJrcliBmSWR13wj7jqoJJ6ZyB6VVuy631u8ABcLgHbyTgjk8+pqPTT88vzsVA3DIyCRngcVU1QSef9qkhaQnGSkjZGehwPoaiT0NY/Eb0t6PKkUOVx8v73AyfpisSzuVe9UNNCwQEttfAwc4BIHXjpWhEJJ0h8xcb+dw+8ePf+tQ2So05LIync2VU5IbOMn3ND1dzSnJJNBKxEru4V4B91pM8E85+vH60vnW1xIsLqFumbliflJ9uOK0ZLqRU3IjKh+Uo68oT3ArILStLJIE8tUyYztK5x94E/8A6qaXRGSdyW2uUHzRs7ptAZhGSd3PQ/T2qoL0PdSXMbTRsHLhDDjGe+Pw/WmLOYYYYt4kMjB8ZJUce5547UkUZKmW5GyTfzubOOeAB6f4079ENvuWHsCrQ3wkkllkJYmUYXaMqF68E8k/hSSFxGsQWHywpZVaXhSO5980ydDLPJcNJ8khwIhklgowDjPGMdqngt4JYmkW4k+Z9uxlA3cZ+XOeOmafoTJ23FMcMywNctGpjPDDGcngAfl0qeWyimUK9y4BDcMvXjPX6VCIUMp82ZWlKjyhHgEcHJwQPakMduuDMVdEPzSEY455FIRZhtZ0LxRFXjB/fOvHGDjrTWEazbrcFZAm4Pu6n0PHcZHFAQPER+9G0YV0k3dexqF2EQjkZpHA4K78gNzx0565xSbBblpIYA0W4qPlLgFCMH29u1DrgMwCME+RSyfMfT8Khd1kEK7GBIAB+936jmkhdyCCk28k7F253AH1NK4rF77TI2/5/KYZUgqcHAxn6f41BI0/yRu0Dwq24HZ/F1wT3FDOUV23sgc4yfvZpfKLRyGTcckf8tAAT34xzRdvQEkiSWVLi1lYiGMlsBQh6HuKqvsGxSNhHGVJ6dqlmt0WFmLZ6dSPmoeMW8g3RkkpnccZzjgdal3YKyK5md9zM0jEn7zdSM+n5U2eVoZhvDsAgyAQdvH/ANekit9yGQBNnQhWIw2fTNKZbeSFisjB3b25Oe+fpUNaFontZ40ZSxRQAQV288+pqvLHF5chk5IIC4HGM/4VO8YYRMzFiw52jAHP61HjywZJWGGysYJI6evv7U2NIkDRFdnm7V2gjzDgZJGcDtVwMoiVJgiyIODngj2wPSq7iC4YJABLkEA7sHpyBT2XdLCFH7tVUttYEn1xmmlYHaxLGI5InkgKoCQrBT945zkj6VGqgwTtG0jBpBhuThfT6UyXyYiu6Vh83GCOhHGadHMoZB9okwwJyoJX8qHuQ1oLGkm5NkpVZlIbggH1zVO8JgiZ4LiKToNw3Bh9OKvko8Qk3MnzdOdpHsajmt02SDAAGAMg5HPSizasSnZ6lVmkMwBdGbAABzyKjM8zCT5F+ViwwOv4mpS+x5JnzmMYBB/Kq9yTKk6MPNR4yu0jjBHNZtmpmXUtxp2t3V1DZC6jnVBujZFePAxjDdu/FLo9k4SZXjELSztN5cLA+WNuMHHGeM/U1mz2v2/Wnt4dIsbp4oY8yzSsvGOF6dcVY0u5msjGg0y3s0uLh4WEL79sm3uPQgcVTV1cyTUZGcpWKV2SRXRuCM/N+NXIZcorGNEZeG8xycflVG3vLaR3MLbNpCqAOTjvkfyqVLl3dtgjJBxhud49TXZbscCmXGdhEZIzGRnjDZA5689ar/aftNyQ28PncMjhjQhUrEisI4e/QEH8qjnUzyI0UpieM/K3BDY/vcVLiaKoX47h1k3ShjtX5lx0+ozU1uZFjZYY0Ri245G9SP8APaqUr/6p3kOEyAigKGPoa0beXEGxpFEgO7kgHmizHzkcE8iK5l3Dcch5gR9QADUc32YttZXkXy8sFwucn19KnuY7fbskMkigdVbOD17U6AecxBd4/LBLDyvug8Ag07FcxEymFVgtovLk++pbPTOdw6denpU7XDiJWvZmjGMKGJK5x3GM96rzTiWLbvuxJGRsMxwOKF1BpLsRLAwhPzNtK9emfWk42LUtC9bSMZoDwWcfvGGcHHTirV1dx28ieZb7WYkKVbLHA5OMdBWHHPM6EPLLsSY8Eglj0J444z3rXW8u/s77nz5hUKVjQcd+p+n1pJDkQptLbg8OxzjBJ3Hg9ulSSkKyXEzuxLKkaq+FI9cfTvUMJRUMyOxnJbCmMMuMc8dvarEaST2BMrOxC/KpIwOgBA70lEaZKyHcUSYM6/P82WBPHXikIZp0knaQfLgYiVQPrntUEd39piaOIsxUhd7HliDyMDqOKkuJ1eMMyttDAY2cD6n60B5D5xIssLxllxnewkOMZx93oavXc8kjxOt4QcHOI8qvT04JqjN5USW5n+RmOEJJ5J75A4qOSxPlr++fcSD8snJI9AO9PYfYk1JDO0FxDE91cRv8ivKQPpirVwxERjkidTLlwAxHGPXHuap6ndSJo0yRb1O4Om4ZIY9uP605WdWTfcKcKCq7TtJPb86WxTehZjWJYkEflHam1sS4bPckdqz9Sjaa9hcIrJwXld24XtjHvmpLCJoGl3ShUdiWJkBA7bcbelVdVtXvLu3CyJGAgWSMjG7nPyn6etTJaFwS5joUzbSMZliyVVuJMDj0/OqAt3e5m8iTKsS6lWLBs+v0xSyLGsBSR5FVUBi68E9R05FV7VohcuEmtkk253heR04z6U7Ep2vYkgt4w7tcpeLErjOwjK47c9utJeXTqkpjuJDkEDfztyeBxx0pqmSZGijnikWMlS4QDHei3lkitpj9qjT5SF4+/wBjux/nin5IXNrdkEbyliwUYAwF29Sfw447VZuXnk05CIy8rNtdl/h+vt2P1pLUNc2NxPenz5kdVZFI+4xGGBODkevNN1MkwxQ2bSxR4dxIpwWcLweT05oWiKvzOyK6FyTcfbR5mSiO6AEY6d8cdKsQCMJtIiEuCxKnGQcDj378U6zE0lrG091A0sQ2svGM4+8MdwR0pNEWdbSb7WkP2hwW3gADPY59fakkJy3JdkwlEsJG1UCjBPGDk/UnGcVa8/ZDkxMZCwO5mzgeuP0p1gIhDtWKR5WOM7vlXHXOD+tNu0jYf8tSoOQdx69ic9qdnuiOa7syOW8XyGX5t/mA4AYYGeORmlljtp4BKYnXkZJZgD6f/rNSr86xqpICjJA2n/P/ANekd5YkjdVmyWwVwD04/lmhBfsVxZ28cokSaEEfdYuSDkdKWHf5I3CEnkDbzgVLd3MiQqNgDA4X5MHHbtilt7qaXgp5iNkABBwQOtS0th3aRWebzNgCRrIpxjP3Rg4498VZMN0QxYIA3PboMds1Cb5GvI/Mbcp77ec59ehq3HcRzIsG6IvI2470wePx4zSSKcrdCP7M0qrGijPJY84B6YNSrGEtF3LIOfm5BDc+namTSvHPyY8AHJycH6+9Mt7szMIQisBlQCTkgnkUlYWrGEw7ypOXc7gWXLDBxVGW3kklkTKAf39gA459OK0biEtKGjj2ngcED+tRRqAkgMgRyCFCZOT9fpQ10Y1Kxn319Hp8Dm6kVIUwdq898HpVq2mW4gjChWRnL7iOV9Of6Vh6xp17c3kM1mFkWLHmRMR8/wCNbFq242qpEA7NjLN8uM9D+lZXd3fY6Xy8qa3LksSvACGR5dxLYXk9en4VAvyTgRIozgKMdh3qcyK6ANLK0iZGFPC80xvLecPvKtsOODgHpVswuVY7gXcN2se5TBKN5UDkinKQXj8g5XJOARwPzqONhBMqTRjJ/h+Y89fxpDbK1us+whWbGUGVqSronFyEdUXBWRsFuyn2NPk1e4lheMMFyeCR156fpWcVZdqZACntn6Z5qNvlBiMn7zO44XqBwDUqT6BZbkstw8MbGXapZsZcACp3uYZUdt/7zG0hTnH0PpVa6mEe7y0QoXGc+o/xpQsIkcRqwAPDM3X29u9Stx9DH1Yuupzf2St4boQp57QOqqo7btwwT9Kl0eK3me3liiune2ZzKkzfN5p6s3qcdKfc2ssOp3EtpcwwedEAySLvRiOB0Oc1f0aOCGKaOSaW4vG3G6eOMACUqCB/uhcdM1stVozHZ3aPOYtVTDINiq3BzztPqDV1bh9wEYXA7huWrzlL6JtrHOfTsauRXQA37mVTwAD0rbmPNO+TUyZvLBIOOS3TPtU8d/GsitgZzkjIw9cfb3K+WrfefqCTjIq9BMkmPmOccHOMH6VSkNI7F7pHBkWNirD0ByfUU20lSadZHUb06bh+uK5eO4ly44CqcKS2M+4q3aXJdWGGCrnLAdqfMNaHSyymVthMjRqN2GPGevAH+NKoSTKQu8YPLMrHBbqM/wCFZSXgVWZgXLDnrx6YotrsRsNku7+ILIOD/wDXqtB81jXuYFZo5JJ5mZDgHdgMR2IP86fEFLK0to4lK4OZOWB6AetRCdYt5DxnecliM4P0z2qOe4R5llJLHICluBgDtzTt2KU7ktwiRmG5dVYLnEW84HrwO/Skt9Ykl1JrRrRFRh+7IbA6dR71GrrHH5kcgKjOAhwTk/lVi3R2XdiRzuO0ycYHcgVLi2zRVEWHaPeEJaYkZLR/xY6fQcd6uq/ykxyMrBV/dg4BGemKrmMFAY02H+JlThh1x702Qh5T5ARWwCzOSMYOMHAoYKVy7ZzG3nYhY2LjH8IAPvT5JA6eVkSt1yVxk57e1VA6GfHygxgMdv3fbB61NbzJBuZAn2hfm3ljkn3/ADqS076iyybIYyTCCnC+YCcZOCc+lJKPMTDRxLFtHzqW9eufWi9aOSAtM6An+FJe3Xn0p/lthAiK8Zx1JYDj+VG47oWymRol8qOzZCCAFcqcep9DTHkhbklDIOXIlbJ7Z4AwaqrHMd5jjR0yMsUxn2q1GJYNyNAxLKcZZ8e5o1aG32M2K4Lal5TR4JGC4z1PIP5fyq5cGdLb986QPgMN/KjHsKpsY5J45OMrncJUbpkAHOeKmnuI3iPnCGTyz1ycNweDnioasa8ydjU093ntE8yWIgRgSOmOe+AcVm2c073pbeZIg5VkdAdvT5sgfoaTR7kSW0f2MoilshVjwCPpj8amt5Gs9UCLLG0j7i7rtLN6Dp6cjmlbYXc0ZvLt53huWQCFsh1QDfxnj65qHUbdYpoWMSjKHCqxYNkj06dKW61HzJkNw8/mSLgKVweOB049DVCzkewWQtdPtL4BkU7OTjPTkE1el7Gava5NujulMJki84lT5b5yU46EH17Gru0JboyQl5oiSqLjdnoefXBJrD1S1WK4R0kjmD/MewQ9yvf2rWRUlJmUyxrGwfOwjA6fXoaS3sU2uhJceVGu4qu8AcNGWZ+cDP0qZbeCRXVmBRsnEqMMe/X8RVa+fbBccucDdEXXdtGOQMgflU9nds9vHumRgz/eLFWYHsO2OlNb6k30uSW7vFLBHHF+52spOCeg9ccde9XJrncF/dvsVQVAcevT07VUE3mrJbNGyzEAud/8PoCf1puoxPK6MoJjz0jGQOcHH40eSDdjvMVoTttjgk7XcjK/iPWmWr+YpjdjFKrZ3EnByfrTo0iht5C1xNtRwoX7rAkYOc+tQzRxrhy7sv3ACwOP8amzKTRPMWmIjaSMHb94rx/PmmJCzyELJbRyABQY/lJH0qvL8mnTTSu4ZOQQDkKOn4etN0eWZmVzIqAnPKbhkD0PNIroPtILr7bh5Y8D5TubGPYY6fj60tu8skoLR5JG3ld23rx0qS1ieZtzyQ3Echyylc4x6H+tJGfLTzCCyt3C5Ix+NK2qK9RWEgkdXEWAu3PQnGMdaj8iRFjkUnAJ246ce9SEgFtzxSFjgApgnuaOUkjheQEKdx29ie2O2KloLkcaSupYSsOScFQQR6Uh3CIO7tx0IC8fhSq0mXcS4CnGBz1PUYqUzwm52kMfmKlicBqSQX1IXtEaTdGynHG0Hls/SmfZ50mCrEYjHJtCyA4J/GraeWsEQkkXczggA54NMaQLJD5yqAzbiH6tz6Zp2TDnZWk3RJIQsQcjDhfX0PvSxNMVVH2lmARWBwCSafLEjSybEQeYxVSW6r14FQXimRY2CjZuyAO+3salpBzE91LHFcxRTnM6oScuD6981TtruN4V+fKiTOADxxUT2iyXwmkXEm0hvlxk4PFKu0AREKFCZJXr14/wpN6jNlAZdysyiQfN83cdMVTuZIVuGKsm1BuJ6Y9qguY3hcMPMxK3DEc7R+NV7lXU4j5D4IyuDtHXpQ3pawKyYtsUN3GYYxKoQl436HP4012lMDFPLWUsSN5IUgdM9+pqlI6JdM8cGzI+baS2D/SnpehLf9/IzxqpZhydoH/6qzj2KZWN1rkhbaumDBADfPwasaYbqwe+l1AW7Szz/ciJIGVA4/KqH2/U5C7Wdh+4JEgEkoVmH5cVdtrhZBEcTLKrESRygfu2x0BHsetaWZCtc+YItQZMESNgGr8WplQDvO4fw9qwzakdP5U3ypF9gK9meAmuh89HEI7Wx1Pd828E+jcj8K0YtVjiaM7/AJ84G44Brz4yyKq7VAHsTUhvJPLA5KjsawlhKi3Rqq6Z6TBqMhgCsPmBzubuKvR6wUKiQsNoAGOgrzm01hgwDMo28knJzWnFr0VxtWXYo74NZypyjui1VTPRFv5ZEBUKADlj7VKL+XJKhjgDgcn6j+dcNa6kisPLm3bePpWhDqRRtwwGz94HIqHctSTO3t9UDrGC+1VIwW7H61djuS25sMY8kll/h/8ArVxVvdQuwExGwnJ5+8a1bbUI4chXzCVPJGQD6EU4tvcrmR1AuInQRFS6DGF4wOO2O1WYx5a/uS2CQUBP3fbPcVzVre+exkgfBX5ORgDjtWlI9wywRh9mPlBByfrVblXNuKRsZKKGQ5OTjA9Rj39amguPPm2kMwIO9IxgMe2KxrqNjAhF1tIyCynkAjnP4gdqbYXTSMUcO8ZBKk8ZPfmjl7j5jZkkLNEDEu5cfL2BHT8akF6LV5GLbmZT6twT+GazoZQ1sEkDuY2OApxjJ6Y9qS6mlcyLAxlAByC2wcds9aXKWpGlPelIyiqrRY4kU4b34J6VbtbpJbUb9obGOIyx/HHSsaxnMlkBbTRqhGGWVstke5qW2uZXuT5EaKWHzMhUZI7+/wCdLYtNM0MKtxGwKqHXIIXbz34PFWAzS/MruMoMMRkeuKyrq9aGa2G58M5DCRCcccY4rQgKiVpCY9wPzfMQBx0xSY+g2OP/AEko6xIwHIeIknvmohaRs4E0qi2zlhFkdfTHvUBvUW73IQWAz/eGc5HJ/CrfmRXTbpJGMj4/5ZgBeDnoPpSsVz2IoJEk1AJCzoYoxuUggjnGBxgnBqj5Yee6eBCd8qnEilcc43enII57VpRJFH5KINkpDFi5OcevSqt6saYICJG2Mgn/ABFJoakyzLdTefuCoFB2blBJA6Z68njjFPsVhWKQyTPKjyFhnI5ydq4IPr09apzTS+TEyvO6gYQIA2PeooLhxPJZttdirfM4wSxGc/yoVrhzWRqXVm91EI9iCIS4MnmDJP8Adxj+tWWmZZGVF3C3jDqS5BYAfrWJAzreRK6nKIBnB69ccHr05qw/kF5T5BlOSflLLnPOAcn9KfmgcjUnkSWwea3IlSUcBpeAWxkEHofeo2t0htUWa1kXCDDf6zaQRggf0qCGe1k00LChjibJ28t+XGSM1YizEkcYeTnkMQSFHrRYlS0K2I2ErpdR+YuQ0XzB1GQc8jkYzWokTKvmRpHlW+TYzrgE5yfX61nrCILtvMf/AF2GB8sAkjtkHnPvTnu1MhMAG0psA3HJxwR6UrDcjU8wSxGUMjuTuLuzcjPJB9BUbSbJi7MkwJ3BMHC5Hb/GspFjDwMxRThtu1sYHuOOO1XbW4FsWFzHtgGQHLnbj14/lSKUhXeR1BW2OYxu5yowOx9KfCSxkl8uIgH5wXLbuPfvSRhJ33wxCRMYbJ5HoRk/0prxqsDOEWNiT84xkjr2/nRYfMi66RJM48gwFR/qwQw9ePzpJSY4pPsvlZC8r3Ax35qmAuxpIAQSvO5yCM4/wpGuC0axja8vIba/yqB3oC424nl/cBk3kLvIDAkD1psdz5d3IXZwpBbJbG7OPyqKQq0VuPNQM3qcHGR8v0qxNIz+aUQ8ABdwBBHscVk9Ni7gZ1VJhHL8zgIPmHFEnktsVI45EYHAySR/k1UgLmebEXlqiYwf59c9f50+GNzLFD0Z1Lbz2+n6ipu9hlsSQr9nilKRk52+WDkHHQ1CqwSeQse1y4yC2cn6570/eJo7QsFaRUYH5Ryc+nFRQrIsasG3LgHAbkMR0/KrsSXbeF9qbPl+TIAGfX1PFNmaSNE3usjDgEHjmqaNL8xdtxWMKMcfnipA81yhROJGYZYnPT2qWMszwPKzDIDFyeox096pQwSi6VIkw5XGBj8e/NXZbpphKWHR8HAAzjj0FRh0aV5PmRg4wTxg/X0puGoKWliOZnDsGm2yIAoXGOvY02WJpZFLKVKRbezDHv61YuIklaYBjvBzgdfp9KrTmdNpR9qu27HYBeKTVgvcr7wgZCRjhfkHBqpKYzFKjs+wqVYHH+QKnvLsSr5ioF2gFwoG7dVNZIJkYb1Kn74YYznqDn2rO9mX0KtlZpCyxf22Y49nyAqjMAO2T2471atDDFE5hu2mkdiX3ncWPqcdOPSsSNdEsXZvNtJdzlxHKiv5Q/u5HUfWrtnLa28JkszCkWd5MeMfgRVuXKjOKu7nzep9hT92e3NQZNPDZ+p6V9pc+ScR0u3HQZpmBnJ70MwPWmg4HtRcEh7xq/XH5U1rVTyB+FKGAPHSpFOeRSsnugvJDNjL92R1b3p6PdRjCzZGOvWnZ980o46+tZyw9KW6Gqs11JbbUZozuZlz6n0q9b665uFBwmRjhqzlK8/0qOaFJBxwR3Fc88vpy20NIYqSep2Nnr8kc4MDYx1UnNdLa+IN7q8xPm/e3AV5HiRMYbB6FgatLeXyfOk2V9DXLPL5R+F3N1ie57XaX8dzEGS4YyHB3njPsKdOZWnjaSZ2RGyVjbHB9vSvIrTXrmAq5jk45O05/Suks/FQlZX+0IGA53jHHoawdCpH4omqrxfU9LtrpSESRBEg+UYGcY6c+lL59pGoYD7xKqYTuHX8vxrkl11JbeNDkqDnchyBU39qJtRo5TGA2MA4BHofY1i7p6m8Z32OptEaKQpHBPMJlLsxfv7DtTLy5ENuJJUuEkibPyjgD35rJtL2NWE/kNvORtVjlc+9aEDJLu2/K4G4oSSSPXg8mlbQ05iyL+K8iV2E8kbDKox247857063vXuwknnRr5YwSGJA9yfWqguIo4thYKhPG3qvsQe9SxsYodzM0KSg/M5xkAcYHSpsaKZctZWF8yyM0gGfnDhlwR6Z4471Ot2bIvtbfK52YxnAPt6e9YEN3FA2+7meEMdqsFU8ZBweKdcEPKyBQ6O3DqnX8un40tim7m8GV2iaTyiwJdiQDgnt/wDrqDVZoWK7ljL9TkjHsfrVa3cwWynariPO5RJk/nUbzxtbSNsKKBuJc5KgepqWrj5yXWNRtNK0maRp2nnKDygI+Cx6KNpxR4cjexsvO1IvJfThnMZyACe34A4rmLaFtQ1xNSupGttMgINvvQnLeuM11V5PBINwdpAF8zeDsyPTqeaSTvcd7ssASpL5UUTKXb7+4jbx0+lWHuQxEUXz7MF4wm4qeOmfes17lY4kV5JWLuDvVThR2GQetW3mWS4i2owL/KYlYMxxz1OOnWi1x8xdWR0Qi686OWQ7A4iZVUdByPbFaweMhpACp3DcSDk+x5rGXUvPtnkZzmJgpUs2SeMdKdHdxsJHG4ruztiJYDI65PoadtCeY1rmSV5oVk3rGhLcKDuB45xkis68ljtxtVYVDsQkbFvpxngGnxagfJjdJmDBwjO/y8/rg1VvbgmTIHnbjhkMh6n8OvND0KWosbPbTDDIgdic+XvxnoPSrcV0bhDtvUdgNpj8raOOSKrW08ZmVWlkRUOSNxypxzkd+aW5ltDvnhkwGPUJgb/U8+/ao8yi7NNOZ22SQO5zkNjABGevY1Abp/nSKM+YFAKRjefr9cfnWYlwiGOWW5ibzGwuA3HHcemT0pY5U+28pEqxsrGQZWRse+fXtS3NNkTr5l3ZAvGrxMDv8lSJMg8Y56GtHTngnkIxcKoBOzBAUDqSTx0rNX7UVuD5jLIHJVt21duOMDuefXtRGsqqN8qyAIAf3mSOnY/j+dCVhXujUmjt1LyWe6Xysv8ANldp/lUenXAuTPEwKFWy3IwPcfrUFkzRQ5A44UYCtlcHsKIrq3inlRBtlwUyx5Jz3HSpcbu4KVkXJ3+yyMBsOIwCWbgiobgIF/dhmaJcNsBG0k/5/Ola9jlkYjfJwFCkdCD7fWl8t/tDLsHm4JODnPTH8s0OPYpTII1llht4ymMhiXLcAZyc/lTH85Z4JJZCkeC+FJUe34VZ3kIoSXeoQ4wpHJPTBFJcRvGSQqsMbNvp6/8A66mSVhX7jIbmRAWIjKE/3sYxzT7a5U4Lqvm/MQBnoAeaqtOnmBUU+UBgknlWNQfaFWUiZWTJC4PPy/XtS8xmzFMBHtKsrCTc2c+vIqRrgtuVGw2/cFDdh65rMjmWV5B5iPmQ4bnt9aZcahBmFNsSEhiWzznpirIuaccqXDucMu6L5iufmz79MU6FE8p0dHjlXgAnB57+9ZdrexNGUuOmB3H3fbnipo7yAnc7jzSDt5zx7fpS1eo2yRreJmZoWXc7fMA3OPeqt/ZR3FrKkgEfmKw3r82BjAJxzUNyyfM9sfNbhiNmACayNTkaS0uGTd5oGEODleO/41L0He5NDJPHZfZF0hnZVCbo2XbwOvbg+9Z1tZTWYuEniijMkobygeE49elU7EbLSO60x2WXOHjZjmXH3g2fx5qzpN9LdR6gx+QNOW2zA5X5V6mlJJoUZWep8/buPenK3rUY6Uo9q+yPmbDyeaQnjrSUe9MLD8j1pytxUf8AKheKBNE4YY7ZpdwH1qLOacDlRnOBQRYlQkjFPBHtUJfKgfhSq3p09KaZLRKcZ6ZphGOc4NGRwM/nR3zxTsJIRWIG0jjPWmvEc7k/Kn8ZI4/GnLwfTHqaPId7CwsYyTDNJEx/utircep30WCZPMx/eFU9inqAaFUDpkfjWUqUZ6SQKbWzNi18Rz27MVjkQHG/yjwfet2x8YRbRH5hVQB8siYP4Vx4AK+/vTWRW4OPxFc0svg/h0NoYuUdz07TdUt7gExuG3HlSAePU1qRXM7uQ235B8gJzx6YPT6144kZhkEsLsrg5yDWnba/fwD5pN+Ou481yzwE18Op0wxsXuep/aZY4FNvIsUgABVucg56gj1p0YMz5ZApZeVRwv14HvXAw+K1lULcAg55IGdvvkVpWOsLtkETq+8DALdG9a5alGcfiR0wxEJLRnSeXJFcssj5ZwDG6KRjH8PoeP5VZeVfsWWBKscMW7889O+KxoNRWS3Q/OJozuAB449quSTrLEjmYHzD93JJ+ufrWCTNVI07BfOVVwRbEttLYx9Mmp7iKV4zuDLHnHyANms+2uQ1v5aNmRM5+fOfwNMe/kEoR1SMkY3Ken5d6coq2pakWLO4O+4s7hQIuojCsB6fmKuxeXPEiSIcRghCByM8duv51QW5ztRWJOeWDEEnsMevvV2KZkgcqqMRyxC/NnnB3CpSLbuMtr5kvSYklVyVZtspUgqcZIPB4x+Vasd7Ig+aYvknYAfvHPU4HB61lRbjFKxEWxDncFzg9qRrXaEnjIDDgqWYDOevoKE3bQRq3ksl8pRWmCyEDOwnYR0J/EUk8gkdLfzeQf3so+Q5zkY9apySyRztHuXdF8ww3B9cZqY3Mlu7sPLm3Kc7ecHGcYot1ZSLdkY475W80SnHl5xyAR3Hek8iP7P5huZC1uoUgZwvOP8AOTVCDUJIgZfLa2kUg7t/rwPqPwqeO92W7ebIA5+UBlHJwcZqdB8zL1wYVt5GHLBQ6kAcnHJHoKh02CMCNpkQGQbgWXJUY6ZNZlpdM5jZSwfeyoWxsKfXt3rWW4XdAY43+eNl4bjvzz15zQtR8xcEiedIq7yhxhVxkEn07cVXvt13APszMk2/GUGCQCOCfpWdDexiQFYmY+Zkj7rZqRZ1khjmhP2iNWLFFbGD6EYoeqBMntdpuVnhVmIJ3KDtAHSnQzK1mvl7JQH2sAB8vvnvS/aI4gN7eUwAYbBg5x0wKqwyfI6wyg+ZIG2Hr06exqWrDuXYJVYuyBh+8GSxwuRx/KnQXJtpo5pTJsYndsPJHbJqtFI7SRZQhTliCcgHt7U8zwqEdfLfjbtAxjmk0NSL0F4s4WZJBu2n34B4o+15ADMdxJIcnoevH9aoGITJI9qNsir94Mc47njms65EsIjEdxBIN24hjkoB6981LTsPmRrBZYsSL5ciqfMkH9CKge4R3hLNJHlt0hCBwAOlZj3rK8hE3325Lc9OlKdQcCeQgluAmwDB9RUblpmtbRxLAxJ+bYWO05zn2pksMEYBidBsH3CTk56mswXpHmNnDMwG0DAI9KsTXJaDeVkJY7wuASB2yapCckXrklIHmVIh5nyryGH1HeiAlxGJusikZPQfSsOG8ciONIZHIGcMuOOmfSn3Fy6wqXLRqoymf5UrhdG4+Y4tgfaB94bgNw7isq6vFgZ5reY7ic+WRgFcdxVG3v4AmGySOTkYOPWqOqyuyuse0+YmwbTjdkfzpOd0CVtRlxqqhneBWMIH32dVHvjNTQSmUB43byjw3GD78Vhx3exLlPIQpISQC6grwMBu4xVzTnBJM2SHYEEkjdwBu/MZrKUQhNnjIpaKK+2PnBR1/Cl7j3oooEJ3xTwMfnRRQJjui8UgNFFMkcOTQpOSKKKOoErcdKB6DiiiggcOWANB+8RRRVIQpOB+OKFPT/OKKKBDkOQaduPB49KKKZIq929ulMXnfnsQKKKTENX5ZeAORk1IvMgPQ46jqKKKLXY2Tpql3ZqVilJGf4hmuk0y6kupYzKepC8ZHWiivLx0YrZHdh5N7sv2MrMwVjn5gc963IkEmnXW/koN6seoP+FFFeejvW5XWdvs8AAAMrhWI7iprNSdPe4VmR0laPCngjd3ooqJbGsTbaYtdyW7qrRLFkA/7uRSY8uwhCEhXD5XORwcUUUSCBUs/wB7OFkAZS44Pvwa0r61WGVdjyYcMCC3T6UUVPQsy5P9ItnEvzbZVAP+frS3TkWc6KFALLyBz1xmiis0It26AeYCSwiRQgJ6VWFzLHKY0bAXdjueh/woopIsdHEkt3aXDr8+d5AJAJ65xVmxlYzRbTtEkbyMB65oopwKnsTR3cjzxI4Vsqck5yeRzV5E3WcEjEkyfez9T+NFFNbsjsUbiV45WjUnYwbIz6Vl3N3NHaM6EBiwXpngUUVMyoky3MhNwQcbFGMe+M02a4c3axELtbaCccnJooqY7FBffLeyR9VY5556Gqd3M8E22NiFALAe+aKKxkXEVLmVzPub7oGB6VdW4kzEvGNqjp6g5/lRRVwIZGJGleNc7AXUfL6Y96Sa4lMn2d2LxBT97k9T3oorR7MXUybS6coS4Vti4G4Z71JBMxLhsMFDEZ7HNFFYPYsydQO24KlUbAyCygmrdpdylUBII54NFFZ9RrY//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A slightly lichenified, erythematous patch and excoriations are present in the antecubital fold.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7045=[""].join("\n");
var outline_f6_56_7045=null;
var title_f6_56_7046="Esterified estrogens: Patient drug information";
var content_f6_56_7046=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Esterified estrogens: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/39/29303?source=see_link\">",
"     see \"Esterified estrogens: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F167700\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Menest&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F167701\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Estragyn;",
"     </li>",
"     <li>",
"      Estratab&reg;;",
"     </li>",
"     <li>",
"      Menest&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10027320\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700311",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Estrogens, when used in women after stopping periods (menopause), may raise the chance of uterine cancer. Progestins may lower this chance. A warning sign for cancer of the uterus is vaginal bleeding. Report any vaginal bleeding to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700259",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take estrogens to stop heart disease or dementia. Using estrogens may raise your chances of having a heart attack, a stroke, breast cancer, or a blood clot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3406344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use estrogens with or without progestin for the shortest time needed at the lowest useful dose.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10027322\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to add estrogen to the body when the ovaries have been taken out or do not work the right way.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691649",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or lower the signs of stopping periods (menopause).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rarely, it is used to treat breast or prostate cancers.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10027321\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to estrogens, esterified or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703380",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Bleeding disorder, blood clots, breast cancer (except in some cases where the cancer has spread), liver disease, recent heart attack, recent stroke, tumor where estrogen makes it grow, or vaginal bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703789",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have surgery and need bed rest.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10027326\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697661",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There may be a higher chance of endometrial or breast cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697221",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have gallbladder disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high calcium levels, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697245",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had high triglyceride levels, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697308",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have migraine headaches, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner, have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698554",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do monthly breast self-exams and have a gynecologic exam every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have an eye exam every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take St John's wort, dong quai, black cohosh, saw palmetto, red clover, or ginseng with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid cigarette smoking. People older than 35 years of age and/or smoking more than 15 cigarettes per day have more chance for heart disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10027327\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697923",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Enlarged breasts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gallbladder disease, blood clots, heart attacks, and other blood vessel problems may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10027329\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698615",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in how contact lenses feel in the eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698598",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A lump in the breast or breast soreness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10027324\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695956",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There may be days when you will not take this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10027325\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10027330\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10027331\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Read the package insert for more details.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12440 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.181.191-9843F0D5B8-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7046=[""].join("\n");
var outline_f6_56_7046=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167700\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167701\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027320\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027322\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027321\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027326\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027327\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027329\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027324\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027325\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027330\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027331\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/39/29303?source=related_link\">",
"      Esterified estrogens: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_56_7047="Cotton wool spots";
var content_f6_56_7047=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F67621%7ENEPH%2F78225%7ENEPH%2F57183&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F67621%7ENEPH%2F78225%7ENEPH%2F57183&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cotton wool spots",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 413px; height: 297px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cotton wool spots are indicative of retinal ischemia. The differential diagnosis includes diabetes, hypertension, AIDS, and the retinal vascular changes of systemic lupus erythematosus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James T Rosenbaum, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Grade IV hypertensive retinopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 385px; height: 307px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Retinal examination in a patient with papilledema due to malignant hypertension. There is blurring of the margins of the optic disc, distension of the retinal veins, two cotton wool spots inferior to the disc, and a flame-shaped hemorrhage at a venous bifurcation (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced by permission from: Gallasch G, Ritz E, Nephrol Dial Transplant 1997; 12:1518.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Grade IV hypertensive retinopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 397px; height: 334px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Retinal examination in a patient with malignant hypertension and grade IV hypertensive retinopathy. The optic disc is swollen with indistinct borders. There is venous tortuosity with multiple cotton wool spots and numerous flame-shaped (large arrows) and punctate hemorrhages (small arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced by permission from: Gallasch G, Ritz E, Nephrol Dial Trans 1997; 12:1518.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7047=[""].join("\n");
var outline_f6_56_7047=null;
var title_f6_56_7048="Indications for antithrombotic therapy in heart failure";
var content_f6_56_7048=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Indications for antithrombotic therapy in heart failure",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/56/7048/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/56/7048/contributors\">",
"     Wilson S Colucci, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/56/7048/contributors\">",
"     Gregory YH Lip, MD, FRCPE, FESC, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/56/7048/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/56/7048/contributors\">",
"     Stephen S Gottlieb, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/56/7048/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/56/7048/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/56/7048/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies in patients with heart failure (HF) and left ventricular systolic dysfunction have noted high rates of thromboembolic events as compared to the general population. Thrombus in the left heart chambers (associated with left heart failure) can lead to embolic stroke or peripheral arterial emboli, while pulmonary emboli originate from either deep venous thrombus or thrombus in the right heart chambers (associated with right heart failure). Low cardiac output, decreased physical activity, and peripheral edema all predispose to venous thrombi.",
"   </p>",
"   <p>",
"    This topic will discuss the risk of thromboembolism and indications for anticoagulation in patients with heart failure.",
"   </p>",
"   <p>",
"    Antithrombotic therapy in other settings that may be associated with HF is discussed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"       \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/25/23958?source=see_link&amp;anchor=H16788164#H16788164\">",
"       \"Treatment of amyloid cardiomyopathy\", section on 'Anticoagulation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41784?source=see_link&amp;anchor=H19#H19\">",
"       \"Isolated left ventricular noncompaction\", section on 'Management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28199?source=see_link\">",
"       \"Atrial fibrillation and other atrial tachyarrhythmias in hypertrophic cardiomyopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/23/5497?source=see_link\">",
"       \"Left ventricular thrombus after acute myocardial infarction\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/60/20425?source=see_link\">",
"       \"Chronic anticoagulation after acute coronary syndromes\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p>",
"    The epidemiology and pathophysiology of thromboembolism in heart failure in sinus rhythm were reviewed in a joint consensus document from the European Society of Cardiology (ESC) Heart Failure Association and the ESC Working Group on Thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Incidence of thromboembolic events",
"    </span>",
"    &nbsp;&mdash;&nbsp;High incidences of thromboembolic events (including stroke, peripheral, and pulmonary emboli) have been observed in patients with systolic heart failure (HF). The incidence of thromboembolism in patients with HF and systolic dysfunction was evaluated by retrospective analyses of data from large trials, including V-HeFT, SOLVD, SAVE AND SCD-HeFT [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. Thromboembolic events ranged from 1.5 to 2.7 per 100 patient-years and stroke rates ranged from 1.2 to 1.8 per 100 patient years in these study populations. Clinical factors that may have affected these thromboembolic rates include atrial fibrillation (history of atrial fibrillation reported in 0 to 15 percent of patients) and anticoagulant therapy (in 8 to 28 percent of patients).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Heart failure as stroke risk factor",
"    </span>",
"    &nbsp;&mdash;&nbsp;The impact of heart failure on the risk of stroke is illustrated by the following community-based observational studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early data on 5184 Framingham Heart Study participants followed for 24 years found that clinical evidence of HF was associated with an increased risk of stroke. HF was associated with adjusted risk ratios for stroke of 4.1 in men and 2.8 in women [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/6\">",
"       6",
"      </a>",
"      ]. However, stroke risk was not adjusted for presence of atrial fibrillation. Left ventricular ejection fraction (LVEF) data were not available.",
"     </li>",
"     <li>",
"      A study from Olmsted County of 630 persons with new HF identified ischemic stroke in 102 (16 percent) during 4.3 years follow-up. During the first 30 days after heart failure diagnosis, the risk of stroke was 17.4-fold higher than in the general population. The stroke risk remained elevated during five years of follow-up (risk ratio 2.9) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/7\">",
"       7",
"      </a>",
"      ]. Atrial fibrillation was not a significant predictor of stroke in this HF population and LVEF was not associated with stroke in a multivariable analysis [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/7\">",
"       7",
"      </a>",
"      ]. However LVEF data were missing in nearly half of the subjects and the mean LVEF among HF subjects was relatively high (43 percent).",
"     </li>",
"     <li>",
"      In the Rotterdam study, there was a more than a threefold increase in the risk of ischemic stroke in the first month after diagnosis after adjustment for age, sex, and cardiovascular risk factors (adjusted hazard ratio [HR] 3.59, 95% CI 2.15&ndash;15.62), but the risk attenuated over time, becoming nonsignificant six months after diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the Diet, Cancer, and Health study, incident HF was a major risk factor for stroke, death, and the composite of &lsquo;stroke and death&rsquo;, particularly in the initial 30 days following diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/9\">",
"       9",
"      </a>",
"      ]. Of note, the use of vitamin K antagonist (VKA) therapy was associated with lower risks of death and of the composite endpoint.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of thromboembolism in heart failure can be considered by reference to Virchow&rsquo;s triad for thrombogenesis, first proposed in the mid 19",
"    <sup>",
"     th",
"    </sup>",
"    century [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      &ldquo;Abnormal flow&rdquo; caused by low cardiac output, dilated cardiac chambers, and poor contractility may contribute to thrombus formation in the left and right heart chambers. In addition, atrial fibrillation is frequently present in patients with heart failure and is frequently associated with slow flow in the atria.",
"      <br/>",
"      <br/>",
"      Low cardiac output, decreased physical activity, and peripheral edema all predispose to venous thrombi.",
"     </li>",
"     <li>",
"      There is laboratory evidence of a hypercoagulable state (&ldquo;abnormal blood constituents&rdquo;) in patients with HF in sinus rhythm as indicated by increases in platelet activation and in plasma viscosity, fibrinogen, von Willebrand factor, and fibrin D-dimer [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/10-13\">",
"       10-13",
"      </a>",
"      ]. The degree of hypercoagulability is related to the severity of the heart failure, but not to the left ventricular ejection fraction (LVEF).",
"      <br/>",
"      <br/>",
"      Hemostatic abnormalities can be improved by anticoagulation with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/14\">",
"       14",
"      </a>",
"      ]. ACE inhibitors, which are routinely used in patients with heart failure, may reduce some components of the prothrombotic state; a similar effect does not appear to occur with beta blockers [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=see_link\">",
"       \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Endothelial dysfunction (&ldquo;vessel wall abnormalities&rdquo;) may also contribute to thromboembolism in patients with HF.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These abnormalities contribute to a prothrombotic state, which increases the risk of thromboembolism in patients with heart failure and impaired left ventricular systolic function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18158406\">",
"    <span class=\"h1\">",
"     RISK FACTORS FOR THROMBOEMBOLISM",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Left ventricular systolic dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;An association between left ventricular ejection fraction and stroke or thromboembolism has been found in some studies of patients with systolic dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. Thromboembolic risk in patients with heart failure with preserved ejection fraction is not well defined [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of thromboembolism in the setting of atrial fibrillation and heart failure may not be affected by the ejection fraction. A study of 7156 patients with atrial fibrillation and HF found no differences in rates of stroke, thromboembolism, or death between patients with preserved ejection fraction and those with reduced ejection fraction [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Atrial fibrillation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk models derived from large clinical trials of anticoagulation in patients with atrial fibrillation have identified heart failure as an important risk factor for embolization as reflected by recommendations in various major society guidelines. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18158268\">",
"    <span class=\"h2\">",
"     Left ventricular thrombus",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is an increased propensity for left ventricular thrombus formation in patients with left ventricular systolic dysfunction. The LVEF is the most important risk factor for thrombus formation, while severe mitral regurgitation may have a protective effect by decreasing stasis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prognostic importance of left ventricular thrombi in patients with HF is uncertain. In most studies, the presence of clot in the left ventricle (as determined by echocardiography) was",
"    <strong>",
"     not",
"    </strong>",
"    a clear risk factor for embolic complications [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/17-19\">",
"     17-19",
"    </a>",
"    ], although many of the patients in these studies were anticoagulated. Other studies have suggested an increase in embolic risk associated with left ventricular thrombi [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/20,21\">",
"     20,21",
"    </a>",
"    ], especially those that protrude into the left ventricular cavity [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/20,22\">",
"     20,22",
"    </a>",
"    ] or are mobile [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with left ventricular thrombus in the setting of an acute myocardial infarction have a significantly increased risk of embolic events. This issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/23/5497?source=see_link\">",
"     \"Left ventricular thrombus after acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ROLE OF ANTITHROMBOTIC THERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Our approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients in sinus rhythm with systolic left ventricular dysfunction",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    heart failure without left ventricular thrombus or other indication for antiplatelet or anticoagulant therapy, we suggest not using antiplatelet or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy.",
"   </p>",
"   <p>",
"    We suggest oral anticoagulant therapy (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    ) in patients with HF",
"    <strong>",
"     due to systolic dysfunction",
"    </strong>",
"    and prior thromboembolic event, although supportive data are limited. There are inadequate data on the novel oral anticoagulants in patients with heart failure in sinus rhythm, and thus, we do not consider new anticoagulants such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/39/8825?source=see_link\">",
"     dabigatran",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/16/5384?source=see_link\">",
"     rivaroxaban",
"    </a>",
"    alternatives to warfarin in this setting.",
"   </p>",
"   <p>",
"    The risk of bleeding should be evaluated in all patients undergoing consideration for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy. Candidates for anticoagulation must have minimal risk factors for bleeding (such as abnormal liver function) and a stable hemodynamic profile. Assessment of risk of bleeding is discussed in detail separately.",
"   </p>",
"   <p>",
"    The optimal degree of anticoagulation has not been established. We aim for an INR (International Normalized Ratio) between 2.0 and 3.0 in patients with prior thromboembolic event or atrial fibrillation. Once the patient is stable, the INR is measured monthly. We reassess the safety of continued anticoagulation if the heart disease progresses.",
"   </p>",
"   <p>",
"    Treatment of patients with heart failure and atrial fibrillation should be governed by applicable guidelines for nonvalvular atrial fibrillation (or for valvular atrial fibrillation, when appropriate). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment of patients with left ventricular thrombus is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/23/5497?source=see_link\">",
"     \"Left ventricular thrombus after acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1015181\">",
"    <span class=\"h2\">",
"     Antithrombotic therapy compared to placebo",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data are inconclusive on the utility of antithrombotic (antiplatelet or anticoagulant) therapy to reduce thromboembolic events or mortality in patients with systolic heart failure who are in sinus rhythm [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/23-25\">",
"     23-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Observational studies (including retrospective analyses of clinical trial data) have provided conflicting data on the effectiveness of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy in this population. Although early small observational studies suggested a reduction in stroke rate in warfarin-treated patients [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/26,27\">",
"     26,27",
"    </a>",
"    ], analysis of observational data from large randomized trials was conflicting, with SOLVD and V-HeFT showing no reduction in embolic rate in patients receiving warfarin [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/2,4\">",
"     2,4",
"    </a>",
"    ] and SAVE showing significant benefit with both warfarin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A systematic review from the Cochrane database concluded that based upon two multicenter randomized trials (HELAS [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/15\">",
"     15",
"    </a>",
"    ] and WASH [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/28\">",
"     28",
"    </a>",
"    ]), there is no convincing evidence that anticoagulant therapy reduces mortality or vascular events in patients with heart failure and sinus rhythm [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"        Warfarin",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"        Aspirin",
"       </a>",
"      </span>",
"      Study in Heart failure (WASH) trial randomized 279 patients to warfarin, aspirin, or no therapy over mean follow-up of 27 months [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/28\">",
"       28",
"      </a>",
"      ]. There were no significant differences between the treatment groups in frequency of the primary composite outcome of death, nonfatal myocardial infarction, or nonfatal stroke. Hospitalization for cardiovascular reasons (especially worsening heart failure) was more frequent in patients randomized to aspirin.",
"     </li>",
"     <li>",
"      The&nbsp;Heart failure Long-term Antithrombotic Study (HELAS) evaluated antithrombotic treatment in 197 patients with HF and LVEF &lt;35 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/15\">",
"       15",
"      </a>",
"      ]. Patients with ischemic heart disease were randomized to receive either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      325 mg or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      . Patients with dilated cardiomyopathy were randomized to receive either&nbsp;warfarin&nbsp;or placebo. There were 2.2 embolic events per 100 patient-years, with no significant differences between treatment groups.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1015206\">",
"    <span class=\"h2\">",
"     Comparison of aspirin to warfarin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Randomized trials have shown that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy does not improve overall outcomes among patients with heart failure compared to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/15,28,30,31\">",
"     15,28,30,31",
"    </a>",
"    ]. Meta-analyses of these trials found no significant difference between warfarin and aspirin therapy in the composite end point of death or stroke and no difference in all-cause mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. While warfarin therapy reduced the rates of stroke (RR 0.56; 95% CI 0.38-0.82) and ischemic stroke (RR 0.45; 95% CI 0.24-0.86) compared to aspirin, it increased the risk of major bleeding (RR 1.95; 95% CI, 1.37-2.76).",
"   </p>",
"   <p>",
"    The best data comparing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    in patients with HF in sinus rhythm come from the WATCH and WARCEF trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the WATCH trial, 1587 adults in sinus rhythm with symptomatic heart failure and LVEF &le;35 percent were randomly assigned to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      (162 mg daily) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"       clopidogrel",
"      </a>",
"      (75 mg daily) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      titrated to a target INR of 2.5 to 3.0 [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/30\">",
"       30",
"      </a>",
"      ]. A majority (74 percent) of the subjects had coronary artery disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      There were no significant differences among the three treatment arms for the primary end point of time to first occurrence of death, nonfatal myocardial infarction, or nonfatal stroke.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       Warfarin",
"      </a>",
"      was associated with significantly fewer nonfatal strokes than",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"       clopidogrel",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      (0.2 versus 2.1 and 1.7 percent). However, when central nervous system bleeds and fatal strokes were included, the effect of warfarin was no longer significant (1.7 versus 2.5 and 2.9 percent, p &gt;0.17 to 0.35).",
"     </li>",
"     <li>",
"      Hospitalization for worsening heart failure occurred more frequently in patients treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      than in those treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      (22.2 versus 16.5 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the WARCEF trial, 2305 adults in sinus rhythm with an LVEF &le;35 percent were randomly assigned to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      (325 mg daily) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      (titrated to a target INR of 2.75 with acceptable range of 2.0 to 3.5) and followed for up to six years [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/31\">",
"       31",
"      </a>",
"      ]. Less than half (43 percent) of the subjects had coronary artery disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      There was no significant difference between",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      for the primary endpoint of ischemic stroke, intracerebral hemorrhage, or death from any cause (7.47 versus 7.93 per 100 patient-years). The hazard ratio changed over time with a marginally significant advantage of warfarin over aspirin by the fourth year of follow-up (p = 0.046).",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       Warfarin",
"      </a>",
"      significantly reduced the rate of ischemic stroke compared to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      (0.72 versus 1.36 events per 100 patient-years). However, major hemorrhage was more frequent in the warfarin group (1.78 versus 0.87 events per 100 patient-years). Rates of intracerebral and intracranial hemorrhage were similar in the two treatment groups (0.27 versus 0.22 events per 100 patient-years).",
"     </li>",
"     <li>",
"      There was a nonsignificant trend (p = 0.053) toward higher rate of hospitalization for heart failure with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      than with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      . This result contrasts with the WASH and WATCH trial results of greater hospitalization for heart failure in patients treated with aspirin as compared to those treated with warfarin [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/28,30\">",
"       28,30",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1015213\">",
"    <span class=\"h2\">",
"     Risks of anticoagulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The uncertain benefit associated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy must be evaluated in relation to the risk of bleeding. In atrial fibrillation trials in patients with normal left ventricular function, for example, the incidence of major bleeding ranges between 0.4 and 2.5 percent per year. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    .)The risk of hemorrhage with warfarin varies with the clinical indication and with the presence of comorbid conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/27,34\">",
"     27,34",
"    </a>",
"    ]. In general, anticoagulation is more difficult to regulate and bleeding complications are more frequent in patients with HF [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42266?source=see_link&amp;anchor=H35#H35\">",
"     \"Therapeutic use of warfarin\", section on 'Excessive anticoagulation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1015606\">",
"    <span class=\"h2\">",
"     Recommendations of others",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2012 American College of Chest Physicians (ACCP) guidelines suggest not to use antiplatelet therapy or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    for patients with left ventricular systolic function without established coronary artery disease and no left ventricular thrombus [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/25\">",
"     25",
"    </a>",
"    ]. For patients with systolic left ventricular dysfunction without established coronary artery disease with identified acute left ventricular thrombus, warfarin therapy (target INR 2.0-3.0) for at least three months is suggested. Recommendations for patients with established coronary artery disease are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/23/5497?source=see_link\">",
"     \"Left ventricular thrombus after acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37066?source=see_link\">",
"     \"Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2005 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (ACC/AHA)",
"    </span>",
"    guidelines with 2009 focused update acknowledge that limited data are available to guide anticoagulant use in patients with HF [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/38\">",
"     38",
"    </a>",
"    ]. However, the guidelines recommend anticoagulation in patients with HF with previous thromboembolic event (",
"    <a class=\"graphic graphic_table graphicRef80859 \" href=\"UTD.htm?41/45/42716\">",
"     table 1",
"    </a>",
"    ). This recommendation does not specify any differences in approach for patients with and without systolic dysfunction. The guidelines also note that some advocate anticoagulation in the presence of visualized (ventricular) thrombi although the potential risk posed by such thrombus is not known.",
"   </p>",
"   <p>",
"    The 2010 Heart Failure Society of America (HFSA) guidelines for heart failure with systolic dysfunction recommend anticoagulation (goal INR 2.0 to 3.0) for all patients with HF and chronic or documented paroxysmal, persistent, or long-standing atrial fibrillation or a history of systemic or pulmonary emboli (including stroke or transient ischemic attack) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2012 joint consensus document from the ESC Heart Failure Association and Working Group on Thrombosis noted that in the absence of a specific indication (such as documented coronary artery disease),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    should",
"    <strong>",
"     not",
"    </strong>",
"    be initiated in patients with heart failure in sinus rhythm [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/1\">",
"     1",
"    </a>",
"    ]. The document also noted that there is currently no compelling reason for routine",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy in HF patients in sinus rhythm.",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     ACC/AHA,",
"    </span>",
"    HFSA, and ESC heart failure guidelines also include recommendations for anticoagulation for patients with HF and atrial fibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7048/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. Management of such patients is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44952018\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with systolic heart failure are at increased risk for thromboembolic events. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Incidence of thromboembolic events'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors for thromboembolism in patients with systolic function have not been definitively established. Some evidence has suggested that severity of systolic dysfunction, presence of protuberant thrombus in the left ventricular cavity, a hypercoagulable state, and presence of atrial fibrillation may be factors but study results have been mixed. (See",
"      <a class=\"local\" href=\"#H18158406\">",
"       'Risk factors for thromboembolism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Data are inconclusive on the utility of antithrombotic therapy (antiplatelet therapy or anticoagulation) to reduce thromboembolic events or mortality in patients with systolic heart failure who are in sinus rhythm. (See",
"      <a class=\"local\" href=\"#H1015181\">",
"       'Antithrombotic therapy compared to placebo'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The results of randomized trials show that",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      therapy does not improve overall outcomes among patients with heart failure compared to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      therapy. The best data come from the WATCH and WARCEF trials in which there was no difference between antiplatelet therapy and warfarin in the risk of mortality and all central nervous system events (all stroke plus central nervous system bleeds). (See",
"      <a class=\"local\" href=\"#H1015181\">",
"       'Antithrombotic therapy compared to placebo'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with left ventricular systolic dysfunction",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      heart failure without left ventricular thrombus or other indication for antiplatelet or anticoagulant therapy, we recommend",
"      <strong>",
"       not",
"      </strong>",
"      administering antiplatelet or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      therapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Our approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with heart failure due to systolic dysfunction and prior thromboembolic event, we suggest oral anticoagulant therapy (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Due to lack of data, we do not consider newer anticoagulants such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/39/8825?source=see_link\">",
"       dabigatran",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/16/5384?source=see_link\">",
"       rivaroxaban",
"      </a>",
"      alternatives to warfarin in this setting. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Our approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of patients with heart failure and atrial fibrillation should be governed by applicable guidelines for nonvalvular atrial fibrillation (or for valvular atrial fibrillation, when appropriate). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"       \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The role of antithrombotic therapy after acute myocardial infarction and in the presence of left ventricular thrombus is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/23/5497?source=see_link\">",
"       \"Left ventricular thrombus after acute myocardial infarction\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/1\">",
"      Lip GY, Ponikowski P, Andreotti F, et al. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Eur J Heart Fail 2012; 14:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/2\">",
"      Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 1997; 29:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/3\">",
"      Loh E, Sutton MS, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997; 336:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/4\">",
"      Dunkman WB, Johnson GR, Carson PE, et al. Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87:VI94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/5\">",
"      Freudenberger RS, Hellkamp AS, Halperin JL, et al. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2007; 115:2637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/6\">",
"      Kannel WB, Wolf PA, Verter J. Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA 1983; 250:2942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/7\">",
"      Witt BJ, Brown RD Jr, Jacobsen SJ, et al. Ischemic stroke after heart failure: a community-based study. Am Heart J 2006; 152:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/8\">",
"      Alberts VP, Bos MJ, Koudstaal P, et al. Heart failure and the risk of stroke: the Rotterdam Study. Eur J Epidemiol 2010; 25:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/9\">",
"      Lip GY, Rasmussen LH, Skj&oslash;th F, et al. Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study. BMJ Open 2012; 2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/10\">",
"      Lip GY, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow's triad revisited. J Am Coll Cardiol 1999; 33:1424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/11\">",
"      Jafri SM, Ozawa T, Mammen E, et al. Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur Heart J 1993; 14:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/12\">",
"      Gibbs CR, Blann AD, Watson RD, Lip GY. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy. Circulation 2001; 103:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/13\">",
"      Cugno M, Mari D, Meroni PL, et al. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation. Br J Haematol 2004; 126:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/14\">",
"      Jafri SM, Mammen EF, Masura J, Goldstein S. Effects of warfarin on markers of hypercoagulability in patients with heart failure. Am Heart J 1997; 134:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/15\">",
"      Cokkinos DV, Haralabopoulos GC, Kostis JB, et al. Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study. Eur J Heart Fail 2006; 8:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/16\">",
"      Kalaria VG, Passannante MR, Shah T, et al. Effect of mitral regurgitation on left ventricular thrombus formation in dilated cardiomyopathy. Am Heart J 1998; 135:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/17\">",
"      Ciaccheri M, Castelli G, Cecchi F, et al. Lack of correlation between intracavitary thrombosis detected by cross sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy. Br Heart J 1989; 62:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/18\">",
"      Gottdiener JS, Gay JA, VanVoorhees L, et al. Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by 2-dimensional echocardiography. Am J Cardiol 1983; 52:1281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/19\">",
"      Cioffi G, Pozzoli M, Forni G, et al. Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients. Eur Heart J 1996; 17:1381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/20\">",
"      Falk RH, Foster E, Coats MH. Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study. Am Heart J 1992; 123:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/21\">",
"      Crawford TC, Smith WT 4th, Velazquez EJ, et al. Prognostic usefulness of left ventricular thrombus by echocardiography in dilated cardiomyopathy in predicting stroke, transient ischemic attack, and death. Am J Cardiol 2004; 93:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/22\">",
"      Stratton JR, Resnick AD. Increased embolic risk in patients with left ventricular thrombi. Circulation 1987; 75:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/23\">",
"      Lip GY, Gibbs CR. Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. QJM 2002; 95:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/24\">",
"      Lip GY, Gibbs CR. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. QJM 2002; 95:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/25\">",
"      Vandvik PO, Lincoff AM, Gore JM, et al. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e637S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/26\">",
"      Fuster V, Gersh BJ, Giuliani ER, et al. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/27\">",
"      Kyrle PA, Korninger C, G&ouml;ssinger H, et al. Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy. Thromb Haemost 1985; 54:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/28\">",
"      Cleland JG, Findlay I, Jafri S, et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 2004; 148:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/29\">",
"      Lip GY, Wrigley BJ, Pisters R. Anticoagulation versus placebo for heart failure in sinus rhythm. Cochrane Database Syst Rev 2012; 6:CD003336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/30\">",
"      Massie BM, Collins JF, Ammon SE, et al. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation 2009; 119:1616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/31\">",
"      Homma S, Thompson JL, Pullicino PM, et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 2012; 366:1859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/32\">",
"      Lee M, Saver JL, Hong KS, et al. Risk-Benefit Profile of Warfarin Versus Aspirin in Patients With Heart Failure and Sinus Rhythm: A Meta-analysis. Circ Heart Fail 2013; 6:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/33\">",
"      Hopper I, Skiba M, Krum H. Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm. Eur J Heart Fail 2013; 15:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/34\">",
"      Levine MN, Raskob G, Hirsh J. Hemorrhagic complications of long-term anticoagulant therapy. Chest 1989; 95:26S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/35\">",
"      Landefeld CS, Cook EF, Flatley M, et al. Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med 1987; 82:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/36\">",
"      Husted S, Andreasen F. Problems encountered in long-term treatment with anticoagulants. Acta Med Scand 1976; 200:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/37\">",
"      Visser LE, Bleumink GS, Trienekens PH, et al. The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants. Br J Haematol 2004; 127:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/38\">",
"      Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119:e391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/39\">",
"      Heart Failure Society of America, Lindenfeld J, Albert NM, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 2010; 16:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7048/abstract/40\">",
"      McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33:1787.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3502 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-118.97.94.19-F0314D4D48-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7048=[""].join("\n");
var outline_f6_56_7048=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H44952018\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Incidence of thromboembolic events",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Heart failure as stroke risk factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18158406\">",
"      RISK FACTORS FOR THROMBOEMBOLISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Left ventricular systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18158268\">",
"      Left ventricular thrombus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ROLE OF ANTITHROMBOTIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Our approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1015181\">",
"      Antithrombotic therapy compared to placebo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1015206\">",
"      Comparison of aspirin to warfarin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1015213\">",
"      Risks of anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1015606\">",
"      Recommendations of others",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H44952018\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/3502\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/3502|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/45/42716\" title=\"table 1\">",
"      ACC AHA Rx HF other diseases",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=related_link\">",
"      Antithrombotic therapy to prevent embolization in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28199?source=related_link\">",
"      Atrial fibrillation and other atrial tachyarrhythmias in hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37066?source=related_link\">",
"      Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/60/20425?source=related_link\">",
"      Chronic anticoagulation after acute coronary syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41784?source=related_link\">",
"      Isolated left ventricular noncompaction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/23/5497?source=related_link\">",
"      Left ventricular thrombus after acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=related_link\">",
"      Overview of the therapy of heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42266?source=related_link\">",
"      Therapeutic use of warfarin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/25/23958?source=related_link\">",
"      Treatment of amyloid cardiomyopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_56_7049="Surgical management of splenic injury in the adult trauma patient";
var content_f6_56_7049=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical management of splenic injury in the adult trauma patient",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/56/7049/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/56/7049/contributors\">",
"     Adrian A Maung, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/56/7049/contributors\">",
"     Lewis J Kaplan, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/56/7049/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/56/7049/contributors\">",
"     Heidi L Frankel, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/56/7049/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/56/7049/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/56/7049/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical management is required in approximately 20 to 40 percent of patients sustaining splenic injury. Open surgical techniques are the current standard of care and are typically used to manage the injured spleen, though laparoscopic techniques have been described in case reports and small series.",
"   </p>",
"   <p>",
"    This topic will discuss the indications and techniques of exploratory laparotomy in the setting of trauma, hemorrhage control from the spleen, splenic salvage and splenectomy.",
"   </p>",
"   <p>",
"    Nonoperative management of splenic injury is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=see_link\">",
"     \"Management of splenic injury in the adult trauma patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR EXPLORATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;We perform initial resuscitation, and diagnostic evaluation of the trauma patient is based upon the Advanced Trauma Life Support (ATLS&reg;) program established by the American College of Surgeons Committee on Trauma. Emergent abdominal surgical exploration is indicated for the hemodynamically unstable trauma patient who has a positive focused assessment with sonography in trauma (FAST exam) or diagnostic peritoneal",
"    <span class=\"nowrap\">",
"     aspiration/lavage",
"    </span>",
"    <span class=\"nowrap\">",
"     (DPA/DPL)",
"    </span>",
"    to control life-threatening hemorrhage, which may be due to an injured spleen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=see_link\">",
"     \"Initial evaluation and management of blunt abdominal trauma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/54/3943?source=see_link\">",
"     \"Initial evaluation and management of abdominal gunshot wounds in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12776?source=see_link\">",
"     \"Initial evaluation and management of abdominal stab wounds in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=see_link\">",
"     \"Initial evaluation and management of blunt thoracic trauma in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The hemodynamically stable trauma patient with splenic injury identified on computerized tomography (CT scan) may be initially observed or undergo angiographic embolization as an adjunct to observational management. However, observational management requires adequate resources, and if unavailable, initial surgical management should be considered depending on the patient&rsquo;s medical comorbidities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=see_link&amp;anchor=H9#H9\">",
"     \"Management of splenic injury in the adult trauma patient\", section on 'Management approach'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Indications for surgical exploration in the hemodynamically stable trauma patient with splenic injury who is being nonoperatively managed (ie, observation with or without splenic embolization) include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Signs of other intra-abdominal injury (eg, free air, peritonitis) necessitating exploration.",
"     </li>",
"     <li>",
"      Failure of nonoperative management. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=see_link&amp;anchor=H16#H16\">",
"       \"Management of splenic injury in the adult trauma patient\", section on 'Failure of nonoperative management'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMY OF THE SPLEEN",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spleen is located posterolaterally in the left upper quadrant of the abdomen (",
"    <a class=\"graphic graphic_figure graphicRef62682 \" href=\"UTD.htm?7/51/7999\">",
"     figure 1",
"    </a>",
"    ) beneath the left hemidiaphragm and lateral to the greater curvature of the stomach. The spleen is surrounded by a fibrous capsule composed of collagen, elastin and smooth muscle. The spleen is important for opsonization of encapsulated organisms. Splenic physiology is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/34/34346?source=see_link&amp;anchor=H3#H3\">",
"     \"Approach to the adult patient with splenomegaly and other splenic disorders\", section on 'Normal splenic function'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The spleen is predominantly perfused by the splenic artery, which is a branch of the celiac trunk. Splenic blood-flow is also derived from the short gastric arteries, which are branches of the left gastric artery. The splenic artery, which can be quite tortuous, traverses along the superior margin of the pancreas, supplying branches to it, before continuing to the spleen (",
"    <a class=\"graphic graphic_figure graphicRef68680 \" href=\"UTD.htm?9/21/9557\">",
"     figure 2",
"    </a>",
"    ). The splenic artery branches to form up to six major arteries before entering the splenic hilum (",
"    <a class=\"graphic graphic_figure graphicRef78584 \" href=\"UTD.htm?32/29/33234\">",
"     figure 3",
"    </a>",
"    ). Each branch runs in the transverse axis of the spleen, progressively branching to peripheral arterioles that open freely into the splenic pulp. The blood flows through the reticular tissue and is collected in the terminal venules, which join to form larger veins (",
"    <a class=\"graphic graphic_figure graphicRef69582 \" href=\"UTD.htm?32/36/33351\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The veins do not accompany the arteries within the spleen. At the hilum, up to six major veins unite to form the splenic vein (",
"    <a class=\"graphic graphic_figure graphicRef78584 \" href=\"UTD.htm?32/29/33234\">",
"     figure 3",
"    </a>",
"    ). The splenic vein joins the superior mesenteric vein to form the portal vein (",
"    <a class=\"graphic graphic_figure graphicRef68680 \" href=\"UTD.htm?9/21/9557\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PREPARATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Preoperative",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Type and crossmatch",
"    </span>",
"    &nbsp;&mdash;&nbsp;For hemodynamically unstable patients, at least 4 units of packed red blood cells (RBCs) should be available for transfusion in the event the patient becomes hemodynamically unstable. A \"massive transfusion protocol\" should be immediately available and include preparation of packed RBC, FFP, and platelets. Some protocols also include activated factor VII. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/25/38294?source=see_link\">",
"     \"Massive blood transfusion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Prophylactic antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prophylactic antibiotics are administered to prevent surgical site infection. For emergent trauma surgery, antibiotic selection is the same as for elective surgery with administration of a first generation cephalosporin (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/2/4136?source=see_link\">",
"     cefazolin",
"    </a>",
"    ). If there is concern for, or confirmed, enteric or colorectal contamination, anaerobic coverage with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    , or alternatively, a higher generation cephalosporin is appropriate (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link\">",
"     \"Overview of control measures to prevent surgical site infection\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Prophylactic immunization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     urgent/emergent",
"    </span>",
"    nature of a trauma laparotomy precludes the ability to immunize the patient prior to possible splenectomy. In general, patients are immunized in the postoperative period if splenectomy is required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=see_link&amp;anchor=H21#H21\">",
"     \"Management of splenic injury in the adult trauma patient\", section on 'Immunocompetence after splenic injury'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Patient/family counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the patient's next of kin (if the patient is",
"    <span class=\"nowrap\">",
"     intubated/unresponsive)",
"    </span>",
"    is informed that the trauma laparotomy is or already has been performed to control bleeding, as well as to identify and treat other related intra-abdominal injuries which may be unknown prior to surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=see_link&amp;anchor=H6#H6\">",
"     \"Management of splenic injury in the adult trauma patient\", section on 'Associated injuries'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Intraoperative",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard trauma laparotomy preparation is performed. Hypothermia adversely impacts enzyme kinetics, including those important for clotting, and therefore measures to impede heat loss should be instituted [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/1\">",
"     1",
"    </a>",
"    ]. These include elevating the operating room temperature (&gt;85&ordm;F [25&ordm;C]), administering warmed fluids through an appropriate infusion device, and using other warming devices, such as a warm water heating pad or forced air convective heating blanket (eg, Bair hugger&reg;).",
"   </p>",
"   <p>",
"    The skin is prepared (eg, chlorhexidine-alcohol, betadine-alcohol) from the suprasternal notch to the mid-thighs, encompassing the entire anterior and lateral surfaces of the abdomen and chest. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10805?source=see_link\">",
"     \"Controversies in control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Autotransfusion devices should be used for red blood cell scavenging from extra-abdominal cavities (eg, pleural spaces) and combined with red cell scavenging devices in the operating room (eg, cell saver) provided gross peritoneal soilage from intestinal injury is absent. These techniques are part of a patient blood-management program to minimize allogeneic exposure to nonautologous blood. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10582?source=see_link\">",
"     \"Intraoperative and postoperative blood salvage\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     EXPLORATORY LAPAROTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;An exploratory laparotomy should be performed whenever the spleen requires surgical intervention due to trauma. All intraperitoneal structures are inspected, and the retroperitoneum explored as needed, depending upon the zone of retroperitoneal injury (eg, mandatory exploration for central [zone 1] injuries) and whether the mechanism is blunt or penetrating.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Incision",
"    </span>",
"    &nbsp;&mdash;&nbsp;A midline incision is performed because it is rapid, and allows for complete visualization and mobilization of intraperitoneal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    retroperitoneal structures. While the flank and chevron incision are appropriate for elective splenic surgery, we avoid these incisions in managing the injured spleen because entry into the abdomen is slower and exposure is more limited compared with that of the midline approach.",
"   </p>",
"   <p>",
"    The skin, subcutaneous tissue, and midline fascia (linea alba) are incised, leaving the peritoneum intact. Then, anesthesia personnel are informed, and should be prepared for blood loss, which may occur once the tamponade of the closed abdomen is released during the opening of the peritoneum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Packing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediately after opening the peritoneum, the abdomen is packed in all four quadrants. Laparotomy pads are first packed in quadrants where active extravasation has been noted on preoperative imaging studies or where bleeding appears most significant. The left upper quadrant is packed by retracting the abdominal wall away from the spleen and placing laparotomy pads into the space between the diaphragm and spleen, and between the lateral abdominal wall and spleen. Additional packs are placed between the spleen and splenic flexure of the colon, and anterior to the spleen. This method creates a \"sandwich,\" compressing the spleen between the laparotomy pads, which helps tamponade any active bleeding.",
"   </p>",
"   <p>",
"    In cases where a laparotomy pad count has not been performed prior to packing, and the abdomen is to be closed, a plain radiograph should be taken at the end of the operation to document whether or not any laparotomy pads have been left in place (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef64696 \" href=\"UTD.htm?26/1/26655\">",
"     image 1",
"    </a>",
"    ). For those patients who are managed with an open abdomen approach (damage control laparotomy), a confirmatory radiograph should be obtained when the operating team believes that they have removed all of the laparotomy pads that were left in place for hemorrhage control.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Abdominal exploration",
"    </span>",
"    &nbsp;&mdash;&nbsp;To explore the abdomen, the abdominal packs are deliberately removed in reverse order, and active bleeding is controlled as it is encountered before addressing any gastrointestinal contamination. The spleen can remain packed while addressing more urgent injuries, providing the packs adequately control the bleeding. Alternatively, if the spleen is suspected to be the sole or primary source of hemorrhage, it can be addressed first and the remaining packs can be left in place.",
"   </p>",
"   <p>",
"    After more life-threatening injuries have been addressed, attention can be directed toward the left-upper quadrant. Adequate inspection of the spleen generally requires full mobilization from its attachments.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Mobilization of the spleen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splenic mobilization is performed by dividing the spleen's ligamentous attachments to the diaphragm, kidney, stomach, and colon (",
"    <a class=\"graphic graphic_figure graphicRef52833 \" href=\"UTD.htm?15/7/15478\">",
"     figure 5",
"    </a>",
"    ). Once mobilization is complete, packs of laparotomy pads are placed behind and lateral to the spleen. During mobilization, bleeding from the spleen can be controlled by manually compressing the splenic vessels in the splenic hilum.",
"   </p>",
"   <p>",
"    The lateral attachments (ie, splenophrenic and splenorenal ligaments) are divided first. This is best accomplished by placing the left hand up and over the diaphragmatic surface of the spleen, gradually and carefully rotating and elevating it medially while dissecting the plane between the pancreas and kidney (eg, Metzenbaum scissors, cautery, blunt dissection).",
"   </p>",
"   <p>",
"    The gastrosplenic ligament is divided, and the short gastric vessels contained within it clamped, divided, and suture ligated. Suture ligation is important in managing the short gastric vessels, because postoperative gastric distension can push off a simple tie and lead to postoperative bleeding. Care is also taken not to entrap the gastric wall in the suture, which can result in tissue necrosis and gastric perforation. The splenocolic ligament is divided to complete splenic mobilization.",
"   </p>",
"   <p>",
"    Following mobilization, the spleen is inspected and an intraoperative splenic injury grade determined. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=see_link&amp;anchor=H8#H8\">",
"     \"Management of splenic injury in the adult trauma patient\", section on 'Splenic injury grading'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SPLENECTOMY VERSUS SALVAGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decision to perform splenectomy versus splenic salvage (ie, splenorrhaphy, partial splenectomy) is made based upon the grade of injury, presence of associated injuries, patient's overall condition, and experience of the surgeon. The small future risk of overwhelming postsplenectomy sepsis needs to be balanced against the more significant risk of recurrent hemorrhage.",
"   </p>",
"   <p>",
"    Splenectomy is a life-saving procedure when bleeding from the spleen is the cause of hemodynamic instability. Splenic salvage was extensively practiced in the 1980s and up to the mid-1990s; however, splenectomy is consistently more commonly used, likely because more lower grade injuries in hemodynamically stable patients are managed nonoperatively. When considering splenic salvage, the surgeon must determine whether the patient can tolerate rebleeding and reoperation for the small, but real, risk of recurrent hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. Splenectomy is often a more appropriate choice for patients with multiple injuries or comorbidities who may not tolerate a significant or recurrent episode of hypotension or a second surgical procedure.",
"   </p>",
"   <p>",
"    Splenectomy is also more appropriate for patients requiring urgent surgical management of other significant injuries that preclude taking the extra time needed for splenic salvage. In the setting of damage control, delayed splenic salvage can be considered (within 24 to 48 hours) for low-grade splenic injuries, provided that the bleeding is controlled with packing. Splenectomy is the safest option, given that most patients who require damage-control surgery are on the brink of physiological collapse, are hypothermic, acidotic, coagulopathic, and will likely only poorly tolerate recurrent hemorrhage.",
"   </p>",
"   <p>",
"    Splenectomy may also be the best option for surgeons whose institutional resources cannot support nonoperative management of splenic injury or who do not have adequate experience with splenic salvage. Lower-grade splenic injuries (I to III) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68648 \" href=\"UTD.htm?37/12/38083\">",
"     image 2",
"    </a>",
"    ) are the most conducive to splenic salvage techniques; however, the shift toward nonoperative management with angiographic embolization has decreased the number of patients who would be ideal candidates for operative splenic salvage techniques. As such, individual surgeon experience with splenic salvage has declined [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=see_link&amp;anchor=H14#H14\">",
"     \"Management of splenic injury in the adult trauma patient\", section on 'Splenic embolization'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SPLENIC SALVAGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of splenic salvage techniques published in journals and textbooks, though no formal comparisons have been made. The selection of specific techniques, materials, and sutures are dependent on individual surgeon experience and preference. Observational management, with or without splenic embolization, has made splenic salvage an infrequent procedure in surgical practice. Most patients who fail nonoperative management will require a splenectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Splenorrhaphy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splenorrhaphy refers to the suture repair of the spleen with or without splenic wrapping, and is generally supplemented by electrocautery techniques for control of parenchymal hemorrhage.",
"   </p>",
"   <p>",
"    Intraparenchymal bleeding is controlled first, followed by reapproximation of the splenic tissue and capsule when possible. Hemostasis can be achieved with topical hemostatic agents, electrocautery, or argon beam coagulation [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. The choice depends upon availability and surgeon preference. A mass closure technique using absorbable sutures, with or without supporting pledgets, is used to reapproximate the splenic tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. When reapproximation of the tissue is not feasible, due to tissue friability, a tongue of omentum can be laid into the open defect and sutured into place.",
"   </p>",
"   <p>",
"    The spleen can be wrapped in an absorbable hemostatic mesh to facilitate tissue approximation and effect tamponade. The use of mesh does not appear to be associated with increased infection rates, even in patients who underwent mesh splenorrhaphy and concomitant bowel repair [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/12\">",
"     12",
"    </a>",
"    ]. Splenic wrapping, however, can be time consuming, particularly in inexperienced hands, and has the potential to cause splenic ischemia if the wrapping is too tight at the hilum, or may allow recurrent hemorrhage if the wrap is too loose. Significant residual bleeding in spite of repair indicates the need for splenectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Partial splenectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Partial splenectomy is a form of splenic salvage and refers to the removal of a portion of the spleen based upon its segmental blood supply. Partial splenectomy leaves behind a raw surface, which may have an unacceptably high risk of recurrent hemorrhage, especially in patients with coagulopathy and those at risk for high venous pressures (eg, portal vein injury, pre-existing cirrhosis). Accordingly, partial splenectomy is an infrequently selected technique to manage splenic injury.",
"   </p>",
"   <p>",
"    The hilar vessels supplying the irreparably damaged portion of spleen are ligated and divided. After the surface of the spleen demarcates into viable and nonviable portions, the nonviable portion is removed using a scalpel or electrocautery. The cut edge of the remaining spleen is managed with the splenorrhaphy techniques discussed above. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Anatomy of the spleen'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SPLENECTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splenectomy removes the entire spleen. Following mobilization, the splenic artery and vein at the hilum are isolated. Each vessel is, ideally, individually ligated and divided to prevent the potential development of an arteriovenous fistula.",
"   </p>",
"   <p>",
"    Care is taken during the isolation and ligation of the hilar vessels to identify and avoid injury to the tail of the pancreas, which is adjacent to the splenic hilum.",
"   </p>",
"   <p>",
"    Once the spleen is removed, the splenic bed is examined for bleeding. Because the region of the splenic bed is deep in the left upper quadrant, bleeding may not be easily visualized. One useful technique is to roll up a laparotomy pad, place it into the left upper quadrant, and slowly roll it toward the divided hilar vessels. Blood that appears on the pad indicates the location requiring further hemostasis.",
"   </p>",
"   <p>",
"    The greater curvature of the stomach is reexamined to ensure control of the divided short gastric vessels. If there is any concern that a tie is encroaching on the gastric wall, that area of gastric wall can be inverted with sutures placed in a Lembert fashion.",
"   </p>",
"   <p>",
"    We do not routinely use drains unless there is concern for another injury that might benefit from closed drainage (eg, known or suspected pancreatic injury, renal collecting system injury). (See",
"    <a class=\"local\" href=\"#H34\">",
"     'Postsplenectomy sepsis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6820137\">",
"    <span class=\"h2\">",
"     Replantation of splenic tissue",
"    </span>",
"    &nbsp;&mdash;&nbsp;If splenectomy for injury is deemed necessary, heterotopic autotransplantation of splenic tissue into omental pockets may provide some splenic function, although this has not been proven conclusively [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. One study that compared the computed volume of splenic tissue identified using scintigraphy with red blood cell pit counts found that 20 to 30 cm",
"    <sup>",
"     3",
"    </sup>",
"    of implanted tissue was sufficient to provide return of some splenic function [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/15\">",
"     15",
"    </a>",
"    ]. However, the degree of clinical immunologic protection offered by this splenic tissue is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/14,16\">",
"     14,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Deliberate autotransplantation of splenic tissue into omental pockets is a relatively simple procedure, but requires a patient without severe concomitant injury who is hemodynamically stable and without acidosis, hypothermia or coagulopathy. These conditions are rarely met, and thus, heterotopic autotransplantation is generally not performed in the setting of acute injury [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Autotransplantation, termed splenosis, is discussed below. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Splenosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     LAPAROSCOPIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Open exploration remains the standard of care for surgical intervention. While the laparoscopic approach has been described in case reports and small case series [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/19-31\">",
"     19-31",
"    </a>",
"    ], a laparoscopic approach to manage splenic injury should only be considered in select cases. For example, a low-grade injury found during diagnostic laparoscopy for penetrating trauma with minimal-to-no hemorrhage in a hemodynamically stable patient, may be amenable to laparoscopic repair, or if needed, laparoscopic splenectomy.",
"   </p>",
"   <p>",
"    The laparoscopic approach is hampered by inadequate visualization due to ongoing hemorrhage and potential hypotension (ie, decreased venous return from pneumoperitoneum). Due to the general success of nonoperative management strategies, surgical intervention is more typically performed in patients who are hemodynamically unstable. Under these circumstances, laparoscopic exploration is contraindicated due to the potential for further hemodynamic compromise.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Much of the postoperative course following surgical management for splenic injury is dictated by the presence of associated injuries.",
"   </p>",
"   <p>",
"    Serial hematocrits and platelet counts are obtained following splenic repair or splenorrhaphy to monitor for postoperative bleeding and thrombocytosis. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Thrombocytosis'",
"    </a>",
"    below.) There is no optimal regimen; however, we check the hematocrit every eight hours for the first 24 hours. Patients who have undergone splenic repair should be monitored similarly to those who are undergoing nonoperative management. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=see_link&amp;anchor=H10#H10\">",
"     \"Management of splenic injury in the adult trauma patient\", section on 'Nonoperative management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients who have had upper abdominal surgery are at a higher-than-average risk for pulmonary complications due to pain associated with the abdominal incision and splinting. Therefore, deep breathing exercises, incentive spirometry, or positive expiratory pressure devices should be instituted to address the potential for significant atelectasis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/51/13113?source=see_link&amp;anchor=H17#H17\">",
"     \"Strategies to reduce postoperative pulmonary complications\", section on 'Postoperative strategies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who are discharged with staples, sutures, or drains in place should follow up with their surgeon within one to two weeks. Some patients require a more prolonged hospitalization and recovery from multiple associated injuries. These patients should be monitored by their surgeon for postoperative complications. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Surgical outcomes and complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Thrombocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The platelet count should be monitored in patients who have developed thrombocytosis in the postoperative period. A modest secondary reactive thrombocytosis following injury without splenectomy occurs in about 20 percent of patients and is due to increases in circulating thrombopoietin, interleukin 6, and other inflammatory mediators [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Following splenectomy, reactive thrombocytosis occurs in 75 to 82 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/34\">",
"     34",
"    </a>",
"    ]. The platelet count commonly increases 30 to 100 percent following splenectomy, usually peaking between 7 and 20 days postoperatively, and then falling to normal levels over weeks to months, but sometimes over years [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/34\">",
"     34",
"    </a>",
"    ]. Counts exceeding",
"    <span class=\"nowrap\">",
"     1,000,000/mcL",
"    </span>",
"    are not uncommon following splenectomy.",
"   </p>",
"   <p>",
"    Thrombocytosis may cause platelet aggregation, which may lead to vessel thrombosis which is not reliably predictable. Thrombocytosis alone is not usually sufficient to lead to clinically significant thrombosis. While most patients with secondary thrombocytosis do not require specific therapy, postoperative patients at high risk for venous thrombosis (eg, thrombophilia, cancer), who have concomitant thrombocytosis may be treated with antiplatelet therapy (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    ). Data are lacking on whether aspirin therapy yields a significant outcome benefit, and for which patient population. Therapy may be instituted when the platelet count exceeds",
"    <span class=\"nowrap\">",
"     1,000,000/mcL,",
"    </span>",
"    if not contraindicated (eg, cerebral trauma). When extreme thrombocytosis (platelet count",
"    <span class=\"nowrap\">",
"     &gt;1,000,000/mcL)",
"    </span>",
"    is coupled with evidence of venous or arterial thrombosis, additional treatment may be required to treat symptoms. The management of patients with thrombophilia and acute thrombosis is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/6/24681?source=see_link\">",
"     \"Approach to the patient with thrombocytosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Immunizations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following splenectomy, the patient should be immunized against encapsulated organisms. Following splenorrhaphy or partial splenectomy, the need to immunize is unclear. Issues pertaining to immunization and timing are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=see_link&amp;anchor=H21#H21\">",
"     \"Management of splenic injury in the adult trauma patient\", section on 'Immunocompetence after splenic injury'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Postsplenectomy identification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient should have identification (eg, bracelet, necklace, wallet card) to notify future health-care providers of prior splenectomy, in the event the patient is unable to do so.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Splenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splenosis consists of transplanted splenic tissue, which, if spontaneous, can be located anywhere within the abdomen or pelvis. The nodules associated with splenosis contain functioning splenic tissue and are usually multiple, with each measuring a few millimeters to a few centimeters in diameter [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/13\">",
"     13",
"    </a>",
"    ]. The presence of splenosis may provide a critical mass of splenic tissue to confer some degree of splenic immunocompetence to the individual, but splenosis may not provide full protection against infection due to small size or poor vascularization [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/14,16\">",
"     14,16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/34/34346?source=see_link&amp;anchor=H6#H6\">",
"     \"Approach to the adult patient with splenomegaly and other splenic disorders\", section on 'Splenosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=see_link&amp;anchor=H21#H21\">",
"     \"Management of splenic injury in the adult trauma patient\", section on 'Immunocompetence after splenic injury'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Splenosis as a consequence of splenic injury is a common benign condition requiring no specific therapy, but which may mimic malignancy or endometriosis on diagnostic studies. The nodules can be grossly distinguished from accessory spleens by the absence of a hilum, capsule, and trabeculae, and location that is often not in association with the splenopancreatic or gastrosplenic ligaments [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SURGICAL OUTCOMES AND COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Morbidity and mortality in multitrauma patients are highly dependent upon the nature and severity of other injuries and medical comorbidities. The mortality rate for patients undergoing surgery for isolated splenic injury is also dependent on the grade of injury, as well as the presence or absence of shock. Mortality can be as high as 22 percent for Grade V injury [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients undergoing splenic salvage or splenectomy are at risk for the commonly reported complications of patients undergoing other abdominal procedures (eg, surgical site infection, ileus, urinary tract infection). Pulmonary complications are the most common complications following splenic surgery after injury with atelectasis found in 38 percent, pneumonia in 9 percent, and pleural effusion in 6 percent of patients in one retrospective study [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Postoperative care'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Postoperative bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common sources of bleeding following splenectomy include the raw edges of the divided splenic attachments, and short gastric or hilar vessel remnants. Bleeding that requires reoperation after isolated splenectomy is rare, but has been reported to occur in 1.6 percent of patients in one series, and may involve hemorrhage from surrounding structures (eg, pancreatic tail) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Gastric perforation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastric perforation is uncommon (case reports only) but can result from necrosis of the gastric wall from the effects of the initial trauma, or ligation of the short gastric vessels where gastric wall tissue is incorporated into the suture ligature. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Splenectomy'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Vascular thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thrombosis occurs in approximately 5 percent of patients following splenectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. Thrombosis of any vein can occur, but the portal, mesenteric, and splenic veins appear to be affected more often [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/41\">",
"     41",
"    </a>",
"    ]. Thrombocytosis may increase the risk for venous or arterial thrombosis following splenectomy, though the relationship between thrombocytosis and thrombosis remains unclear. The relative contributions of immobility, thrombogenic fluid administration, other injuries, repeat operation, recurrent hypotension, and other factors may contribute more to thrombotic complications than thrombocytosis. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Thrombocytosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Pancreatic fistula",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic fistula develops in approximately 1.5 percent of patients following splenectomy, due to injury of the tail of the pancreas, either from the initial trauma or due to splenic hilar dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Mobilization of the spleen'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Any patient who develops left upper quadrant pain, fever, and leukocytosis after splenectomy should be imaged with ultrasound or CT scan to identify any left upper quadrant fluid collections. The diagnosis of pancreatic fistula can be made by guided percutaneous fluid sampling, demonstrating amylase-rich fluid indicative of a pancreatic leak. Cultures of the fluid should also be sent to rule out an abscess, which is more common than a pancreatic leak.",
"   </p>",
"   <p>",
"    In addition to percutaneous drainage of pancreatic fluid, endoscopic management (ERCP with stenting) can be used to promote internal drainage of pancreatic secretions, which reduces flow through the fistula tract. The diagnosis and management of pancreatic fistula are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23878?source=see_link&amp;anchor=H12#H12\">",
"     \"Treatment of pancreatic fistulas\", section on 'Endoscopic treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Perioperative infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following splenectomy, the patient is at a small but increased risk for postoperative infection [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Splenic preservation in patients with blunt splenic injury by operative or nonoperative management has been reported to lead to lower early infection rates (in adults) compared with splenectomy. As an example, one prospective study reported adult patients managed with observation, splenic repair, and splenectomy had postoperative infection rates of 5, 15, and 49 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/42\">",
"     42",
"    </a>",
"    ]. It is unclear whether the determining factor was the preservation of splenic tissue, or a reflection of injury severity allowing observation or requiring splenectomy. Pneumonia was the most common postoperative infection in all three groups, but not all infections were due to encapsulated organisms.",
"   </p>",
"   <p>",
"    Intra-abdominal abscess complicates splenectomy in 3 to 13 percent of patients, and is associated with concomitant intestinal tract injuries, and the presence of splenic bed drains [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Postsplenectomy sepsis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postsplenectomy sepsis is a fulminant and rapidly fatal illness due to encapsulated pathogens [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. The incidence of postsplenectomy sepsis associated with splenic injury appears to be lower than that for splenectomy performed for other indications. Autotransplantation of splenic tissue at the time of the injury (ie, splenosis) may provide a critical mass of splenic tissue to confer some degree of splenic immunocompetence to the patient, although this is not reliably established [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7049/abstract/45\">",
"     45",
"    </a>",
"    ]. An alternate explanation is that splenectomy for trauma is more commonly performed in otherwise healthier (notwithstanding their traumatic injuries) individuals who have fewer medical comorbidities as compared with those undergoing splenectomy for other reasons. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/42/9895?source=see_link\">",
"     \"Clinical features and management of sepsis in the asplenic patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Emergent surgical exploration of the abdomen is indicated for hemodynamically unstable trauma patients who have a positive focused assessment with sonography in trauma (FAST exam) or diagnostic peritoneal",
"      <span class=\"nowrap\">",
"       aspiration/lavage",
"      </span>",
"      <span class=\"nowrap\">",
"       (DPA/DPL)",
"      </span>",
"      to control life-threatening hemorrhage, which may be due to an injured spleen. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications for exploration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Exploratory laparotomy for trauma consists of initial control of hemorrhage by abdominal cavity packing, followed by systematic inspection of all intraperitoneal structures, followed by exploration of the retroperitoneum, as needed, depending upon the zone of retroperitoneal injury. Active bleeding is managed prior to addressing gastrointestinal injury. The spleen may remain packed to address more urgent injuries, provided the packs adequately control bleeding. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Exploratory laparotomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Indications for surgical exploration in the hemodynamically stable trauma patient with splenic injury include a contraindication to nonoperative management, evidence of another intra-abdominal injury requiring surgery, and failure of nonoperative management. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications for exploration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Open surgical techniques to manage splenic injury include partial or total splenectomy or splenorrhaphy (ie, splenic repair). The choice of technique depends upon the extent of splenic injury, the presence of associated injuries, medical comorbidities, the experience of the surgeon, as well as the hemodynamic stability of the patient. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Splenectomy versus salvage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For hemodynamically unstable patients with ongoing bleeding from splenic injury, splenectomy is a necessary, life-saving procedure. For patients requiring urgent surgical management of other significant injuries, splenectomy is more appropriate than splenic salvage. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Splenectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who have failed nonoperative management, including splenic embolization, we suggest splenectomy over operative splenic salvage (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For splenic injury, we suggest an open approach via conventional laparotomy over a laparoscopic approach (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The role of laparoscopy in the management of the injured spleen is not yet defined. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Laparoscopic approach'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/1\">",
"      Tsuei BJ, Kearney PA. Hypothermia in the trauma patient. Injury 2004; 35:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/2\">",
"      Root HD. Splenic injury: angiogram vs. operation. J Trauma 2007; 62:S27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/3\">",
"      Dent D. Splenic injury: angio vs. operation. J Trauma 2007; 62:S26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/4\">",
"      Franklin GA, Cas&oacute;s SR. Current advances in the surgical approach to abdominal trauma. Injury 2006; 37:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/5\">",
"      Casali M, Di Saverio S, Tugnoli G, et al. [Penetrating abdominal trauma: 20 years experience in a Western European Trauma Center]. Ann Ital Chir 2008; 79:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/6\">",
"      Harbrecht BG, Zenati MS, Ochoa JB, et al. Evaluation of a 15-year experience with splenic injuries in a state trauma system. Surgery 2007; 141:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/7\">",
"      Louredo AM, Alonso A, de Llano J JA, et al. [Usefulness of absorbable meshes in the management of splenic trauma]. Cir Esp 2005; 77:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/8\">",
"      Achneck HE, Sileshi B, Jamiolkowski RM, et al. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg 2010; 251:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/9\">",
"      Go PM, Goodman GR, Bruhn EW, Hunter JG. The argon beam coagulator provides rapid hemostasis of experimental hepatic and splenic hemorrhage in anticoagulated dogs. J Trauma 1991; 31:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/10\">",
"      Styrt B. Infection associated with asplenia: risks, mechanisms, and prevention. Am J Med 1990; 88:33N.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/11\">",
"      Tsaroucha AK, Pitiakoudis MS, Chanos G, et al. U-stitching splenorraphy technique: experimental and clinical study. ANZ J Surg 2005; 75:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/12\">",
"      Berry MF, Rosato EF, Williams NN. Dexon mesh splenorrhaphy for intraoperative splenic injuries. Am Surg 2003; 69:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/13\">",
"      Fremont RD, Rice TW. Splenosis: a review. South Med J 2007; 100:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/14\">",
"      Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet 2011; 378:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/15\">",
"      Corazza GR, Tarozzi C, Vaira D, et al. Return of splenic function after splenectomy: how much tissue is needed? Br Med J (Clin Res Ed) 1984; 289:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/16\">",
"      Connell NT, Brunner AM, Kerr CA, Schiffman FJ. Splenosis and sepsis: The born-again spleen provides poor protection. Virulence 2011; 2:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/17\">",
"      Di Carlo I, Pulvirenti E, Toro A. A new technique for spleen autotransplantation. Surg Innov 2012; 19:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/18\">",
"      Pisters PW, Pachter HL. Autologous splenic transplantation for splenic trauma. Ann Surg 1994; 219:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/19\">",
"      Pucci E, Brody F, Zemon H, et al. Laparoscopic splenectomy for delayed splenic rupture after embolization. J Trauma 2007; 63:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/20\">",
"      Kaban GK, Novitsky YW, Perugini RA, et al. Use of laparoscopy in evaluation and treatment of penetrating and blunt abdominal injuries. Surg Innov 2008; 15:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/21\">",
"      Becker HP, Willms A, Schwab R. [Laparoscopy for abdominal trauma]. Chirurg 2006; 77:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/22\">",
"      Stein DM, Scalea TM. Nonoperative management of spleen and liver injuries. J Intensive Care Med 2006; 21:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/23\">",
"      Ren CJ, Salky B, Reiner M. Hand-assisted laparoscopic splenectomy for ruptured spleen. Surg Endosc 2001; 15:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/24\">",
"      Basso N, Silecchia G, Raparelli L, et al. Laparoscopic splenectomy for ruptured spleen: lessons learned from a case. J Laparoendosc Adv Surg Tech A 2003; 13:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/25\">",
"      Huscher CG, Mingoli A, Sgarzini G, et al. Laparoscopic treatment of blunt splenic injuries: initial experience with 11 patients. Surg Endosc 2006; 20:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/26\">",
"      Carobbi A, Romagnani F, Antonelli G, Bianchini M. Laparoscopic splenectomy for severe blunt trauma: initial experience of ten consecutive cases with a fast hemostatic technique. Surg Endosc 2010; 24:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/27\">",
"      Feliz A, Shultz B, McKenna C, Gaines BA. Diagnostic and therapeutic laparoscopy in pediatric abdominal trauma. J Pediatr Surg 2006; 41:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/28\">",
"      Taner AS, Topgul K, Kucukel F, et al. Diagnostic laparoscopy decreases the rate of unnecessary laparotomies and reduces hospital costs in trauma patients. J Laparoendosc Adv Surg Tech A 2001; 11:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/29\">",
"      Kawahara NT, Alster C, Fujimura I, et al. Standard examination system for laparoscopy in penetrating abdominal trauma. J Trauma 2009; 67:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/30\">",
"      Sauerland S, Agresta F, Bergamaschi R, et al. Laparoscopy for abdominal emergencies: evidence-based guidelines of the European Association for Endoscopic Surgery. Surg Endosc 2006; 20:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/31\">",
"      Ayiomamitis GD, Alkari B, Owera A, Ammori BJ. Emergency laparoscopic splenectomy for splenic trauma in a Jehovah's Witness patient. Surg Laparosc Endosc Percutan Tech 2008; 18:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/32\">",
"      Valade N, Decailliot F, R&eacute;bufat Y, et al. Thrombocytosis after trauma: incidence, aetiology, and clinical significance. Br J Anaesth 2005; 94:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/33\">",
"      Ahmed R, Isaac AM. Postsplenectomy thrombocytosis and pseudohyperkalemia in trauma: a case report and review of literature. J Trauma 2009; 67:E17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/34\">",
"      Khan PN, Nair RJ, Olivares J, et al. Postsplenectomy reactive thrombocytosis. Proc (Bayl Univ Med Cent) 2009; 22:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/35\">",
"      Tinkoff G, Esposito TJ, Reed J, et al. American Association for the Surgery of Trauma Organ Injury Scale I: spleen, liver, and kidney, validation based on the National Trauma Data Bank. J Am Coll Surg 2008; 207:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/36\">",
"      Clancy TV, Ramshaw DG, Maxwell JG, et al. Management outcomes in splenic injury: a statewide trauma center review. Ann Surg 1997; 226:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/37\">",
"      Livingston CD, Sirinek KR, Levine BA, Aust JB. Traumatic splenic injury: its management in a patient population with a high incidence of associated injury. Arch Surg 1982; 117:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/38\">",
"      Shackford SR, Molin M. Management of splenic injuries. Surg Clin North Am 1990; 70:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/39\">",
"      Boxer MA, Braun J, Ellman L. Thromboembolic risk of postsplenectomy thrombocytosis. Arch Surg 1978; 113:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/40\">",
"      Watters JM, Sambasivan CN, Zink K, et al. Splenectomy leads to a persistent hypercoagulable state after trauma. Am J Surg 2010; 199:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/41\">",
"      Stamou KM, Toutouzas KG, Kekis PB, et al. Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg 2006; 141:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/42\">",
"      Gauer JM, Gerber-Paulet S, Seiler C, Schweizer WP. Twenty years of splenic preservation in trauma: lower early infection rate than in splenectomy. World J Surg 2008; 32:2730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/43\">",
"      Schwartz PE, Sterioff S, Mucha P, et al. Postsplenectomy sepsis and mortality in adults. JAMA 1982; 248:2279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/44\">",
"      Forsythe RM, Harbrecht BG, Peitzman AB. Blunt splenic trauma. Scand J Surg 2006; 95:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7049/abstract/45\">",
"      Shatz DV. Vaccination practices among North American trauma surgeons in splenectomy for trauma. J Trauma 2002; 53:950.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7955 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-806F72AFFC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7049=[""].join("\n");
var outline_f6_56_7049=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H35\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS FOR EXPLORATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMY OF THE SPLEEN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Preoperative",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Type and crossmatch",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Prophylactic antibiotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Prophylactic immunization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Patient/family counseling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Intraoperative",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      EXPLORATORY LAPAROTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Incision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Packing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Abdominal exploration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Mobilization of the spleen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SPLENECTOMY VERSUS SALVAGE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SPLENIC SALVAGE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Splenorrhaphy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Partial splenectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SPLENECTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6820137\">",
"      Replantation of splenic tissue",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      LAPAROSCOPIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      POSTOPERATIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      POSTOPERATIVE ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Thrombocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Immunizations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Postsplenectomy identification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Splenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SURGICAL OUTCOMES AND COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Postoperative bleeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Gastric perforation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Vascular thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Pancreatic fistula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Perioperative infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Postsplenectomy sepsis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/7955\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/7955|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/1/26655\" title=\"diagnostic image 1\">",
"      Plain abdominal film of retained surgical sponge",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/12/38083\" title=\"diagnostic image 2\">",
"      Splenic injury on computed tomography of the abdomen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/7955|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/51/7999\" title=\"figure 1\">",
"      Anterior view of upper abdominal structures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/21/9557\" title=\"figure 2\">",
"      Vascular supply of the spleen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/29/33234\" title=\"figure 3\">",
"      Visceral surface spleen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/36/33351\" title=\"figure 4\">",
"      Structure of the spleen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/7/15478\" title=\"figure 5\">",
"      Upper abdominal cross-sectional anatomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/34/34346?source=related_link\">",
"      Approach to the adult patient with splenomegaly and other splenic disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/6/24681?source=related_link\">",
"      Approach to the patient with thrombocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/42/9895?source=related_link\">",
"      Clinical features and management of sepsis in the asplenic patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10805?source=related_link\">",
"      Controversies in control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/54/3943?source=related_link\">",
"      Initial evaluation and management of abdominal gunshot wounds in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12776?source=related_link\">",
"      Initial evaluation and management of abdominal stab wounds in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=related_link\">",
"      Initial evaluation and management of blunt abdominal trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=related_link\">",
"      Initial evaluation and management of blunt thoracic trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10582?source=related_link\">",
"      Intraoperative and postoperative blood salvage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=related_link\">",
"      Management of splenic injury in the adult trauma patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/25/38294?source=related_link\">",
"      Massive blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/51/13113?source=related_link\">",
"      Strategies to reduce postoperative pulmonary complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23878?source=related_link\">",
"      Treatment of pancreatic fistulas",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_56_7050="Respiratory syncytial virus infection: Clinical features and diagnosis";
var content_f6_56_7050=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Respiratory syncytial virus infection: Clinical features and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/56/7050/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/56/7050/contributors\">",
"     Frederick E Barr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/56/7050/contributors\">",
"     Barney S Graham, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/56/7050/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/56/7050/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/56/7050/contributors\">",
"     Gregory Redding, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/56/7050/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/56/7050/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/56/7050/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory syncytial virus (RSV) causes acute respiratory tract illness in persons of all ages. The clinical manifestations vary with age, health status, and whether the infection is primary or secondary.",
"   </p>",
"   <p>",
"    The epidemiology, microbiology, clinical manifestations, and diagnosis of RSV infection will be presented here. The treatment and prevention of RSV infection and the treatment of bronchiolitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/27/38327?source=see_link\">",
"     \"Respiratory syncytial virus infection: Treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/19/27962?source=see_link\">",
"     \"Bronchiolitis in infants and children: Treatment; outcome; and prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Seasonality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory syncytial virus (RSV) causes seasonal outbreaks throughout the world. In the northern hemisphere, these usually occur from November to April, with a peak in January or February [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In the southern hemisphere, wintertime epidemics occur from May to September, with a peak in May, June, or July. In tropical and semitropical climates, the seasonal outbreaks usually are associated with the rainy season. The epidemic peaks are not as sharp as in temperate climates, and in some settings RSV can be isolated in as many as eight months of the year [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Morbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory syncytial virus (RSV) causes acute respiratory tract illness in persons of all ages. Almost all children are infected by two years of age, and reinfection is common [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     In children",
"    </span>",
"    &nbsp;&mdash;&nbsp;RSV is the most common cause of lower respiratory tract infection (LRTI) in children younger than one year [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/2\">",
"     2",
"    </a>",
"    ]. Each year in the United States, it is associated with an estimated 132,000 to 172,000 pediatric hospitalizations among children younger than five years and is increasing in frequency [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Although the rate of hospitalization is greatest in children younger than three months of age, more than 40 percent of total hospitalizations in the under five age group occur in children older than one year. Globally, it is estimated that RSV causes about 34 million episodes of acute lower respiratory infections in children younger than five years, resulting in about 3.4 million hospitalizations per year [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     In adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;RSV also is a significant and often unrecognized cause of LRTI in both elderly and immunosuppressed patients [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. It is estimated that RSV may be responsible for as much as 25 percent of excess wintertime mortality, previously attributed solely to influenza [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/13\">",
"     13",
"    </a>",
"    ]. The epidemiology and clinical impact of RSV was compared with influenza in a large prospective cohort study of respiratory illnesses in 608 healthy elderly patients, 540 high-risk adults, and 1388 hospitalized patients [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/14\">",
"     14",
"    </a>",
"    ]. Diagnostic testing for RSV and influenza infection included culture, reverse-transcriptase polymerase chain reaction (RT-PCR), and serology. The study results were significant for the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The annual incidence of RSV infection in the prospective cohorts averaged 5.5 percent and was relatively constant during the four years and nearly twice that of influenza A",
"     </li>",
"     <li>",
"      RSV infection developed annually in 3 to 7 percent of the healthy elderly group and in 4 to 10 percent in the high-risk group",
"     </li>",
"     <li>",
"      In the hospitalized cohort, RSV infection and influenza A resulted in comparable lengths of stay, need for intensive care monitoring, and mortality (8 and 7 percent, respectively)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Acute respiratory disease caused by RSV is not restricted to pediatric and high-risk adult populations. Healthy adults are infected repeatedly throughout their lives and typically have symptoms restricted to the upper respiratory tract. In a study of 256 military trainees with respiratory symptoms, RSV infection was identified in 11 percent of patients through serologic testing and real-time PCR [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/15\">",
"     15",
"    </a>",
"    ]. Other identified viral pathogens included adenovirus (48 percent), influenza (11 percent), parainfluenza (3 percent), and enterovirus (&lt;1 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;In data compiled by the Centers for Disease Control, RSV pneumonia has been blamed for an average of 2700 adult and pediatric deaths each year [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/13\">",
"     13",
"    </a>",
"    ]. Globally, it is estimated to result in as many as 199,000 deaths per year [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients at risk for lower respiratory tract disease include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infants younger than six months of age [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/16\">",
"       16",
"      </a>",
"      ], particularly those who are born during the first half of the RSV season and those attending daycare [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/17,18\">",
"       17,18",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Infants and children with underlying lung disease, such as chronic lung disease (bronchopulmonary dysplasia) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/2,16,19\">",
"       2,16,19",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Infants born before 35 weeks' gestation [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/16,19\">",
"       16,19",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Infants and children with congenital heart disease [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/16,20,21\">",
"       16,20,21",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Infants exposed to secondhand smoke [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/22,23\">",
"       22,23",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Immunocompromised patients (eg, severe combined immunodeficiency, leukemia, or bone marrow or lung transplant) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/20,24-27\">",
"       20,24-27",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Patients of any age group with significant asthma",
"     </li>",
"     <li>",
"      Adults with cardiopulmonary disease [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/28\">",
"       28",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Residence at altitude &gt;2500 m [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/29\">",
"       29",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Institutionalized elderly [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/11\">",
"       11",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Elderly patients with chronic pulmonary disease or functional disability [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/30\">",
"       30",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Genetic predisposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies evaluating potential genetic predisposition to severe RSV disease have revealed associations with polymorphisms in cytokine- and chemokine-related genes including IL-4 and its receptor, IL-8, IL-10, IL-13 and CCR5 [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/31-36\">",
"     31-36",
"    </a>",
"    ]. Genetic polymorphisms in genes related to potential virus-cell surface interactions or cell signaling such as TLR-4, CX3CR1, SP-A, and SP-D also have been associated with severe RSV disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/37-41\">",
"     37-41",
"    </a>",
"    ]. These types of analyses will continue to expand understanding of disease pathogenesis and one day may improve the ability to predict which infants are predisposed to severe illness from RSV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory syncytial virus (RSV) is a single-stranded, negative-sense RNA virus and a member of the",
"    <em>",
"     Paramyxoviridae",
"    </em>",
"    family. Two subtypes, A and B, are simultaneously present in most outbreaks, with A subtypes typically causing more severe disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/42-46\">",
"     42-46",
"    </a>",
"    ]. Several distinct genotypes within these subtypes predominate within a community; the dominant strains shift yearly, perhaps accounting for frequent reinfections [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/42,47\">",
"     42,47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transmission of RSV is primarily by inoculation of nasopharyngeal or ocular mucous membranes after contact with virus-containing secretions or fomites [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. Direct contact is the most common route of transmission, but large aerosol droplets also have been implicated [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. RSV can survive for several hours on hands and fomites [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/42\">",
"     42",
"    </a>",
"    ]. Hand washing and contact precautions are therefore important measures to prevent nosocomial spread. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15640?source=see_link&amp;anchor=H104278849#H104278849\">",
"     \"Respiratory syncytial virus infection: Prevention\", section on 'Nosocomial infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The period of viral shedding usually is three to eight days, but it may last up to four weeks in young infants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Incubation period",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incubation period is usually four to six days (range two to eight days) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although virtually all individuals have been infected with RSV by age three years, previous infection with RSV does not appear to convey complete protection against reinfection, even when significant specific antibody titers are present [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/52\">",
"     52",
"    </a>",
"    ]. Humoral immunity may be more important in ameliorating the severity of RSV infection than in preventing disease entirely, based upon the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Individuals can be infected more than once in the same RSV season; however, subsequent infections are usually milder whether they occur in the same season or in different years [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Transplacentally acquired antibody against RSV does not protect infants against infection. However, infants with high antibody titers usually have milder symptoms restricted to the upper respiratory tract [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/54\">",
"       54",
"      </a>",
"      ]. In a population-based study, mean cord blood RSV antibody titer was inversely correlated with RSV hospitalizations among infants younger than six months of age [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/55\">",
"       55",
"      </a>",
"      ]. As mean cord RSV antibody titers decreased, hospitalizations increased.",
"     </li>",
"     <li>",
"      Elderly individuals with lower IgG anti-RSV titers are significantly more likely to develop symptomatic RSV infection than are similar patients with higher titers [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The role of cellular immunity against RSV in humans is not defined, although there are many observations in animal models that have informed our understanding [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. It is hoped these and other insights will contribute to the development of an effective vaccine; however, results to date have been disappointing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15640?source=see_link&amp;anchor=H104278905#H104278905\">",
"     \"Respiratory syncytial virus infection: Prevention\", section on 'Vaccine development'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;After replicating in the nasopharynx, respiratory syncytial virus (RSV) infects the small bronchiolar epithelium, sparing the basal cells, then extends to the type 1 and 2 alveolar pneumocytes in lung, presumably by cell-to-cell spread or aspiration of secretions; lower respiratory tract infection (LRTI) occurs one to three days later [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. Pathologic findings of RSV include necrosis of epithelial cells, occasional proliferation of the bronchiolar epithelium, infiltrates of monocytes and T cells centered on bronchial and pulmonary arterioles, and neutrophils between the vascular structures and small airways [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/58,60\">",
"     58,60",
"    </a>",
"    ]. This leads to airway obstruction, air trapping, and increased airway resistance, and also is associated with a finding of neutrophilia in bronchoalveolar lavage [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    RSV is highly restricted to the respiratory epithelium and is shed apically into the lumen of the airways. In very rare cases, RSV may be recovered from extrapulmonary tissues, such as liver [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/62\">",
"     62",
"    </a>",
"    ], cerebrospinal fluid (CSF) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/63\">",
"     63",
"    </a>",
"    ], or pericardial fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/64\">",
"     64",
"    </a>",
"    ]. RSV has never been isolated from blood, although two reports have identified evidence of RSV genome by polymerase chain reaction in blood [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. Since there is evidence that viable virus is rarely present in extrapulmonary tissue, the PCR findings may represent phagocytized virus present in circulating monocytes.",
"   </p>",
"   <p>",
"    The immune response to RSV, especially cytokine and chemokine release, appears to play a role in the pathogenesis and severity of bronchiolitis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/67-72\">",
"     67-72",
"    </a>",
"    ]. The cytokines IL-8, IL-6, TNF-alpha, and IL-1 beta can be detected in airway secretions of infected children [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/73-75\">",
"     73-75",
"    </a>",
"    ], and IL-6 levels correlate with severe disease. Chemokines identified in respiratory tract secretions of children include CCL3 (macrophage inflammatory protein-1 [MIP-1 alpha]), CCL2 (monocyte chemoattractant protein-1 [MCP-1]), CCL11 (eotaxin), and CCL5 (RANTES [regulated on activation, normal T-cell expressed and secreted]) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/68,76\">",
"     68,76",
"    </a>",
"    ], but only the beta-chemokines, particularly MIP-1 alpha, are associated with severe disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/68,76,77\">",
"     68,76,77",
"    </a>",
"    ]. RSV infection of explanted polarized, differentiated respiratory epithelium in tissue culture elicits IL-8 and CCL5 [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/78\">",
"     78",
"    </a>",
"    ], suggesting these epithelium-derived factors may be important for attracting inflammatory cells to the infected lung. Soluble factors associated with severe disease are primarily derived from cells associated with the immune response. It is not fully resolved whether the cytokines and chemokines associated with severe disease are the cause of disease or the byproduct of higher RSV antigen load stimulating a stronger inflammatory response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations vary depending upon the patient's age, health status, and whether the infection is primary or secondary. Infants and young children with primary infections usually present with lower respiratory tract infection ([LRTI] bronchiolitis or pneumonia) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/79\">",
"     79",
"    </a>",
"    ], whereas older children and adults typically have upper respiratory tract symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/80\">",
"     80",
"    </a>",
"    ] or tracheobronchitis but may develop other types of lower respiratory tract illness, particularly if they are elderly (in institutions) or immunocompromised [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Apnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;In infants, respiratory syncytial virus (RSV) can cause significant apnea via unknown mechanisms [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/81\">",
"     81",
"    </a>",
"    ]. RSV has been postulated to alter the sensitivity of laryngeal chemoreceptors and reinforce reflex apnea [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Apnea is the presenting symptom in up to 20 percent of infants admitted to the hospital with RSV [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/83-88\">",
"     83-88",
"    </a>",
"    ] and has been speculated to be associated with sudden infant death syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/89\">",
"     89",
"    </a>",
"    ]. Apnea is more likely to occur in young patients, those born prematurely, those with a history of apnea of prematurity, and those with more severe hypoxemia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/84-87\">",
"     84-87",
"    </a>",
"    ]. The prognosis is unknown. In most infants, apnea does not recur, even with subsequent respiratory infections [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/81,85\">",
"     81,85",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Respiratory disease",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Lower tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;RSV can cause severe lower respiratory tract disease, bronchiolitis, bronchospasm, pneumonia, and acute respiratory failure in children. Lower respiratory tract usually occurs with primary infection and may occur in more than 50 percent of second infections [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/53,79\">",
"     53,79",
"    </a>",
"    ]. Although disease severity diminishes after the third infection, even in healthy adults, about one-fourth have signs of LRTI [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 20 percent of infants develop RSV-associated wheezing during the first year of life; 2 to 3 percent require hospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/16,79\">",
"     16,79",
"    </a>",
"    ]. In addition, wheezing occurs in approximately 80 percent of children hospitalized with RSV bronchiolitis and 50 percent of children with outpatient bronchiolitis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/90\">",
"     90",
"    </a>",
"    ]. The clinical features of bronchiolitis, which may be caused by viruses other than RSV, are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/44/16074?source=see_link&amp;anchor=H7#H7\">",
"     \"Bronchiolitis in infants and children: Clinical features and diagnosis\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Wheezing and shortness of breath have been described in adult patients with and without underlying comorbidities or hyperreactive airways [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/11,15\">",
"     11,15",
"    </a>",
"    ]. Wheezing occurs in approximately 35 percent of elderly patients with RSV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H400085837\">",
"    <span class=\"h4\">",
"     Inappropriate secretion of ADH",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with other types of pulmonary disease, RSV infection of the lower respiratory tract may be associated with inappropriate secretion of antidiuretic hormone (ADH), resulting in hyponatremia, particularly in patients who require mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/91-93\">",
"     91-93",
"    </a>",
"    ]. Hyponatremia also may result from inappropriate administration of hypotonic intravenous fluids to critically ill children. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/46/7913?source=see_link&amp;anchor=H13#H13\">",
"     \"Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)\", section on 'Pulmonary disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/20/21832?source=see_link&amp;anchor=H11#H11\">",
"     \"Evaluation of the patient with hyponatremia\", section on 'Findings in SIADH'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/17/17688?source=see_link\">",
"     \"Treatment of hypovolemia (dehydration) in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Upper tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repeat RSV infections occur frequently in children and young adults and result in significant upper respiratory tract symptoms. Signs include cough, coryza, rhinorrhea, and conjunctivitis. Compared with other respiratory viruses, RSV is more likely to cause sinus and ear involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Comorbid bacterial infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have evaluated the presence of bacteremia or other bacterial infections in previously healthy febrile infants and young children with bronchiolitis or RSV [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/94-99\">",
"     94-99",
"    </a>",
"    ]. As a general rule, the risk for bacteremia or meningitis among febrile infants &lt;60 to 90 days of age with RSV bronchiolitis is low (less than 1 to 2 percent); the risk of urinary tract infection ranges from 1 to 5 percent (lower than that for febrile infants without bronchiolitis, but not neglible) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/94,95,97,98\">",
"     94,95,97,98",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link&amp;anchor=H28#H28\">",
"     \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\", section on 'Concomitant viral infections'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/44/16074?source=see_link\">",
"     \"Bronchiolitis in infants and children: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Clinical course",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical course of bronchiolitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/44/16074?source=see_link&amp;anchor=H16#H16\">",
"     \"Bronchiolitis in infants and children: Clinical features and diagnosis\", section on 'Clinical course'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     PULMONARY SEQUELAE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory syncytial virus (RSV) infection usually is a self-limited process that results in no apparent long-term pulmonary sequelae. However, RSV infection is correlated with recurrent wheezing in some patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Airway reactivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The associations between RSV infection, IgE, atopy, and airway reactivity are subjects of active investigation. A correlation may exist between infection with RSV during infancy and the later development of reactive airways [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/100-105\">",
"     100-105",
"    </a>",
"    ]. As an example, approximately 25 percent of infants with severe RSV infection requiring hospitalization subsequently develop bronchospastic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/106\">",
"     106",
"    </a>",
"    ]. In addition, the prevention of RSV lower respiratory tract infection (LRTI) in premature infants through administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/27/40371?source=see_link\">",
"     palivizumab",
"    </a>",
"    appears to be associated with a decreased incidence of recurrent wheezing episodes in early childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/107\">",
"     107",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Tucson Children's Respiratory Study enrolled a birth cohort with more than 1200 children between 1980 and 1984; more than 900 were still being followed at 13 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/108\">",
"     108",
"    </a>",
"    ]. Among these children, RSV LRTI was associated with an increased risk of wheezing through age six, but the risk decreased with age and was not significant by age 13; an association between severe LRTI and atopy was not found [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/100\">",
"     100",
"    </a>",
"    ]. The magnitude of the specific IgE response at the time of RSV infection may positively correlate with the development of subsequent reactive airway disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/106,109\">",
"     106,109",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study found that only 20 percent of infants with no IgE response developed reactive airway disease [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/109\">",
"       109",
"      </a>",
"      ]. By comparison, 70 percent of infants with a high IgE response had recurrent wheezing.",
"     </li>",
"     <li>",
"      Another study compared the IgE response in children hospitalized with RSV during infancy to the response in a control group [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/106\">",
"       106",
"      </a>",
"      ]. More children in the RSV group had elevated IgE levels (32 versus 9 percent) and subsequently developed reactive airway disease (23 versus 1 percent). RSV bronchiolitis was the strongest predictor of recurrent wheezing.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the only study that has reviewed respiratory morbidity following early RSV infection in young adults, abnormalities in pulmonary function tests (flow-volume spirometry) were more common in young adults who had been hospitalized for RSV during the first two years of life than among control subjects who had no evidence of early RSV infection (44 versus 11 percent), even after adjustment for atopy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    RSV infection in adults also may cause short-term airway reactivity. A study that measured pulmonary function in 10 previously healthy adults who were infected with RSV showed altered airway reactivity eight weeks after infection [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/111\">",
"     111",
"    </a>",
"    ]. All subjects had return of airway resistance to normal levels by four months [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/111\">",
"     111",
"    </a>",
"    ]. How RSV infection affects long-term pulmonary function in adult patients with asthma or chronic obstructive pulmonary disease (COPD) is controversial. One study suggests RSV can be detected in asymptomatic periods between COPD exacerbations [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/112\">",
"     112",
"    </a>",
"    ], and another study detected RSV only during periods of symptomatic respiratory disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/113\">",
"     113",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Immunocompromised patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;RSV pneumonia leading to respiratory failure can be a significant cause of acute morbidity and mortality in the immunocompromised host, with mortality rates of 70 to 100 percent being described in bone marrow transplant patients [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/114,115\">",
"     114,115",
"    </a>",
"    ]. Long-term pulmonary sequelae in these patients have not been adequately studied. However, chronic pulmonary dysfunction as a result of RSV infection does not appear to be a problem in lung or renal transplant patients, as indicated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lung transplant patients showed a return to baseline spirometry five months after RSV infection [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/116\">",
"       116",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pediatric renal transplant patients showed a return to baseline pulmonary function three months after RSV infection [",
"      <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/117\">",
"       117",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Clinical diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the appropriate clinical and epidemiologic setting, diagnosis of respiratory syncytial virus (RSV) infection can be made clinically with reasonable accuracy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/90\">",
"     90",
"    </a>",
"    ]. Clinical features that support the diagnosis include age (&lt;12 months), clinical syndrome (lower respiratory tract disease, particularly bronchiolitis), and epidemiology (winter season, known circulation of RSV). Prior to specific treatment, laboratory confirmation of RSV infection should be obtained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Laboratory diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laboratory diagnosis of RSV is made by analysis of respiratory secretions. In healthy children, a nasal wash usually provides the best yield [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/118\">",
"     118",
"    </a>",
"    ], but a nasopharyngeal swab or throat swab may be adequate if a nasal wash is not possible. In patients who are intubated or are undergoing bronchoscopy, a tracheal aspirate or bronchoalveolar lavage should be obtained. This is particularly true for immune-compromised adults in whom lower respiratory secretions have a higher rate of positivity than nasal secretions [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/10,119\">",
"     10,119",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The standard for definitive diagnosis is isolation of the virus in HEp-2 cells. Identification of typical plaque morphology with syncytium formation and immunofluorescent staining confirms the diagnosis.",
"   </p>",
"   <p>",
"    Rapid assays utilizing antigen capture technology that can be performed in less than 30 minutes are now available. The sensitivity and specificity of most of these tests exceed 90 percent, and they are a mainstay of the diagnostic algorithm in most clinical laboratories, as the identification by culture can take from four days to two weeks.",
"   </p>",
"   <p>",
"    Diagnostic serology is not helpful in infants because of maternal antibody and is not warranted in adults because repeated infections throughout a person's life result in a stable and sustained level of RSV-specific antibody.",
"   </p>",
"   <p>",
"    There are now PCR-based diagnostic technologies that are US Food and Drug Administration (FDA) approved for RSV. They typically are designed as part of a multiplex PCR assay that can detect multiple respiratory pathogens [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/120\">",
"     120",
"    </a>",
"    ]. PCR-based assays are an alternative to culture for confirming the result of rapid antigen detection assay. PCR may be preferred in adult patients in whom the antigen capture assays are less sensitive [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/121,122\">",
"     121,122",
"    </a>",
"    ], and may be more reliable in the setting of passively administered antibody to RSV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of RSV includes parainfluenza virus, metapneumovirus, influenza virus, rhinovirus, coronavirus, human bocavirus, and adenovirus in infants (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/44/16074?source=see_link&amp;anchor=H3#H3\">",
"     \"Bronchiolitis in infants and children: Clinical features and diagnosis\", section on 'Microbiology'",
"    </a>",
"    ); influenza in the elderly; and parainfluenza in immunocompromised patients. In severe cases of RSV bronchiolitis, the possibility of coinfection with other viruses, mycoplasma, or bacteria, including Bordetella pertussis, should be considered [",
"    <a class=\"abstract\" href=\"UTD.htm?6/56/7050/abstract/123-125\">",
"     123-125",
"    </a>",
"    ]. (See appropriate topic reviews.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/10/39074?source=see_link\">",
"       \"Patient information: Bronchiolitis (and RSV) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/19/27958?source=see_link\">",
"       \"Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Respiratory syncytial virus (RSV) causes seasonal outbreaks of respiratory tract illness throughout the world, usually during the winter season. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Seasonality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      RSV causes acute respiratory tract illness in persons of all ages. It is the most common cause of lower respiratory tract infection (LRTI) in children younger than one year, and the most common cause of medically attended LRTI in children younger than five years. Almost all children are infected by two years of age, and reinfection is common. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Morbidity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      RSV has the potential to cause severe LRTI in certain high-risk groups: young, premature infants with chronic lung disease or congenital heart disease; patients with significant asthma; patients who are immunocompromised; and the elderly. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical manifestations vary depending upon the patient's age, health status, and whether the infection is primary or secondary. Infants and young children with primary infections usually present with LRTI. Older children and adults typically have primarily upper respiratory tract symptoms but may develop LRTI, particularly if they are elderly or immunocompromised. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Apnea may be the presenting symptom in approximately 20 percent of infants hospitalized with RSV and may be the cause of sudden unexpected death. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Apnea'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      RSV infection usually is a self-limited process, but it is associated with recurrent wheezing in some patients. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Pulmonary sequelae'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Confirmation of RSV infection requires analysis of respiratory secretions. Rapid antigen testing is confirmed by either isolation of the virus in HEp-2 cells or PCR-based approaches. Nucleic-acid-based diagnostic approaches are more sensitive, particularly in adults. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Laboratory diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of RSV includes parainfluenza virus, metapneumovirus, influenza virus, rhinovirus, coronavirus, bocavirus, and adenovirus. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/1\">",
"      Centers for Disease Control and Prevention (CDC). Respiratory syncytial virus activity--United States, 1999-2000 season. MMWR Morb Mortal Wkly Rep 2000; 49:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/2\">",
"      Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 360:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/3\">",
"      Spence L, Barratt N. Respiratory syncytial virus associated with acute respiratory infections in Trinidadian patients. Am J Epidemiol 1968; 88:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/4\">",
"      Sung RY, Murray HG, Chan RC, et al. Seasonal patterns of respiratory syncytial virus infection in Hong Kong: a preliminary report. J Infect Dis 1987; 156:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/5\">",
"      Cane PA. Molecular epidemiology of respiratory syncytial virus. Rev Med Virol 2001; 11:103.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Respiratory syncytial virus. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th, Pickering LK.  (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.609.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/7\">",
"      Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999; 282:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/8\">",
"      Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J 2012; 31:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/9\">",
"      Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010; 375:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/10\">",
"      Walsh EE, Falsey AR, Hennessey PA. Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med 1999; 160:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/11\">",
"      Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000; 13:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/12\">",
"      Wald TG, Miller BA, Shult P, et al. Can respiratory syncytial virus and influenza A be distinguished clinically in institutionalized older persons? J Am Geriatr Soc 1995; 43:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/13\">",
"      Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/14\">",
"      Falsey AR, Hennessey PA, Formica MA, et al. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/15\">",
"      O'Shea MK, Ryan MA, Hawksworth AW, et al. Symptomatic respiratory syncytial virus infection in previously healthy young adults living in a crowded military environment. Clin Infect Dis 2005; 41:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/16\">",
"      Boyce TG, Mellen BG, Mitchel EF Jr, et al. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 2000; 137:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/17\">",
"      Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr 2003; 143:S118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/18\">",
"      Houben ML, Bont L, Wilbrink B, et al. Clinical prediction rule for RSV bronchiolitis in healthy newborns: prognostic birth cohort study. Pediatrics 2011; 127:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/19\">",
"      Wang EE, Law BJ, Boucher FD, et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1996; 129:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/20\">",
"      Navas L, Wang E, de Carvalho V, Robinson J. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr 1992; 121:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/21\">",
"      Kristensen K, Stensballe LG, Bjerre J, et al. Risk factors for respiratory syncytial virus hospitalisation in children with heart disease. Arch Dis Child 2009; 94:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/22\">",
"      von Linstow ML, H&oslash;gh M, Nordb&oslash; SA, et al. A community study of clinical traits and risk factors for human metapneumovirus and respiratory syncytial virus infection during the first year of life. Eur J Pediatr 2008; 167:1125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/23\">",
"      Bradley JP, Bacharier LB, Bonfiglio J, et al. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 2005; 115:e7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/24\">",
"      Hall CB, Powell KR, MacDonald NE, et al. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 1986; 315:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/25\">",
"      Milner ME, de la Monte SM, Hutchins GM. Fatal respiratory syncytial virus infection in severe combined immunodeficiency syndrome. Am J Dis Child 1985; 139:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/26\">",
"      King JC Jr, Burke AR, Clemens JD, et al. Respiratory syncytial virus illnesses in human immunodeficiency virus- and noninfected children. Pediatr Infect Dis J 1993; 12:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/27\">",
"      El Saleeby CM, Somes GW, DeVincenzo JP, Gaur AH. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age. Pediatrics 2008; 121:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/28\">",
"      Duncan CB, Walsh EE, Peterson DR, et al. Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults. J Infect Dis 2009; 200:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/29\">",
"      Choudhuri JA, Ogden LG, Ruttenber AJ, et al. Effect of altitude on hospitalizations for respiratory syncytial virus infection. Pediatrics 2006; 117:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/30\">",
"      Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis 2004; 189:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/31\">",
"      Choi EH, Lee HJ, Yoo T, Chanock SJ. A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 2002; 186:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/32\">",
"      Hoebee B, Rietveld E, Bont L, et al. Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J Infect Dis 2003; 187:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/33\">",
"      Goetghebuer T, Isles K, Moore C, et al. Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis. Clin Exp Allergy 2004; 34:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/34\">",
"      Hoebee B, Bont L, Rietveld E, et al. Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis. J Infect Dis 2004; 189:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/35\">",
"      Hull J, Rowlands K, Lockhart E, et al. Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus. J Infect Dis 2003; 188:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/36\">",
"      Puthothu B, Krueger M, Forster J, Heinzmann A. Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes. J Infect Dis 2006; 193:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/37\">",
"      L&ouml;fgren J, R&auml;met M, Renko M, et al. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis 2002; 185:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/38\">",
"      Lahti M, Lofgren J, Marttila R, et al. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res 2002; 51:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/39\">",
"      Tal G, Mandelberg A, Dalal I, et al. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 2004; 189:2057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/40\">",
"      Amanatidou V, Sourvinos G, Apostolakis S, et al. T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J 2006; 25:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/41\">",
"      El Saleeby CM, Li R, Somes GW, et al. Surfactant protein A2 polymorphisms and disease severity in a respiratory syncytial virus-infected population. J Pediatr 2010; 156:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/42\">",
"      Hall CB, Walsh EE, Schnabel KC, et al. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis 1990; 162:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/43\">",
"      McConnochie KM, Hall CB, Walsh EE, Roghmann KJ. Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr 1990; 117:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/44\">",
"      Papadopoulos NG, Gourgiotis D, Javadyan A, et al. Does respiratory syncytial virus subtype influences the severity of acute bronchiolitis in hospitalized infants? Respir Med 2004; 98:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/45\">",
"      Walsh EE, McConnochie KM, Long CE, Hall CB. Severity of respiratory syncytial virus infection is related to virus strain. J Infect Dis 1997; 175:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/46\">",
"      Gilca R, De Serres G, Tremblay M, et al. Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons. J Infect Dis 2006; 193:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/47\">",
"      Peret TC, Hall CB, Schnabel KC, et al. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol 1998; 79 ( Pt 9):2221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/48\">",
"      Hall CB, Douglas RG Jr. Modes of transmission of respiratory syncytial virus. J Pediatr 1981; 99:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/49\">",
"      Hall CB, Douglas RG Jr, Schnabel KC, Geiman JM. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun 1981; 33:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/50\">",
"      Hall CB, Douglas RG Jr, Geiman JM. Quantitative shedding patterns of respiratory syncytial virus in infants. J Infect Dis 1975; 132:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/51\">",
"      Hendley JO, Wenzel RP, Gwaltney JM Jr. Transmission of rhinovirus colds by self-inoculation. N Engl J Med 1973; 288:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/52\">",
"      Hall CB, Walsh EE, Long CE, Schnabel KC. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 1991; 163:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/53\">",
"      Henderson FW, Collier AM, Clyde WA Jr, Denny FW. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med 1979; 300:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/54\">",
"      Glezen WP, Paredes A, Allison JE, et al. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981; 98:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/55\">",
"      Stensballe LG, Ravn H, Kristensen K, et al. Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus. J Pediatr 2009; 154:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/56\">",
"      Braciale TJ. Respiratory syncytial virus and T cells: interplay between the virus and the host adaptive immune system. Proc Am Thorac Soc 2005; 2:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/57\">",
"      Peebles RS Jr, Graham BS. Pathogenesis of respiratory syncytial virus infection in the murine model. Proc Am Thorac Soc 2005; 2:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/58\">",
"      Johnson JE, Gonzales RA, Olson SJ, et al. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 2007; 20:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/59\">",
"      Hoffman SJ, Laham FR, Polack FP. Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response. Microbes Infect 2004; 6:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/60\">",
"      Aherne W, Bird T, Court SD, et al. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970; 23:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/61\">",
"      Everard ML, Swarbrick A, Wrightham M, et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 1994; 71:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/62\">",
"      Nadal D, Wunderli W, Meurmann O, et al. Isolation of respiratory syncytial virus from liver tissue and extrahepatic biliary atresia material. Scand J Infect Dis 1990; 22:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/63\">",
"      Zlateva KT, Van Ranst M. Detection of subgroup B respiratory syncytial virus in the cerebrospinal fluid of a patient with respiratory syncytial virus pneumonia. Pediatr Infect Dis J 2004; 23:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/64\">",
"      Fishaut M, Tubergen D, McIntosh K. Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J Pediatr 1980; 96:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/65\">",
"      Rohwedder A, Keminer O, Forster J, et al. Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction. J Med Virol 1998; 54:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/66\">",
"      O'Donnell DR, McGarvey MJ, Tully JM, et al. Respiratory syncytial virus RNA in cells from the peripheral blood during acute infection. J Pediatr 1998; 133:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/67\">",
"      Legg JP, Hussain IR, Warner JA, et al. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003; 168:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/68\">",
"      Garofalo RP, Patti J, Hintz KA, et al. Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis 2001; 184:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/69\">",
"      Tripp RA, Moore D, Barskey A 4th, et al. Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA. J Infect Dis 2002; 185:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/70\">",
"      van Benten IJ, van Drunen CM, Koopman LP, et al. RSV-induced bronchiolitis but not upper respiratory tract infection is accompanied by an increased nasal IL-18 response. J Med Virol 2003; 71:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/71\">",
"      Einarsson O, Geba GP, Zhu Z, et al. Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest 1996; 97:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/72\">",
"      Puthothu B, Krueger M, Forster J, et al. Interleukin (IL)-18 polymorphism 133C/G is associated with severe respiratory syncytial virus infection. Pediatr Infect Dis J 2007; 26:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/73\">",
"      Noah TL, Henderson FW, Wortman IA, et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 1995; 171:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/74\">",
"      Matsuda K, Tsutsumi H, Okamoto Y, Chiba C. Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. Clin Diagn Lab Immunol 1995; 2:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/75\">",
"      Smyth RL, Fletcher JN, Thomas HM, Hart CA. Immunological responses to respiratory syncytial virus infection in infancy. Arch Dis Child 1997; 76:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/76\">",
"      Welliver RC, Garofalo RP, Ogra PL. Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection. Pediatr Infect Dis J 2002; 21:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/77\">",
"      Garofalo RP, Hintz KH, Hill V, et al. A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus. J Med Virol 2005; 75:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/78\">",
"      Mellow TE, Murphy PC, Carson JL, et al. The effect of respiratory synctial virus on chemokine release by differentiated airway epithelium. Exp Lung Res 2004; 30:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/79\">",
"      Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/80\">",
"      Hall CB, Long CE, Schnabel KC. Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis 2001; 33:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/81\">",
"      Rayyan M, Naulaers G, Daniels H, et al. Characteristics of respiratory syncytial virus-related apnoea in three infants. Acta Paediatr 2004; 93:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/82\">",
"      Lindgren C, Jing L, Graham B, et al. Respiratory syncytial virus infection reinforces reflex apnea in young lambs. Pediatr Res 1992; 31:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/83\">",
"      Anas N, Boettrich C, Hall CB, Brooks JG. The association of apnea and respiratory syncytial virus infection in infants. J Pediatr 1982; 101:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/84\">",
"      Bruhn FW, Mokrohisky ST, McIntosh K. Apnea associated with respiratory syncytial virus infection in young infants. J Pediatr 1977; 90:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/85\">",
"      Church NR, Anas NG, Hall CB, Brooks JG. Respiratory syncytial virus-related apnea in infants. Demographics and outcome. Am J Dis Child 1984; 138:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/86\">",
"      Hall CB, Hall WJ, Speers DM. Clinical and physiological manifestations of bronchiolitis and pneumonia. Outcome of respiratory syncytial virus. Am J Dis Child 1979; 133:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/87\">",
"      Arms JL, Ortega H, Reid S. Chronological and clinical characteristics of apnea associated with respiratory syncytial virus infection: a retrospective case series. Clin Pediatr (Phila) 2008; 47:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/88\">",
"      Ralston S, Hill V. Incidence of apnea in infants hospitalized with respiratory syncytial virus bronchiolitis: a systematic review. J Pediatr 2009; 155:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/89\">",
"      Uren EC, Williams AL, Jack I, Rees JW. Association of respiratory virus infections with sudden infant death syndrome. Med J Aust 1980; 1:417.",
"     </a>",
"    </li>",
"    <li>",
"     Hall CB, Walsh EE. Respiratory syncytial virus. In: Textbook of Pediatric Infectious Diseases, 6th ed, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.2462.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/91\">",
"      Eisenhut M. Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review. Crit Care 2006; 10:R107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/92\">",
"      Hanna S, Tibby SM, Durward A, Murdoch IA. Incidence of hyponatraemia and hyponatraemic seizures in severe respiratory syncytial virus bronchiolitis. Acta Paediatr 2003; 92:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/93\">",
"      van Steensel-Moll HA, Hazelzet JA, van der Voort E, et al. Excessive secretion of antidiuretic hormone in infections with respiratory syncytial virus. Arch Dis Child 1990; 65:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/94\">",
"      Levine DA, Platt SL, Dayan PS, et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics 2004; 113:1728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/95\">",
"      Titus MO, Wright SW. Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infection. Pediatrics 2003; 112:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/96\">",
"      Kuppermann N, Bank DE, Walton EA, et al. Risks for bacteremia and urinary tract infections in young febrile children with bronchiolitis. Arch Pediatr Adolesc Med 1997; 151:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/97\">",
"      Bilavsky E, Shouval DS, Yarden-Bilavsky H, et al. A prospective study of the risk for serious bacterial infections in hospitalized febrile infants with or without bronchiolitis. Pediatr Infect Dis J 2008; 27:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/98\">",
"      Ralston S, Hill V, Waters A. Occult serious bacterial infection in infants younger than 60 to 90 days with bronchiolitis: a systematic review. Arch Pediatr Adolesc Med 2011; 165:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/99\">",
"      Purcell K, Fergie J. Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. Arch Pediatr Adolesc Med 2002; 156:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/100\">",
"      Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/101\">",
"      Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161:1501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/102\">",
"      Steyerberg EW, de Groot R, Moll HA. Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review. Acta Paediatr 2000; 89:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/103\">",
"      Hall CB, Hall WJ, Gala CL, et al. Long-term prospective study in children after respiratory syncytial virus infection. J Pediatr 1984; 105:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/104\">",
"      Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005; 171:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/105\">",
"      Henderson J, Hilliard TN, Sherriff A, et al. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol 2005; 16:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/106\">",
"      Sigurs N, Bjarnason R, Sigurbergsson F, et al. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995; 95:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/107\">",
"      Simoes EA, Groothuis JR, Carbonell-Estrany X, et al. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr 2007; 151:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/108\">",
"      Martinez FD. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J 2003; 22:S76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/109\">",
"      Welliver RC, Sun M, Rinaldo D, Ogra PL. Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis. J Pediatr 1986; 109:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/110\">",
"      Korppi M, Piippo-Savolainen E, Korhonen K, Remes S. Respiratory morbidity 20 years after RSV infection in infancy. Pediatr Pulmonol 2004; 38:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/111\">",
"      Hall WJ, Hall CB, Speers DM. Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies. Ann Intern Med 1978; 88:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/112\">",
"      Wilkinson TM, Donaldson GC, Johnston SL, et al. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/113\">",
"      Falsey AR, Formica MA, Hennessey PA, et al. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/114\">",
"      Hertz MI, Englund JA, Snover D, et al. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine (Baltimore) 1989; 68:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/115\">",
"      Whimbey E, Champlin RE, Englund JA, et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995; 16:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/116\">",
"      Wendt CH, Fox JM, Hertz MI. Paramyxovirus infection in lung transplant recipients. J Heart Lung Transplant 1995; 14:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/117\">",
"      Miller RB, Chavers BM. Respiratory syncytial virus infections in pediatric renal transplant recipients. Pediatr Nephrol 1996; 10:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/118\">",
"      Ahluwalia G, Embree J, McNicol P, et al. Comparison of nasopharyngeal aspirate and nasopharyngeal swab specimens for respiratory syncytial virus diagnosis by cell culture, indirect immunofluorescence assay, and enzyme-linked immunosorbent assay. J Clin Microbiol 1987; 25:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/119\">",
"      Englund JA, Piedra PA, Jewell A, et al. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J Clin Microbiol 1996; 34:1649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/120\">",
"      Puppe W, Weigl JA, Aron G, et al. Evaluation of a multiplex reverse transcriptase PCR ELISA for the detection of nine respiratory tract pathogens. J Clin Virol 2004; 30:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/121\">",
"      Casiano-Col&oacute;n AE, Hulbert BB, Mayer TK, et al. Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults. J Clin Virol 2003; 28:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/122\">",
"      Moore C, Valappil M, Corden S, Westmoreland D. Enhanced clinical utility of the NucliSens EasyQ RSV A+B Assay for rapid detection of respiratory syncytial virus in clinical samples. Eur J Clin Microbiol Infect Dis 2006; 25:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/123\">",
"      Greensill J, McNamara PS, Dove W, et al. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg Infect Dis 2003; 9:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/124\">",
"      Crowcroft NS, Booy R, Harrison T, et al. Severe and unrecognised: pertussis in UK infants. Arch Dis Child 2003; 88:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/56/7050/abstract/125\">",
"      Nuolivirta K, Koponen P, He Q, et al. Bordetella pertussis infection is common in nonvaccinated infants admitted for bronchiolitis. Pediatr Infect Dis J 2010; 29:1013.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5994 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-122.72.80.101-2F8DE301F2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7050=[""].join("\n");
var outline_f6_56_7050=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Seasonality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Morbidity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - In children",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - In adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Genetic predisposition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Transmission",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Incubation period",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Immunity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Apnea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Respiratory disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Lower tract",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H400085837\">",
"      Inappropriate secretion of ADH",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Upper tract",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Comorbid bacterial infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Clinical course",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      PULMONARY SEQUELAE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Airway reactivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Immunocompromised patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Clinical diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Laboratory diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/44/16074?source=related_link\">",
"      Bronchiolitis in infants and children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/19/27962?source=related_link\">",
"      Bronchiolitis in infants and children: Treatment; outcome; and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=related_link\">",
"      Evaluation and management of fever in the neonate and young infant (less than three months of age)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/20/21832?source=related_link\">",
"      Evaluation of the patient with hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/46/7913?source=related_link\">",
"      Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/10/39074?source=related_link\">",
"      Patient information: Bronchiolitis (and RSV) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/19/27958?source=related_link\">",
"      Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15640?source=related_link\">",
"      Respiratory syncytial virus infection: Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/27/38327?source=related_link\">",
"      Respiratory syncytial virus infection: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/17/17688?source=related_link\">",
"      Treatment of hypovolemia (dehydration) in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_56_7051="Causes bone excrescences";
var content_f6_56_7051=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F58056&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F58056&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of spinal bony excrescences",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Diffuse idiopathic skeletal hyperostosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spondylitis deformans",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ankylosing spondylitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acromegaly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypoparathyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fluorosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ochronosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Retinoids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        X-linked hypophosphatemic osteomalacia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Utsinger, PD. Diffuse idiopathic skeletal hyperostosis. Clin Rheum Dis 1985; 11:325. Copyright &copy; 1985 W.B. Saunders Company.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7051=[""].join("\n");
var outline_f6_56_7051=null;
var title_f6_56_7052="Electrophysiology in SVTach";
var content_f6_56_7052=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F53347&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F53347&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Electrophysiologic characteristics of the different types of supraventricular tachycardia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Characteristic",
"       </td>",
"       <td class=\"subtitle1\">",
"        Reentrant",
"       </td>",
"       <td class=\"subtitle1\">",
"        Triggered",
"       </td>",
"       <td class=\"subtitle1\">",
"        Automatic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Initiation by extrastimuli and/or continuous pacing",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Initiation by continuous pacing depends upon the rate and number of stimuli",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Termination by extrastimuli",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Termination by continuous pacing (overdrive)",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Overdrive suppression of tachycardia",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Overdrive enhancement of tachycardia",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Entrainment possible",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        First P wave identical to P waves in arrhythmia",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Sometimes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Warm-up or acceleration of pacemaker after onset",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Sometimes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7052=[""].join("\n");
var outline_f6_56_7052=null;
var title_f6_56_7053="Medicines that can cause AIN PI";
var content_f6_56_7053=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F83922&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F83922&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Medicines that can cause acute interstitial nephritis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type of drug&nbsp;and generic name(s)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Brand names in US",
"       </td>",
"       <td class=\"subtitle1\">",
"        Used to treat",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        <strong>",
"         Pain relievers",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Nonsteroidal drugs (also called NSAIDs):&nbsp; examples&nbsp;include&nbsp;ibuprofen, naproxen&nbsp;and diclofenac.",
"        </p>",
"       </td>",
"       <td>",
"        Advil&reg;, Aleve&reg;, Voltaren&reg;, many others",
"       </td>",
"       <td>",
"        <p>",
"         Aches and pains",
"        </p>",
"        <p>",
"         Inflammation",
"        </p>",
"        <p>",
"         Fever&nbsp;",
"        </p>",
"        <p>",
"         Arthritis pain",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Celecoxib",
"       </td>",
"       <td>",
"        Celebrex&reg;",
"       </td>",
"       <td>",
"        Arthritis pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        <strong>",
"         Acid lowering medicines",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cimetidine",
"       </td>",
"       <td>",
"        Tagamet HB&reg;",
"       </td>",
"       <td rowspan=\"3\">",
"        <p>",
"         Heart burn",
"        </p>",
"        <p>",
"         Indigestion",
"        </p>",
"        <p>",
"         Acid reflux",
"        </p>",
"        <p>",
"         Stomach ulcer",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Omeprazole",
"       </td>",
"       <td>",
"        Prilosec OTC&reg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lansoprazole",
"       </td>",
"       <td>",
"        Prevacid 24 hour&reg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        <strong>",
"         Antibiotics",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Penicillins",
"       </td>",
"       <td>",
"        Bicillin&reg;, Pfizerpen&reg;, others",
"       </td>",
"       <td rowspan=\"6\">",
"        Infections",
"        <br/>",
"        <br/>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cephalosporins: examples include cephalexin and cefuroxime",
"       </td>",
"       <td>",
"        Keflex&reg;, Ceftin&reg;, many others",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ciprofloxacin",
"       </td>",
"       <td>",
"        Cipro&reg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trimethoprim-sulfamethoxazole (also called co-trimoxazole)",
"       </td>",
"       <td>",
"        Bactrim&trade; DS, Septra&reg; DS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rifampin",
"       </td>",
"       <td>",
"        Rifadin&reg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Indinavir",
"       </td>",
"       <td>",
"        Crixivan&reg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        <strong>",
"         Diuretics (also called \"water pills\")",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Furosemide",
"       </td>",
"       <td>",
"        Lasix&reg;",
"       </td>",
"       <td rowspan=\"2\">",
"        <p>",
"         Excess fluid in the body",
"        </p>",
"        <p>",
"         Heart failure",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bumetanide",
"       </td>",
"       <td>",
"        Bumex&reg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydrochlorothiazide (also called HCTZ)",
"       </td>",
"       <td>",
"        Microzide&reg;",
"       </td>",
"       <td>",
"        High blood pressure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        <strong>",
"         Ulcerative colitis medicines",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mesalamine (also called mesalazine), balsalazide, sulfasalazine, olsalazine",
"       </td>",
"       <td>",
"        Apriso&trade;, Asacol&reg;, Canasa&reg;, Lialda&reg;, Pentasa&reg;, Roawasa&reg;, Colazal&reg;, Dipentum&reg;",
"       </td>",
"       <td>",
"        Ulcerative colitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        <strong>",
"         Other",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Allopurinol&nbsp;&nbsp;&nbsp;&nbsp;",
"       </td>",
"       <td>",
"        Zyloprim&reg;, Aloprim&reg;",
"       </td>",
"       <td>",
"        Gout",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7053=[""].join("\n");
var outline_f6_56_7053=null;
var title_f6_56_7054="ASCO summary guideline recs";
var content_f6_56_7054=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F75536&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F75536&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Summary of the joint ASCO/CAP guideline recommendations for assessment of HER2 status",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Optimal algorithm for HER2 testing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Positive for HER2 is either IHC HER2 3+ (defined as uniform intense membrane staining of &gt;30 percent of invasive tumor cells) or FISH amplified (ratio of HER2 to CEP17 of &gt;2.2 or average HER2 gene copy number &gt;6 signals/nucleus for those test systems without an internal control probe)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Equivocal for HER2 is defined as either IHC 2+ or FISH ratio of 1.8-2.2 or average HER2 gene copy number four to six signals/nucleus for test systems without an internal control probe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Negative for HER2 is defined as either IHC 0-1+ or FISH ratio of &lt;1.8 or average HER2 gene copy number of &lt;4 signals/nucleus for test systems without an internal control probe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtlist1_start\">",
"        These definitions depend on laboratory documentation of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. Proof of initial testing validation in which positive and negative HER2 categories are 95 percent concordant with alternative validated method or same validated method for HER2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. Ongoing internal QA procedures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3. Participation in external proficiency testing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        4. Current accreditation by valid accrediting agency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Optimal FISH testing requirements",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fixation for fewer than&nbsp;six hours or longer than 48 hours is not recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Test is rejected and repeated if:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Controls are not as expected",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Observer cannot find and count as least two areas of invasive tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &gt;25 percent of signals are unscorable due to weak signals",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &gt;10 percent of signals occur over cytoplasm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Nuclear resolution is poor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Autofluorescence is strong",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interpretation done by counting at least 20 cells; a pathologist must confirm that counting involved invasive tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sample is subjected to increased counting and/or repeated if equivocal; report must include guideline-detailed elements",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Optimal IHC testing requirements",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fixation for fewer than&nbsp;six hours or longer than 48 hours is not recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Test is rejected and repeated or tested by FISH if:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Controls are not as expected",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Artifacts involve most of sample",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Sample has strong membrane staining of normal breast ducts (internal controls)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Interpretation follows guideline recommendation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Positive HER2 result requires homogeneous, dark circumferential (chicken wire) pattern in &gt;30 percent of invasive tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Interpreters have method to maintain consistency and competency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sample is subjected to confirmatory FISH testing if equivocal based on initial results",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Report must include guideline-detailed elements",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Optimal tissue handling requirements",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Time from tissue acquisition to fixation should be as short as possible; samples from HER2 testing are fixed in neutral buffered formalin for 6 to 48 hours; samples should be sliced at 5 to 10 mm intervals after appropriate gross inspection and margins designation and placed in sufficient volume of neutral buffered formalin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sections should ideally not be used for HER2 testing if cut &gt;6 weeks earlier; this may vary with primary fixation or storage conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Time to fixation and duration of fixation if available should be recorded for each sample",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Optimal internal validation procedure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Validation of test must be done before test is offered",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Initial test validation requires 25 to 100 samples tested by alternative validated method in the same laboratory or by validated method in another laboratory",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Proof of initial testing validation in which positive and negative HER2 categories are 95 percent concordant with alternative validated method or same validated method for HER2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ongoing validation should be done biannually",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Optimal internal QA procedures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Initial test validation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ongoing quality control and equipment maintenance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Initial and ongoing laboratory personnel training and competency assessment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use of standard operating procedures including routine use of control materials",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Revalidation of procedure if changed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ongoing competency assessment and education of pathologists",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Optimal external proficiency assessment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Participation in external proficiency testing program with at least two testing events (mailings)/year",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Satisfactory performance requires at least 90 percent correct responses on graded challenges for either test",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Unsatisfactory performance will require laboratory to respond according to accreditation agency program requirements",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Optimal laboratory accreditation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Onsite inspection every other year with annual requirement for self-inspection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Reviews laboratory validation, procedures, QA results and processes, results and reports",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Unsatisfactory performance results in suspension of laboratory testing for HER2 for that method",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     HER2: human epidermal growth factor receptor 2; IHC: immunohistochemistry; FISH: fluorescent in situ hybridization; QA: quality assurance.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Wolff AC, Hammond EH, Schwartz JN. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Onc 2007; 25:1. Copyright &copy; 2007 the American Society of Clinical Oncology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7054=[""].join("\n");
var outline_f6_56_7054=null;
var title_f6_56_7055="Mucosal tag CD";
var content_f6_56_7055=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70350&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70350&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mucosal tag",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 408px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mucosal tag on the buccal aspect of the gingiva of a child with Crohn disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Hardy S, Fleming P, Rowland M, et al. A prospective study of the oral manefestations of Crohn's disease. Clin Gastroenterol Hepatol 2005; 3:886. Copyright &copy; 2005 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_56_7055=[""].join("\n");
var outline_f6_56_7055=null;
